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Defects in the oral cavity, caused from gingival recessions, trauma, chronic infections 
and oral cancer, have demonstrated a great challenge to treat because of the limitation 
of donor oral tissue. Oral mucosa tissue engineering is a science that aims to engineer 
a three-dimensional oral mucosa able to reconstruct the native oral mucosa tissue to 
treat defects in the oral cavity. Within the tissue engineering field biomaterials are 
used, called scaffolds, to support and promote the cell growth. Until now, no synthetic 
scaffolds have been used for oral mucosa tissue engineering clinically. Thus, the aim 
of this thesis was to develop synthetic poly(glycerol sebacate urethane) (PGSU) 
scaffolds that mimic the native oral mucosa’s structure for potential oral mucosa tissue 
graft. 
Large three-dimensional PGSU scaffolds were successfully fabricated, 
demonstrating high porosity and water permeability. The freeze drying protocol was 
characterised, illustrating that the pore size, pore structure and mechanical properties 
can vary significantly between different protocols. However, the porosity and water 
permeability were not affected by the freeze drying protocol. The scaffolds were 
sterilised and found that these scaffolds were not affected by the sterilisation method, 
however, the microstructure and mechanical properties of the scaffold were not 
suitable for tissue engineering oral mucosa tissue. 
To optimise both the microstructure and mechanical properties of the scaffold the 
polymer concentration was altered and the freeze drying technique improved. It was 
found that the pore size and porosity of the scaffolds could be closely controlled using 
these techniques which led to the generation of scaffolds with improved mechanical 
properties. The scaffolds made with higher polymer concentration had smaller pore 
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sizes and porosity but higher mechanical properties. The enhanced mechanical 
properties of the scaffolds were closer to the oral mucosa’s biomechanical properties 
and it was demonstrated that the shape and strength of the scaffolds can be recovered 
after loading. During in vitro cell culture the cell metabolic activity significantly 
increased over time and the microstructure did not affect the metabolic activity but did  
affect the cell distribution. The cells could not penetrate the smaller pore size 
scaffolds; therefore the cell distribution was poor. Cells deposited significantly more 
collagen in scaffolds with higher porosity compared to those which were less porous 
during in vitro cell culture. 
In the final chapter more complex scaffold structures were fabricated by combining 
freeze drying, mould technology and airbrushing fabrication techniques. Novel PGSU 
isotropic, anisotropic and hierarchical multilayer scaffolds were developed by altering 
the freeze drying mould while a two-layer scaffold with a layer that mimics the 
basement membrane of the oral mucosa was generated using airbrushing. The 
basement membrane-like layer of the scaffold successfully acted as a cell barrier with 
limited infiltration from the epithelium layer and a multilayer epithelium was evident 
after co-culture with oral fibroblasts. The collagen production from the multilayer 
scaffold was higher than the one-layer scaffolds characterised previously in this study. 
In this thesis we fabricated a synthetic, elastomeric, biomimetic PGSU scaffold 
with potential to be used in oral mucosa tissue engineering and other areas of soft 
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Chapter 1 Literature Review 
1.1. Introduction 
Tissue Engineering (TE) is a multidisciplinary field, aiming towards regenerating or 
replacing disordered and malfunctioned tissues or organs [3]. This field is based on 
the ability of the cells to adhere, migrate, proliferate and metabolise to a specific tissue 
in vivo and in vitro. In addition, a synthetic and/or biological biomaterial, known as 
scaffold, is used to provide the cells with a three-dimensional (3D) structure for the 
cells to be seeded within their structure and apply their physiological/biological 
ability. The cells will then start developing their extra cellular matrix which will 
replace the biodegradable scaffold [4]. Both cells and scaffold have been and still are 
under extensive research on how they affect the tissue generation and the method that 
the cell seeded scaffold is being cultured in vitro is of critical importance. Both 
parameters, cells and scaffold, depend on the tissue that is being engineered, because 
dissimilar tissues are constructed with different cells, different structure and under 
different biological environment. In this project the focus is on oral mucosa tissue 
engineering (OMTE). The development of a tissue engineered oral mucosa will aid in 
replacing soft tissue defects found in the oral cavity such as gingival recessions or 
defects resulting from trauma, chronic infections and oral cancer. Treating wounds in 
the oral cavity has been a challenge due to limitation of donor oral tissue. Since this 
science aims to replace dysfunctional or damaged organs, it is of critical importance 
to mimic the properties of the native tissue. The optimum objective of multiple 
research groups is to engineer a 3D oral mucosa able to reconstruct the native oral 





mechanically stable is necessary. This project will investigate a polymer based on 
poly(glycerol sebacate) (PGS) because of its physical and biological properties.  
1.2. Oral mucosa 
1.2.1. Structure of oral mucosa 
Oral mucosa is the lining of the oral cavity. It consists of a thick stratified squamous 
epithelium that overlies the lamina propria, which is attached at the basement 
membrane. The epithelium functions by protecting the underlying tissue from 
mechanical damage as it can withstand considerable friction [5]. The lamina propria 
is comprised of fibroblasts, capillaries, inflammatory cells and extra cellular matrix 
(ECM), and it functions by providing resistance to tear and compression forces 
maintaining the integrity of the tissue. The native structure of oral mucosa is shown in 
Figure 1.1, along with histology images of human oral mucosa and a tissue engineered 
oral mucosa made using de-epithelialised dermis (DED). Another important function 
of oral mucosa is that when injured it produces antimicrobial peptides called defensins, 
not allowing the entry of microorganisms and toxic substances into the body [6]. Oral 
mucosa at different regions of the oral cavity has different properties, for example, 
more strength is required at the hard palate and gingiva, and more elasticity at lips, 
cheek and floor of the mouth. Additionally, depending on the function of the region, 
the epithelium of oral mucosa is keratinised (masticatory mucosa), non-keratinised 
(lining mucosa) or both (specialised mucosa) for example the dorsum of the tongue.  
The keratinisation is there to give extra protection against abrasion during eating, and 
it is found on gingiva, hard palate and the dorsum of the tongue. The non-keratinised 








1.2.2. Ultrastructure of oral mucosa 
The epithelium of oral mucosa is composed by different cell layers that have various 
degrees of differentiation called basal layer, spinous layer, granular or intermediate 
layer (keratinised or non-keratinised epithelium) and keratinised layer [8]. The cells 
within the basal layer of the epithelium are responsible for cell division and 
production. These cells are the smallest ones and least differentiated forming one or 
two layers in the epithelium. While the cells differentiate, they move to the spinous 
layer where they increase in size and change shape obtaining more desmosomes and 
keratin filaments. For the granular or intermediate layer the cells are flattened and have 
a high percentage of keratin filaments [8]. Again, depending on the location of the oral 
mucosa the epithelium’s thickness is different. The mucosa lining the cheek has the 
Figure 1.1: Schematic of the general structure of oral mucosa; A) histological sample of oral mucosa taken from 
human patients and B) tissue engineered oral mucosa constructs using de-epithelialised dermis [2]. (ECM = 






thickest epithelium, 540 ± 90 μm, where the thickness of the hard palate and the floor 
of the mouth is 310 ± 50 μm and 190 ± 40 μm respectively [9]. 
The basement membrane is the location where the epithelium and the lamina 
propria attach. The epithelium is attached by hemidesmosomal attachment of the basal 
cells to a basal lamina, where the lamina propria is attached by anchoring fibrils 
(collagen VII) to collagen fibres of lamina propria [9]. Its functionality is to orchestrate 
growth factor-mediated extracellular communication, cellular adhesion, migration and 
differentiation [10]. The basement membrane consists of two layers, the lamina lucida 
and lamina densa, shown in Figure 1.2. The lamina lucida is responsible for cell 
attachment and acts as a permeability barrier, whereas lamina densa is responsible for 
structure support [11]. Lamina lucida is 15 – 65 nm thick and is mainly composed of 
laminin, a large asymmetric molecule containing three A chains and one B chain, that 
facilitates cell attachment [11, 12]. The lamina densa is 15 – 125 nm thick and is 
mainly composed of proteoglycan and collagen IV, which proteoglycan blocks the 
passage of some anionic macromolecules and collagen IV provide the basic scaffold 
of the basement membrane [11-13]. The effect that fibroblasts have on the basement 
membrane formation was studied in Ghalbzouri et al. [14] and they showed that 
fibroblasts induced the expression of a great variety of basement membrane proteins, 
including collagen IV and laminin [14]. Furthermore, it was found that laminin is 
expressed by keratinocytes only when fibroblasts are present, signifying the 






Figure 1.2: Schematic of the epidermal basement membrane. Adapted from Stanely et al. [11] with permission 
from Elsevier, copyright 1982. 
Last, the lamina propria is comprised of fibroblasts and occasionally macrophages, 
plasma cells, mast cells and lymphocytes [15]. The fibroblasts function by producing 
collagen type I, III, V and VI fibres [8]. 
1.2.3. Biomechanical properties of oral mucosa 
Oral mucosa tissue is subjected to a variety of mechanical forces such as compression, 
elongation, friction and hydrodynamic forces. These forces are generated by normal 
everyday actions, including mastication, teeth brushing, speech and saliva flow. These 
mechanical properties are dependent on the location of the mucosa. There is limited 
descriptive analysis published describing the biomechanical properties of oral mucosa. 
However, Goktas et al, have investigated the mechanical behaviour of porcine oral 
soft tissues, that morphologically and histologically resemble human oral soft tissue 
[16]. They showed that the attached gingiva, which is firmly attached to the underlying 
cementum and alveolar bone, is significantly stiffer and has higher resistance to stress, 
than in other regions. This occurs because the attached oral mucosa is keratinised. 
Table 1.1, shows the biomechanical properties obtained from the above-mentioned 





lingual and buccal mucosae mentioned in the table. The highest ultimate tensile 
strength (UTS) and Young’s modulus is found on buccal attached gingiva (3.94 ± 1.19 
MPa and 19.75 ± 6.20 MPa respectively) which is located at the side gum. The lowest 
UTS and Young’s modulus (1.06 ± 0.10 MPa and 2.48 ± 0.37 MPa respectively) is 
observed on buccal mucosa, the tissue located immediately adjacent to the side lips. 
Table 1.1: The tensile properties and stress relaxation data obtained from Gakto et al. studying Porcine Oral Soft 
Tissue [16]. The results are shown as mean ± SD at n=9. 
Region 



























8.93 ± 2.06 1.29 ± 0.19 5.74 ± 1.15 0.21 ± 0.02 0.09 ± 0.01 
Buccal 
mucosa 






1.2.4. Reconstruction of oral mucosa defects 
1.2.4.1. Graft source  
Usually to reconstruct oral mucosa defects, transplants obtained from the inner cheek 
and the palate are used [17]. The transplantation is done by firstly dissecting the 
diseased or injured mucosa using CO2 gas laser and then securing the transplants onto 
the defect using 7-0 nylon sutures [18]. However as mentioned previously the oral 
tissue is limited in size and quantity, hence when extensively needed, skin tissue and 
intestinal mucosa are commonly used. Using this alternative grafts has two 
disadvantages, the donor site morbidity and negligible assimilation [19]. This 
assimilation occurs because of the difference between properties of the skin and oral 
mucosa, such as the pattern of keratinisation and hair growth [20]. These 
disadvantages produced the need of an alternative defect reconstruction approach, 
which tissue engineering researchers are currently investigating. 
1.2.4.2. Epithelial cell sheet engineering 
Following success of epidermal cell sheets fabricated for skin defects, researchers 
started applying similar techniques to grow oral epithelial cell sheets in vitro. Cell 





sheet engineering is a TE methodology without using a scaffold. There are multiple 
techniques for oral mucosa cell sheet engineering; the most popular are culturing on 
amniotic membranes (AM), on collagen membranes and on temperature responsive 
culture dishes [18, 21, 22]. 
Amniotic membrane attracted a high interest as a cell culture substrate. It was found 
multiple times that it can excellently facilitate in vitro cell proliferation, differentiation 
and functional organisation [18]. AM is a thin parenchymal tissue that surrounds the 
surface of placenta, that has distinctive characteristics such as anti-infection and anti-
inflammatory properties [23, 24]. It was used as a cell culture substrate by Amemiya 
et al. [18]. They cultured oral mucosal epithelial cells and they used them as grafts to 
five patients. A 12-month follow-up study showed good cell differentiation and the 
cells had stratified from five to seven layers. This indicates that AM based epithelial 
cell sheets can be a useful method for oral mucosa reconstruction [18], however, more 
research is necessary. 
The epithelial cell sheets, made from any of the above cell culture substrates, have 
the great advantage of having high regenerative capabilities allowing a rapid healing 
without forming a scar [25]. It has been reported that epithelial sheets were formed in 
12 days and maintained in vitro for 30 days [26]. Results obtained from clinical trials 
were again successful in accelerating healing of oral mucosa defects having a smooth 
keratinised region. For example, a cultured epithelial sheet was used to cover the 
mouth floor after partial resection due to tongue cancer, and 10 days after normal oral 
mucosa was formed [20]. In another study, epithelial cell sheets cultured in vitro for 
14 days with autologous oral cells were used to transplant on the palatal mucosa, and 





further evaluated 3 months after transplantation. Additionally, in both studies 
mentioned no infections or scar contractions were found [20, 27]. 
Nevertheless, the epithelial cell sheets have a disadvantage of being fragile, making 
them difficult to handle and not possible to fill deep defects [28]. Therefore, 
bioengineers moved on to developing 3D oral mucosa equivalents. 
1.2.4.3. 3D Tissue engineered oral mucosa 
3D tissue engineered grafts are usually fabricated using a scaffold seeded with oral 
keratinocytes and fibroblasts. In this case these 3D models can fill deep defects, 
resembling the complex structure of the oral mucosa’s native tissue, having 
epithelium, lamina propria and a basement membrane between them, high degree of 
differentiation and ability to histologically assess the tissue development process [29]. 
These 3D tissue engineered grafts are substantially superior in terms of their tensile 






strength compared to the epithelial cell sheets mentioned previously, which can be 
seen comparing Figure 1.4 and Figure 1.5. 
Multiple scaffolds have been used for reconstructing full-thickness oral mucosa, 
including animal dermis, acellular cadaver dermis from human skin and synthetic 
polymeric scaffolds [28, 30-32]. The animal dermis and cadaver scaffolds lacked 
fibroblasts, and this affected the lamina propria development. Additionally, it was 
found that fibroblasts promote epithelial cells to grow and differentiate, along with the 
formation of a basement membrane [29, 33]. An in vivo study has been attempted by 
Ophof et al. [34] using acellular dermis and autologous epithelial cells, transplanted 
in dogs. During their study they concluded that probably due to insufficient 
vascularisation of the graft the healing was not better compared to control incisions. 
A clinically successful tissue engineered oral mucosa graft was demonstrated by Izumi 
et al [1]. Their ex vivo produced oral mucosa equivalent (EVPOME) was composed 
using AlloDerm® (or allogenic human acellular dermis) with autologous epithelial 
cells, shown in Figure 1.5. The result was better and faster healing compared to 
AlloDerm® alone. Non-keratinised oral mucosa was also developed using epithelial 
cells isolated from the cheek based on collagen-glycosaminoglycan-chitosan scaffold 
Figure 1.5: Ex vivo produced oral mucosa equivalent (EVPOME) illustrating its tensile strength. Adapted  from  





[35]. They demonstrated that a 9-10 layers thick epithelium was developed under 
specific culture conditions, which were 7 days culture with their sample fully 
submerged in media followed by 14 days culture at the air-liquid interface [35]. They 
also concluded that this biomimicity was obtained because of the interaction between 
fibroblasts of lamina propria and epithelial cells of oral mucosa.  
These full thickness oral mucosa equivalents have also been used for in vitro 
cytotoxicity testing of oral care products, and even for urethral reconstruction with 
successful results [36, 37]. Another study aiming to generate a tissue engineered oral 
mucosa equivalent, compared three different commercially available scaffolds, 
Tissufoil E (collagen membrane from purified collagen I), dermal regeneration 
template (porous matrix of fibres made from crosslinked bovine tendon collagen and 
glycosaminoglycan) and Vicryl (woven polyglycin which is the copolymer of 
glycolide and lactide) [38]. To test these scaffolds, they cultured human oral cells, 
keratinocytes and fibroblasts, up to 20 days and examined the tissue development 
using histology and immunohistochemistry. They concluded that the dermal 
regeneration template scaffold was more suitable for generating an oral mucosa tissue 
equivalent, due to better combination of fibroblast cell growth and keratinocytes 
stratification [38]. Aiming to develop a full-thickness oral mucosa model for 
biological assessment of dental biomaterials, Moharamzadeh et al. [30] compared the 
suitability of 10 different scaffolds (shown in Table 1.2 below) evaluating their 
biocompatibility, biostability, porosity, and ability to mimic native oral mucosa 
morphology. Their conclusions were that collagen-glycosaminoglycan-chitosan 
(CGC) scaffold demonstrated a differentiated and reproducible oral mucosa model 






Table 1.2: Summary of the results from the scaffolds tested in Moharamzadeh et al. [30]. PET = Poly(ethylene 
terephthalate) membrane (pore size 3.0 μm); PC = Polycarbonate membrane (pore size 3.0 μm); PLLA = Poly L-
lactic acid scaffold; PS = Polystyrene scaffold; CGC = Collagen-glycosaminoglycan-chitosan scaffold. Adapted 
by permission from Moharamzadeh et al. [30]: Springer Nature, copyright 2007. 
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Simsek et al. [39], fabricated three synthetic scaffolds and compared them with 
natural dermis (Euroskin). Using electrospinning they fabricated scaffolds composed 
of either microfibrous poly(lactic acid) (PLA); nanofibrous poly(3-hydroxybutyrate-
co-3-hydroxyvalerate) (PHBV); and a micro-/nanofibrous trilayer of PLA-PHBV-
PLA. These three synthetic scaffolds and Euroskin were seeded with oral 
keratinocytes and fibroblasts and in terms of metabolic activity there was no 
significant difference between them during the 28 days in vitro cell culture [39]. They 
concluded their work by suggesting that their trilayer (PLA-PHBV-PLA) scaffold 
presented a good alternative to allodermis because it was suitable for oral keratinocyte 
and fibroblast growth with good cell viability and minimal contraction as well as it 
had good mechanical properties [39]. 
Due to large similarities of oral mucosa and skin (Figure 1.6) it is worth mentioning 
some of the advances in skin TE. Skin is the largest organ of the human body. Its 
functionality is to protect the human body from the surrounding environment by 
forming a barrier that keeps pathogens and microorganisms from entering the body 
[40]. The majority of skin TE applications are involved into healing acute and chronic 
wounds [41]. Due to its role the skin tissue is constantly exposed to microbes, thermal 





epidermis, dermis and hypodermis. The epidermis is separated by a basement 
membrane from the dermis, and has a compact surface to permit water retention and 
reduce dehydration as well as protect itself from infection [42]. Skin tissue and oral 
mucosa have similar functions and epithelial structure. Both function as a protective 
barrier and are comprised from a stratified squamous epithelium and an underlying 
connective tissue. The oral mucosa has higher concentration of vasculature and 
permeability compared to skin and there is an absence of hair follicles and sweat 
glands [6]. The mechanical properties and cell architecture of the oral mucosa vary 
according to its location and functionality [6]. 
Developing scaffolds for skin tissue engineering is one of the most researched areas 
in tissue engineering [43-45]. Poly (ethyleneglycolterephthalate)- poly (butylene 
terephthalate) (PEGT/PBT) co-polymer was used in skin tissue engineering [45]. This 
biodegradable scaffold showed good mechanical properties, however the seeding of 
the scaffold was not ideal and fibroblast-populated collagen or fibrin was required to 
seed into the pores of the scaffold. To compare natural and synthetic dermal matrices 
a dermal scaffold composed of knitted poly(lactic-co-glycolic acid) (10:90)-poly(ε-
caprolactone) (PLGA-PCL) mesh was fabricated. Human dermal fibroblasts were 
cultured on it for over 3 weeks. The synthetic mesh has demonstrated a better cell 
distribution and tissue formation compared to three natural scaffolds, equine collagen 
foam (TissuFleece®), acellular dermal replacement (Alloderm®) and chitosan 
scaffold. From these results they showed that physical characteristics such as porosity 







Figure 1.6: Schematic of oral mucosa and skin demonstrating the similarities between tissue layers. Adapted from 
Evans et al. [47] with permission from Elsevier, copyright 2017. 
1.3. Scaffolds in tissue engineering 
From the previous sections it was understood that the success of oral mucosa TE is 
somehow depended on the scaffold and its properties. Therefore, understanding 
individually each scaffold property is important when developing scaffolds for TE. 
1.3.1. General properties 
Several biomaterials have been used to produce scaffolds for TE and researchers have 
developed skin [45], oral mucosa [35], cartilage and bone [48], blood vessels [49], 
bladder [50], pancreas [51], nerves [52], adipose tissue [53] and various other soft 
tissues using synthetic, natural or combination scaffolds. All these scaffolds are 
designed so they possess the following properties:  





This property is a primary criterion that all scaffolds should have. The scaffolds should 
be biocompatible without causing any toxic and inflammatory effects in vivo, promote 
cell adhesion, cell-biomaterial interaction and ECM deposition. The term 
biocompatible biomaterial has been changing over the past 50 years because it depends 
heavily on the intended application of the biomaterial. The 1st generation definition of 
biocompatibility was that a material is biocompatible when the material is less reactive 
chemically [54]. The 2nd generation definition of biocompatibility was derived after 
realising that (i) the response to specific materials could vary from one application site 
to another; (ii) sometimes the material should react with the tissue rather than be inert; 
and (iii) some applications required the material to be biodegradable. Therefore, they 
defined biocompatibility as “Biocompatibility refers to the ability of a material to 
perform with an appropriate host response in a specific situation” [54]. This definition 
was adequate to define both 2nd and 3rd generation biomaterials that included materials 
that could mimic physical and biological properties of tissues. However, due to the 
emergence of multiple uses of biomaterials (e.g. regenerative medicine, drug delivery, 
gene delivery etc) a new definition of biocompatibility has been proposed from 
Williams [54] stating that “Biocompatibility refers to the ability of a biomaterial to 
perform its desired function with respect to a medical therapy, without eliciting any 
undesirable local or system effects in the recipient or beneficiary of that therapy, but 
generating the most appropriate beneficial cellular or tissue response in that specific 
situation, and optimising the clinically relevant performance of that therapy” [54]. 
ii) Biodegradable 
As mentioned earlier, the scaffolds provide a temporary structure to the cells allowing 
them to produce their own ECM to replace it. Therefore, it should be biodegradable, 





iii) Mechanical properties 
The scaffold should also be mechanically stable to be manipulated during surgical 
implantation. Additionally, it is beneficial when the scaffolds have mechanical 
properties similar to native tissues and are strong enough to withstand in vivo dynamic 
forces as for some tissues these forces are significantly strong, such as cartilage and 
bone. 
iv) Scaffold architecture 
The scaffold architecture is one of the most important aspects to consider in tissue 
engineering, because the structure of the scaffold is what will allow the cell penetration 
and survival. There are four characteristics that are considered when characterising the 
scaffold architecture; pore size, pore shape, porosity and pore interconnectivity. These 
four characteristics work together to allow adequate transportation of nutrients, gas 
and wastes essential for cell viability, proliferation and differentiation 
v) Reproducible 
The fabrication technique and the biomaterial should be reproducible and cost 
effective to allow this scaffold to be clinically and commercially viable. 
Many if not all of the above mentioned properties that a scaffold should possess are 
affected by the biomaterial and fabrication method. Therefore, understanding the 
advantages and disadvantages of each available material and fabrication methods is of 
critical importance. 
1.3.2. Scaffold characterisation 
Characterising the scaffold is a necessity to successfully engineer a tissue. The 
characterisations required to fabricate 3D scaffolds that meet the properties mentioned 





d) interface adherence and biocompatibility, e) biodegradation, and f) mechanical 
properties [55]. 
1.3.2.1. External morphology 
Beginning with the external geometry, as in most cases the scaffold should be 
mimicking the ECM structure and properties. The key role of ECM is to provide 
structural support and stability of the tissue. The same applies for the scaffold. 
Fabricating scaffolds, designing them with micro- and nano- scale architectures, has 
attracted high attention from tissue engineers, as this preciseness mimics the native 
ECM geometrical structure. Synthetic materials allow a versatile variety of external 
geometry characteristics to be produced. Most importantly a scaffold should be highly 
porous, with interconnected pores, have a high surface density; and high surface-to-
volume ratio to promote cell attachment and proliferation [55]. 
1.3.2.2. Surface properties 
Surface properties involve the chemical and topographical characteristics of the 
scaffold which control the cell adhesion and proliferation [56, 57]. The surface of the 
scaffold is the site where the cells first interact, and since the proliferation of most 
cells used in TE is dependent on anchorage the scaffold’s surface should allow their 
attachment. Studies have shown that cell adhesion always follows protein adsorption 
[58]. Surface chemistry affects the protein adsorption significantly, and there is a large 
number of functional groups that were characterised for cell adhesion, such as 
hydroxyl, carboxylic acid and amine groups [59, 60]. They used self-assembling 
monolayers (SAM) terminated with different functional groups to study the cell 
interaction. SAM are highly ordered surface coatings that can be coated on specific 
substrates [57]. Using human fibroblasts the carboxylic acid terminated SAM had 





used SAM terminated with multiple functional groups and they found that human 
fibroblast adhered significantly better on the SAM terminated with amine groups as 
opposed to hydroxyl groups [57, 60].  The surface properties can be altered using 
surface chemical gradient, SAM, surface-active bulk additive and surface chemical 
reaction [57]. The properties that can be altered by surface modification are 
hydrophobicity/hydrophilicity, the ability to form covalent bonds and the formation of 
protective barriers. These modifications will then allow the control and improvement 
of cell adhesion, the bonding of reactive components and the cell response, making 
the scaffold more biocompatible allowing the cells to recognise it [61]. In most cases, 
immobilising the surface with biomolecules favours the functionality of the scaffold 
in TE. For example, the tri-amino acid arginine-glycine-aspartate (RGD) peptide has 
been used to direct cell attachment on multiple biomaterials (PEG [62], 
polycaprolactone [63], PLGA [64], polyurethane [65], collagen [63] and fibrin [66]) 
due to its functionality which is the principal integrin-binding domain within ECM 
proteins [67]. Additional biomolecules can be fibronectin, collagen and growth factors 
such as epidermal growth factors (EGF), basic fibroblast growth factors (bFGF) and 
insulin. Usually these biomolecules can be covalently attached, self-assembled or 
electrostatically absorbed on the scaffold’s surface [68]. 
1.3.2.3. Scaffold architecture: Pore size, shape, porosity and interconnectivity 
While designing a scaffold for TE, characterising its porosity and pore size is 
important. A highly porous scaffold with interconnected pores will allow uniform cell 
distribution after seeding, cell ingrowth and enable neovascularisation [69]. While 
characterising the porosity of the scaffold, the characteristics that need to be examined 
are pore size and distribution, pore interconnectivity, pore volume, pore shape and 





size affects tissue regeneration. There is a large degree of variation in the values found 
to be most effective, but examples include studies which show, that a pore size of 5 
μm is optimum for neovascularisation [71], 5-15 μm for fibroblast growth  and 20-125 
μm for regeneration of adult mammalian skin [72]. Chitosan scaffolds were fabricated 
with multiple pore sizes and porosities to characterize the effect that they have on 
fibroblasts [73]. The range of the pore size that these scaffolds exhibited was between 
80 – 400 μm and it was found that the scaffolds with ~190 μm and ~87% porous had 
the highest cell metabolic activity during a 56 days cell culture [73]. These results are 
contrary to the collagen-glucosaminoglycan scaffolds with pore sizes 5-15 μm that 
were found optimum for fibroblast growth [72] which indicate that maybe the material 
used has an effect as well. In addition, poly(l-lactic acid) scaffolds were fabricated 
with pore sizes ranging from 38 - 150 μm and 90% porous, and when seeded and 
cultured with fibroblasts it was found that the scaffolds with 106 – 150 μm had the 
highest metabolic activity but the lowest ECM deposition, which the highest was 
exhibited from the scaffold with <38 μm pores [74]. Regarding neovascularisation, a 
study performed by the author of this thesis and others, demonstrated that the optimum 
pore size and porosity for angiogenesis and tissue ingrowth was 26.5 μm and 96 % 
[75, 76]. Concerning pore shape, a study fabricated hydroxyapatite scaffolds with 4 
different pore shapes (triangular, square, hexagonal and circular) aiming to investigate 
their effect on tissue growth. It was found that two geometrical parameters of the pore 
can affect the kinetics of tissue growth; the pore surface area (related to its perimeter) 
and the curvature of the pore [77]. For triangular, square and hexagonal shapes the 
tissue growth began from inside the angles of the pore to form a round central opening, 
whereas for the circular shaped pores the growth was simultaneous from the perimeter 





the importance of the pore size and shape the interconnectivity plays a crucial role 
because cells need to be within 200 μm from blood supply in order to allow gas and 
nutrient exchange [78]. In addition to this, for oral mucosa tissue engineering the 
lamina propria and epithelium need to be separated into two distinct layers.  
 
Figure 1.7: (a) Images of tissue development in three-dimensional matrix channels. Actin stress fibres were stained 
with phalloidin-FITC and visualised using confocal microscopy. (i) Triangular (ii) Square (iii) hexagonal and (iv) 
circular shape. (b) shows with red doted lines the tissue development at three time point (1 = early time point and 
3 = latest time point). Adapted from Rumpler et al. [77] with permission from Royal Society, copyright 2008. 
1.3.2.3.1. Mimicking basement membrane matrices 
The basement membrane functions by separating the tissue layers, and in oral mucosa 
the lamina propria from the epithelium. It is structured in such way (low pore size and 
porosity) that allows gas and nutrient exchange but does not allow cell penetration. 
Therefore, although the porosity of the scaffold promotes the fibroblast ingrowth, in a 
recent study a porous surface for the epithelial side resulted into keratinocyte invasion 
into the scaffold forming epithelial islands within it [30]. To address this issue, they 
used cell culture inserts to laminate the scaffold with Matrigel™, obtaining a 
controllable epithelium size and high accuracy in terms of reproducibility. Matrigel™ 





1000 proteins mainly by laminin, collagen IV, heparin sulphate proteoglycans and 
entactin, which forms a 3D gel under 37oC that supports cell differentiation, growth 
and morphogenesis [79, 80]. It has been used before as a BM-like structure for 
oncogenesis [81], epithelial morphogenesis [82] and intestinal organoids generation 
[83]. Laminin has also been used as BM-like matrix for 2D and 3D culture system, 
more specifically laminin-111 which can be isolated from mouse sarcoma cells [84]. 
The limitations of these natural BM-like matrices are reproducibility (composition and 
structure variability) and mechanical properties [80]. These limitations decrease the 
reliability of these natural matrices and renders them unsuitable for clinical use. 
Synthetic hydrogels made from poly(acrylic acid) (PAA) [85], poly(ethylene 
glycol) (PEG) [86] and poly(vinyl alcohol) (PVA) [87] have been fabricated to 
replicate a BM-like matrix . Hydrogels are defined as hydrophilic, water-swollen 
polymeric network, crosslinked either though covalent bonding or non-covalent 
interactions that involve hydrogen bonds, ionic interactions or polymer crystallites 
[88, 89]. The reasoning behind using synthetic hydrogels is first they closely resemble 
natural BM-like matrices such as Matrigel in terms of physical properties, but most 
importantly because biofunctional molecules can be loaded to enhance the epithelial 
cell attachment as well as proliferation, differentiation and migration [84]. For 
example, a photocurable PVA hydrogel has been modified with cell adhesion peptides 
to induce fibroblast proliferation and ECM production [90]. Another study, developed 
a hydrogel scaffold made from PEG to analyse disease development and drug 
screening. Puperi et al., developed a system were the PEG hydrogel had localised 
adhesive ligands and it was shown that cell specific adhesion could be organised 





fabricate multilayer scaffolds to facilitate cell co-culture, using additive manufacturing 
[92] and layering techniques [93]. 
Despite the advances in cell co-culture, and mimicking the native ECM structure, 
the BM-like matrices and scaffolds fabricated until now were used to understand cell 
to cell interaction, disease development or drug screening but not to replace a 
dysfunctional or damaged tissue. However, a study published by Bye et al. [94], 
developed two-layer electrospun scaffolds using poly(hydroxybutyrate-co-
hydroxyavalerate) (PHBV) and PLA or PCL. The aim of this study was to demonstrate 
the procedure of fabricating thicker electrospun scaffolds by building the scaffold 
layer by layer and at the same time to function as BM and separate the cell layers for 
co-culture [94]. The scaffolds were seeded with human dermal fibroblasts and the cells 
were restricted within the seeded layer [94]. 
1.3.2.4. Degradation rate 
Scaffold degradation occurs through degradation mechanisms that can either be 
physical, chemical or biological, in order for the scaffold to degrade and get replaced 
by newly formed tissue [95]. The scaffold can undergo bulk or surface erosion, where 
bulk erosion is when the scaffold erodes from the internal structure reducing its 
molecular mass and surface erosion is when it breaks down from the surface 
maintaining its bulk structure [96]. This polymer erosion occurs by the cleavage of 
hydrolytically or enzymatically sensitive bonds found in the chemical structure of the 
polymer [97]. Therefore, the biodegradation rate is dependent on the chemical 
structure, the presence of hydrolytically unstable bonds, its 
hydrophobicity/hydrophilicity, its crystalline/amorphous structure, the copolymer 





previously, the biodegradation rate of the scaffold should synchronise and match the 
rate of the tissue growth in vitro and in vivo. 
1.3.2.5. Mechanical properties 
Williams et al. [99], mentioned that a biomaterial has to perform and exist with the 
most appropriate response, biological and physical, which depends on the application. 
In the report the authors stated that biomaterials should be also selected with enough 
mechanical and physical properties, to withstand mechanical in vivo forces such as 
tensile loading (e.g. oral mucosa), compression (e.g. bone) and fluid flow dynamics 
(e.g. blood vessels) [99]. These mechanical forces can affect the scaffold’s 
construction integrity, which will eventually affect the cells seeded into it. It was found 
that having mechanical properties that are similar to the native tissue is important for 
the scaffold’s biostability. The importance of mechanical properties biomimicry arises 
for two reasons. First the scaffold is strong enough to withstand in vivo mechanical 
forces, and in the case of this study, mechanical forces acting on oral mucosa are 
tensile load, compression load, friction and hydrodynamic forces, mainly due to 
mastication, speech, toothbrushing and saliva flow [16]. Second reason is based on 
findings from multiple studies, that suggest that cells adhere and proliferate better 
when attached to substrates (scaffolds) with the appropriate mechanical properties 
[100, 101]. For example, one study investigated the effect that the Young’s modulus 
of polydimethylsiloxane (PDMS) surfaces has on epidermal keratinocytes, and it 
demonstrated that that the stiffer surface (2.0 MPa) had an increase in cell number, 
colony size and DNA synthesis compared to the softer surface (0.18 MPa) [100]. 
Additionally, when human dermal fibroblasts were seeded on collagen gels had a 2 





on soft collagen gels (0.42 MPa), concluding to that the proliferation of fibroblasts 
increases with the increase of stiffness (Young’s modulus) [101]. 
1.3.3. Oral mucosa scaffold properties 
Consequently, a scaffold for oral mucosa regeneration should have a highly 
interconnected pore structure with high surface-to-volume ratio. The surface of the 
scaffold should allow cell attachment and proliferation but keep the cell layers distinct 
from each other. Since oral mucosa is consisted from two cell layers separated by a 
BM, and it is known that the epithelium does not need a porous scaffold for the 
epithelial cells to grow into a 3D stratified epithelium, the scaffold should be porous 
were the lamina propria is situated and have a thin BM-like layer that will allow 
epithelial cells to adhere on and grow upwards, without cell penetration into the other 
layer. Therefore, the lamina propria part of the scaffold should be porous with enough 
pore size (20-30 μm) for cells to be seeded and grow, and high porosity (>90% porous) 
to increase the surface-to-volume ratio as well as sufficient gas and nutrient exchange. 
At the same time the scaffold is required to have a BM-like layer on top of the porous 
structure for the epithelial cells to grow, while having nanoscale pores (80 - 100 nm) 
to allow cell communication and nutrient exchange. The degradation rate of the 
scaffold should be synchronised with the tissue development (at least 30 days before 
fully degraded [102]) and degrade gradually without a burst in mass loss, which will 
result in structure support failure. 
Knowing that oral mucosa has elastomeric properties and different strength and 
stiffness dependent on its location in the oral cavity, it is logical that the scaffold 
should be elastomeric and have tailorable mechanical properties without affecting its 





the scaffold can retain its mechanical properties while degrading until the cell 
produced ECM can support the structure of the tissue. 
1.3.4. Biomaterials 
All the aforementioned scaffold properties are depended on the biomaterial they are 
composed of and the fabrication method. In this section the natural and synthetic 
biomaterials used in OMTE will be reviewed and compared between them. 
1.3.4.1. Natural biomaterials 
There are multiple natural biomaterials used previously in TE, such as collagen, 
various proteoglycans, alginate-based substrates and chitosan [103]. All these 
biomaterials have the advantage of being extremely biocompatible, as well as 
biodegradable. Additionally, natural biomaterials are bioactive, meaning they can 
affect their biological surroundings by promoting cell adhesion and growth [103, 104]. 
The main disadvantage of the natural biomaterials is fabricating scaffolds with 
homogeneous porous and reproducible structures is difficult [103]. Furthermore, 
usually these materials have poor mechanical properties, not allowing them to be used 
in applications where the scaffold will be under high dynamic environment [103]. 
Collagen 
Collagen is the most used natural biomaterial in TE, due to its similar composition to 
the native ECM, and low immunogenicity and cytotoxicity [105, 106]. Collagen can 
be used crosslinked and non-crosslinked, and the degree of crosslinking can be 
controlled in some extent, which allows the material to have slower degradation rates 
and higher mechanical properties (non-crosslinked: UTS = 37.7 ± 4.5 MPa, Young’s 
modulus = 1.1 ± 0.1 GPa and elongation at break = 6.8 ± 1.9 %; crosslinked: UTS = 





6.5 ± 1.4 % [107]) which are both desired in OMTE [15]. However, during collagen 
crosslinking a disadvantage arises because mainly chemical crosslinking is necessary 
which involves toxic reagents [108]. It is fair to note that these mechanical properties 
are achieved from collagen films (non-porous structures), therefore the structure’s 
mechanical properties will be significantly decreased when porosity is introduced 
(sponge structure: UTS = ~20 KPa) or it is fabricated as hydrogel. This is also true for 
all materials mentioned in this thesis. Collagen can also be used as a based material 
for incorporating glycosaminoglycan (GAG) and chitosan. These scaffolds have 
shown great success in the areas of oral mucosa and skin tissue engineering. GAG are 
polysaccharide molecules that enhances the ECM’s physical properties. Additionally, 
GAG’s form proteoglycans that have the important functionality of binding growth 
factors and cytokines [109]. Chitosan is also widely used in soft tissue TE because of 
its excellent biodegradability, biocompatibility and bioactivity. It is derived from the 
deacetylation of natural chitin and it can be fabricated into a scaffold via covalent/ionic 
crosslinking with another polymer (usually collagen) [110]. 
In OMTE, (i) collagen type I, (ii) crosslinked collagen, and (iii) collagen-
glycosaminoglycan-chitosan (CGC) were used for engineering an oral mucosa for 
testing dental biomaterials.  
(i) When the collagen type I was seeded with oral keratinocytes and fibroblasts, a 
stratified squamous epithelium was formed (9-12 layers) but epithelial cells 
infiltrated into the porous areas of the scaffold which formed epithelial islands. 
Additionally, few fibroblast cells were found inside the pores of the scaffold. 
Finally, this scaffold could not be used for the purpose of testing dental 
biomaterials because the engineered mucosa could not survive more than 2 weeks 





(ii) The cross-linked collagen had an improved biostability compared to the 
uncrosslinked and it could survive for more than 3 weeks. However, in terms of 
histological analysis similar results were observed as the scaffold discussed above 
(collagen type I) with epithelial island formations and low fibroblast infiltration 
[30]. 
(iii)The CGC crosslinked sponges demonstrated the best results from this study. It was 
found to exhibit excellent biocompatibility, biostability and porosity to facilitate a 
multilayer epithelium development, and fibrobalsts were able to infiltrate within 
the scaffold pores and produce new collagen and other connective tissue 
components [30]. 
As mentioned above, natural biomaterials, especially collagen, possess many 
advantages that made it the most used biomaterial for OMTE. However, collagen is 
mostly isolated from human or animal tissue which limits their availability, they have 
badge-to-badge variations, and usually it is expensive [15]. Some of these 
disadvantages could probably be solved in the future, but until then researchers have 
also considered using synthetic biomaterials to fabricate scaffolds for OMTE. 
1.3.4.2. Synthetic biomaterials 
In tissue engineering synthetic scaffolds play a very important role, as these scaffolds 
can be tailored with specific properties dependent on the native tissue. The ability of 
their mechanical properties to be designed with biomimicity is the great advantage that 
they possess over natural scaffolds. Additionally, synthetic scaffolds can be fabricated 
with various formulations and methods, giving different pore sizes, interconnectivity 
and degradation rates [55, 103]. As mentioned previously this is again very important 
in tissue engineering as cells can exchange nutrients and gas efficiently, angiogenesis 





produce their own ECM to replace the scaffold construct without losing their structure 
integrity meanwhile. Needless to say there are also disadvantages in synthetic 
biomaterials such as, the risk of rejection due to low bioactivity, and their degradation 
by-products can be toxic or reduce the local pH causing cell and tissue necrosis [111]. 
Most of the synthetic biomaterials that will be described below were investigated by 
only one research group, therefore there is a lack of comparing results. 
Poly(L-lactic acid) 
Poly(L-lactic acid) (PLLA) is a hydrophobic polyester that was characterised 
numerous times with good biocompatibility and biodegradability [112]. PLLA is a 
stiff polymer with mechanical properties ranging between 34.5-67.2 MPa UTS, 1.57-
4.18 GPa Young’s modulus and 2.43-8.57% elongation at break [113]. 
In OMTE, it was used to co-culture oral fibroblasts and keratinocytes aiming to 
develop an oral mucosa for testing dental biomaterials. Using electrospinning a PLLA 
scaffold was fabricated and seeded with oral cells. After 14 days culture the scaffolds 
were characterised with good biocompatibility and bio-stability, and keratinocytes 
formed multi-layer epithelium and fibroblasts were found underneath the generated 
epithelium [30]. 
Poly(ethylene terephthalate) 
Poly(ethylene terephthalate) (PET) is a non-degradable hydrophobic polyester that 
was found to exhibit good biocompatibility properties [112]. It is usually used as 
surgical meshes for long-term implants, such as rhinoplasty or ligament reconstruction 
[114, 115]. PET was characterised with 48-72 MPa UTS, 2.8-4.1 GPa Young’s 





Regarding OMTE, PET membranes were purchased from Greiner bio-one, 
Germany with 3 μm pore size and after 14 days of oral fibroblast/keratinocytes co-
culture the samples were characterised using histology and immunohistochemistry. It 
was found that the PET membranes provided the pore size and porosity for good cell 
communication, however the membrane lacked from a 3D a matrix development. 
Polycarbonate 
Polycarbonate (PC) is thermoplastic polymer that exhibits hydrophobic properties and 
is considered as a biologically inert material [112]. Its mechanical properties range 
between 60-121 MPa UTS, 2.1-2.4 GPa Young’s modulus and 65-150% elongation at 
break [113]. 
In OMTE, PC membranes were purchased from Costar, USA with 3 μm pore size, 
seeded with oral fibroblasts and keratinocytes and characterised the tissue 
development using histology and immunohistochemistry [30]. As with PET, it was 
found that the keratinocytes were able to be co-cultured with fibroblasts however the 
connective tissue layer lacked from ECM development [30]. 
Polystyrene 
Polystyrene (PS) is a biocompatible, non-degradable material that is used vastly for 
cell culture in 2D (tissue culture plastic) and it can also be fabricated into 3D structure 
but only for in vitro use [112, 116]. Its mechanical properties range between 32-44 
MPa UTS, 1.9-2.9 GPa Young’s modulus and 1.8-40% elongation at break [113]. 
Regarding the use of PS in OMTE, electrospinning was used to fabricate PS 
scaffolds which were therefore seeded and cultured with oral cells for 14 days. It was 





cells were able to infiltrate into the pores of the scaffold and keratinocytes could grow 
on the surface of it [30]. 
1.3.4.3. Natural vs synthetic biomaterials 
Currently most of the research groups have found that natural scaffolds fit well in 
engineering oral mucosa equivalents [6, 15]. However, natural scaffolds have the 
disadvantages of disease transmittance, availability and reproducibility. 
Notwithstanding the architecture and biological parameters of the scaffold, the 
mechanical properties of the scaffold are also of great importance, as Williams et al. 
reported [99]. They defined biocompatibility as “the ability of a material to perform 
with an appropriate response in a specific application” [99]. Williams published a 
leading opinion paper where he discusses the term biocompatibility and how it should 
be approached when is used as a characteristic of a biomaterial for medical use [117]. 
A summary of the biocompatibility pathways is shown below in Figure 1.8. It 
represents the influence of events within the in vivo environment by mechanical and 
molecular signalling in a simple way from a cell biology perspective [117]. Target 
cells are the cells that the therapy is aimed for, defensive cells are the cells whose 
functionality is based on repelling and removing harmful external agents 
(inflammatory cells, platelets) and interfering cells are the cells that may interfere 
during the tissue generation (osteoclasts in bone and fibroblast infiltration to the 
epithelium in oral mucosa) [117]. Essentially, according to Williams, a biocompatible 
biomaterial in tissue engineering is when defensive cells do not induce adverse effects, 
the target cells interact with the biomaterial and are metabolically active and the 






Figure 1.8: Schematic showing the summary of biocompatibility pathways between biomaterial and the defensive, 
target and interfering cells with their relevant clinical outcomes. Adapted from Williams D. [117] with permission 
from Elsevier, copyright 2014. 
A gap of knowledge was identified from the literature review in using synthetic 
scaffolds for OMTE, probably due to the great success of using Alloderm or collagen 
based scaffolds. However, these grafts and materials have limitations in 
reproducibility (due to batch-to-batch variations), risk of transmitting diseases, 
processability, and at the moment high cost. In contrast, synthetic materials can be 
synthesised with specific chemical structures that exhibit biocompatibility, 
biostability, reproducibility, processability and in some cases produced at a low cost 
mainly because of the availability of the raw materials (e.g. monomers). For these 
reasons we believe that there is still room for improvement in developing scaffold for 
OMTE. Additionally, the synthetic scaffolds that were used do not exhibit elastomeric 
properties and all undergo plastic deformation when loaded, which is a disadvantage 
in OMTE, since the native oral mucosa is highly flexible due to its functionality 
(e.g. resistance to tear). Hence, this thesis will focus on synthesising and fabricating 





1.4. Poly(glycerol sebacate) 
1.4.1. Introduction to poly(glycerol sebacate) 
PGS is a synthetic elastomer synthesised by polycondensation of glycerol and sebacic 
acid [118]. This material is biocompatible and biodegradable with sufficient 
mechanical properties to suit as a scaffold for the initial development of many soft 
tissues such as cardiac muscle, retinal and nerve tissue engineering [119]. PGS is 
derived by glycerol and sebacic acid which both form randomly crosslinked coils 
during the synthesis. The most common synthesis method happens in two steps [120]. 
The first step results in the synthesis of PGS pre-polymer, a highly viscous material, 
and during the second step the pre-polymer is polymerised to a crosslinked polymer, 
shown in Figure 1.9.  
 
Figure 1.9: The synthesis and chemical structure of PGS. Reprinted from Li et al. [121] with permission from 
SAGE JOURNALS, copyright 2014.. 
The reason that this polymer, as well as others, can act as a scaffold for multiple 





according to the need, by controlling temperature, curing time and the reactants molar 
ratio. PGS has elastomeric tensile strength with non-linear stress-strain behaviour. The 
mechanical properties can vary between 0.05 – 2.12 MPa Young’s modulus, 0.23 – 
0.79 MPa tensile strength and 69-448% strain at break [118]. The main advantage of 
PGS over other synthetic polymers is that it was shown that it exhibits stable 
mechanical properties after cyclic loading, with minimal loss of tensile strength [122]. 
This demonstrates good flexibility with mechanical integrity to withstand 
mechanically dynamic environments. Other popular synthetic materials, such as PLA, 
PGA, PCL as well as their copolymers, undergo plastic deformation after exposure to 
mechanical stress, making them unsuitable for many TE applications [123]. 
Regarding the degradation of PGS, it undergoes linear degradation and it degrades 
by surface erosion due to hydrolysis of ester groups, into oligomers and monomers 
that can be resorbed and eliminated through natural pathways [119]. Again, this is an 
advantage because surface erosion allows the scaffold to retain its geometry as well as 
retain its mechanical properties relative to the mass loss [124, 125]. When degrading 
PGS in vivo it was noticed that the degradation rate was faster than in vitro, exhibiting 
complete degradation in 60 days, whereas 18% mass loss was observed in vitro [120]. 
When degrading in vivo PGS preserves its geometry and maintains its mechanical 
strength, losing about 8% of mechanical strength every week [120, 126]. After ~70% 
degradation of the PGS, the Young’s modulus was more than 50% from its initial 
value, which is an important characteristic that other polymeric biomaterials fail to 
achieve [126]. As mentioned earlier the degradation rate can be tuned by changing the 
crosslink density, which means the higher the crosslinking the less the water diffusion 





When PGS was examined for its biocompatibility it showed good in vitro and in 
vivo results, enhanced hemocompatibility and a low inflammatory response [118, 120, 
124, 126, 128]. The reason that PGS is biocompatible is due to its monomers, glycerol 
and sebacic acid, which are basic component of lipids and a derivative of fatty acids 
respectively [120]. These monomers are considered as nontoxic and have been 
approved by the United States Food and Drug Administration (FDA) [120]. Compared 
to other polyesters, PGS showed better or similar biocompatibility [120]. For example 
the in vitro 3T3 fibroblast cell activity was compared between PGS coated dishes and 
poly(lactic-co-glycolic acid) (PLGA) coated dishes, and it was observed that there was 
better cell adhesion and growth on the PGS samples [120]. Similar observations were 
found when using Schwann cells [129] and smooth muscle cells [130]. When in vivo, 
PGS resulted in a lower inflammatory response into rat samples compared to PLGA, 
lower fibrous capsule formation and did not induce the foreign body giant cell 
response [120, 129]. These results are partly due to the surface erosion which gradually 
resorbs inducing less inflammatory response, compared to the rapid mass loss from a 
PLGA sample [129]. 
All the aforementioned studies involved PGS characterisation in a 2D structure and 
with evidence that PGS can outperform popular synthetic polymers research began 
looking into fabricating PGS scaffolds. It was quickly realised that the performance of 
PGS scaffolds in terms of biocompatibility, biodegradation and mechanical strength 
was also heavily dependent on factors such as pore size, porosity [125], hydrophilicity 
[131], surface and bulk morphology [132]. The issue that arises when attempting to 
fabricate PGS 3D scaffolds is the harsh curing conditions required during synthesis, 
which are high temperatures (110-165oC), long curing duration (24-114 hours) and 





scaffolds. As described previously porous scaffolds are essential for tissue generation 
as they aim to replace ECM-like structures with high surface-to-volume area to allow 
large tissues to be engineered. As mentioned earlier, fabricating 3D porous scaffolds 
out of PGS presented a great challenge due to its harsh synthesis and curing conditions. 
1.4.2. Poly(glycerol sebacate) scaffold preparation techniques 
This limitation is not presented for materials such as PCL, PLA or PLGA, where most 
if not all scaffold fabrication techniques can be applied. To explain further the effect 
of the harsh curing conditions, to crosslink PGS high temperature (110-165oC) is 
required under vacuum environment, and this causes the pre-polymer to liquify which 
destroys the porous structure that was produced before curing [133]. 
A summary of the fabrication techniques that were developed to produce PGS in a 
3D porous scaffold is shown in the Table 1.3 below. All these methods work but they 
have great limitations in terms of fabrication cost and the size of the final product is 
small with low reproducibility. More importantly in many cases the fabrication 
technique does not allow control of pore size and porosity which affects the cell 
viability.  
Micromoulding is a fabrication technique based on injection moulding technique 
but to a micro-scale resolution. Aiming to use a scaffold to deliver cells to the retina, 
Neeley et al. fabricated a porous PGS membrane using micromoulding. The resulting 
scaffold had good mechanical properties resembling those of retinal tissue and 
preliminary results showed cell adherence and proliferation [125]. However, this 
scaffold was very thin (80 μm thickness) and required more than 16 days to fabricate, 
Figure 1.10. A laser micro-ablation technique allowed the fabrication of porous PGS 





multi-layered PGS scaffold [134]. The resulting scaffold had approximately ~400 μm 
thickness and dependent on the pore structure, the ultimate tensile strength ranged 
between 40 – 100 kPa. Similar to micromoulding, the inability to produce large 3D 
porous scaffolds from both techniques limits their applicability in TE, Figure 1.11. A 
completely different method was utilised to fabricate PGS scaffolds using solid free-
form technique. In this case a sacrificial mould was used, made from hydroxyapatite, 
that is the inverse structure of a 3D printed wax mould, and PGS prepolymer was cast 
in the mould followed by curing. The resulting scaffold had large pore size (~1 mm) 
and low porosity (48%), Figure 1.12. Electrospinning is a more established fabrication 
technique for PGS, however a blend of natural or synthetic polymers with PGS is 
necessary to adjust the viscosity of the PGS prepolymer solution to values suitable for 
electrospinning [131]. The carrier polymers tested for PGS blend solutions are gelatin 
[135], PVA [136], PCL [131] and polylactic acid (PLLA) [137], Figure 1.13. The 
PGS-based scaffolds fabricated with electrospinning had fibre diameters ranging 
between 0.3 – 8.3 μm, with large surface area and fibres could be randomly dispersed 
or aligned. The issue in fabricating scaffolds with PGS and electrospinning is the 
inability to crosslink the PGS prepolymer because of the high curing temperature (110 
– 165 oC) meaning only thin scaffolds can be produced. The last, least complicated 
technique utilised for PGS scaffold fabrication is porogen leaching and fusion 
technique [138, 139]. This fabrication technique involves mixing melted PGS 
prepolymer with a porogen, usually salt, and after PGS thermal crosslinking the 
porogen is leached using water. Therefore, the pore size depends on the size of the 
porogen, with an average pore size in the range of 20 – 300 μm, and the porosity 
depends on the concentration of the porogen, in the range of 75 – 95 %, Figure 1.14. 





interconnectivity adjustment is limited. Furthermore, because the PGS melts while 
crosslinking, the porogen tends to sink resulting in a dense skin layer formed on the 
top of the scaffold and subsequently relatively thin scaffolds, 1-5 mm thickness [138, 
139]. 
Sophisticated fabrication techniques were developed and utilised to fabricate 
pristine PGS scaffolds, but all these scaffolds were characterised with a low 
throughput and small size scaffolds [119]. Additionally, porous structures and 
porosities were not easily controlled, not allowing the usage of PGS scaffolds in a vast 





Table 1.3: PGS scaffold fabrication techniques review table. 
Fabrication 
technique 










Figure 1.10: SEM images of PGS scaffolds fabricated with micromoulding. (A) Top view, (B) 60o angle view, 
(C) pore view at 30o angle and (D) edge view at 60o angle. Reprinted from Neeley et al. [125] with permission 


















Figure 1.11: SEM images of (a) accordion-like, (b) square and (c) rectangular honeycomb PGS scaffolds made 
using laser microablation. Scale bar is 100 μm. Reprinted with permission from Springer Nature:  Engelmayr et 



















Figure 1.12: Micro-CT (a,b) and digital (c,d)  images of PGS scaffold fabricated using solid freeform 
fabrication. (a) side view, (b) top view, (c) side view, (d) top view. Reprinted from Kemppainen et al. [143] with 
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Figure 1.13: SEM image of PGS/PLLA core/shell nanofibres. Reprinted from Yi et al. [133], with permission 























Figure 1.14: SEM image of PGS scaffold fabricated using porogen leaching. Reprinted from Radisic et al. [139], 






1.4.3. Poly(glycerol sebacate) modifications 
All these fabrication limitations are solely because of the harsh curing conditions that 
PGS requires to crosslink. Therefore PGS-based copolymers, blends and composites, 
were developed to overcome the fabrication limitations, and to modify the mechanical 
properties, biocompatibility, degradation and hydrophilic properties of the scaffolds 
[127, 131, 144]. 
Nijst et al. [144] addressed these limitations by chemically modifying the PGS 
synthesis by adding reactive acrylate moieties, making poly(glycerol sebacate) 
acrylate (PGSA). This new acrylated material was then able to be cured using UV 
radiation by dissolving it in a photo initiator 2-dimethoxy-2-phenylacetophenone. The 
curing time was reduced significantly to a few minutes compared to 48 hours and it 
also overcame the thermal curing limitation, allowing an expansion in its applications. 
Additionally, by controlling the acrylate moieties in the PGSA, the mechanical 
properties could also be tuned [144]. 
Poly(glycerol sebacate) methacrylate (PGSM) was also synthesised which could be 
cured using UV light. The synthesis procedure was similar to PGSA but methacrylate 
groups were used to functionalise the PGS and render it photocurable. This material 
was mostly studied as a film showing human dermal fibroblasts were metabolically 
active and no adverse effects were found within the 7 days culture [145]. As proof of 
concept a 3D scaffold was also fabricated using a technique called 2-photon 
polymerisation. The mechanical properties and degradation rates could be controlled 
by changing the molecular weight and degree of methacrylation [145]. 
A polymer blend, PGS/PLLA, was also developed to enhance the fabrication 





[146]. PLLA acted as a structure supporting polymer because of its high melting point 
(173 -178oC) which allowed the scaffold to maintain its structure during the harsh 
curing conditions of PGS, after giving its porous structure using freeze-drying. These 
results demonstrated the ability to fabricate large porous scaffolds with good pore 
interconnectivity, but fast degradation rate [146]. 
1.4.4. Poly(glycerol sebacate urethane) 
Another approach to extend the capabilities of the PGS material was successfully 
attempted by Pereira et al. [147]. In their study they developed a new material, 
poly(glycerol sebacate urethane) (PGSU).  Incorporating urethane linkages is a simple 
processing method to fabricate elastomers with a wide range of mechanical properties 
demonstrating an advantage over other techniques. PGSU was synthesised by 
introducing isocyanate that reacted with the hydroxyl groups to form a cross-linked 
PGSU. This method had the advantage of using mild temperature (55oC) to crosslink. 
The PGSU was then shown to be biocompatible with tuneable biodegradation rate 
dependent on the degree of crosslinking, shown in Figure 1.15. Additionally, PGSU 
exhibits the ability of producing materials with various mechanical properties by 
altering the reactants ratio, summarised in Figure 1.16. 
 
Figure 1.15: In vitro enzymatic degradation of PGSU films synthesised using different reactants ratio and cured 






Figure 1.16: (A) FTIR spectroscopy analysis of PGS and PGSU, (B) summary of the mechanical properties of 
PGSU, (C) representative stress-strain curves of PGSU and cured PGS, (D) stress-strain curve of PGSU during 
100 cyclic loading cycles. PGSU-SF = solvent free synthesis, PGSU-S = with solvent synthesis, YM = Young’s 
modulus, UTS = ultimate tensile strength, EL = elongation at break. Reprinted from Pereira et al. [147], with 
permission from John Wiley and Sons, copyright 2012. 
In the following figures, Figure 1.17 and Figure 1.18, the ultimate tensile strength 
(UTS) and Young’s modulus measured in Pereira’s work compared to the minimum 
and maximum UTS and Young’s modulus of oral mucosa, are plotted. In both cases 
the UTS and Young’s modulus increase while the isocyanate increases. This occurs 
because of the higher crosslinking density [147]. Additionally, the mechanical 
properties obtained from his study lie between the maximum and minimum values of 
the mechanical properties of oral mucosa, demonstrating that PGSU is a polymeric 
material that has the potential to replicate the mechanical properties of oral mucosa. 
Furthermore, biomaterials are often manipulated prior to transplantation and thus they 
should maintain their structure integrity. Therefore, taking into consideration that 





forces, Pereira et al., examined PGSU and showed minimal creep deformation and 
minimal loss of tensile strength after 100 tensile cycles, Figure 1.16 (D) [147]. 
 
Figure 1.17: Ultimate Tensile strength of PGSU obtained from literature. Horizontal lines indicate the maximum 
and minimum UTS of oral mucosa dependent on the location. Data used in this figure were obtained from [16, 
147] and plotted by the author. 
 
Figure 1.18: Young’s modulus of PGSU obtained from literature. Horizontal lines indicate the maximum and 
minimum Young’s Modulus of oral mucosa dependent on the location. Data used in this figure were obtained from 
[16, 147] and plotted by the author. 
The assessment of biodegradation and cytocompatibility in vitro was also evaluated 
(Figure 1.15). Using cholesterol esterase, the PGSU films demonstrated a degradation 
profile dependent on the degree of crosslinking. Specifically, cured PGS had lower 





approximately 50%, 90% and 95% remaining mass respectively. This indicates that 
ester groups found on the polymer backbone are sensitive to enzymatic degradation, 
but by incorporating urethane linkages the ester bonds are hindered resulting in 
significantly slower degradation rate [147]. For their in vitro cytocompatibility test 
they seeded human mesenchymal stem cells on PGSU films and assessed their 
metabolism using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay, having cells cultured on TCP as a positive control. On day 1 fewer cells 
were found on the PGSU films but towards day 8 the cells proliferated giving no 
statistical significance from cells on TCP. 
Considering the success of the cytocompatibility results they then moved in vivo 
examining acute and chronic inflammatory response, Figure 1.19 (A, B). PGSU films 
were transplanted subcutaneous in a rat animal model and compared with PLGA 
which is a biodegradable material that has been approved by FDA for internal use. 
During the 40-week period no adverse reaction or any complications were observed. 
Specifically, at time points week 1 and 4, the PLGA showed a significantly higher 






Figure 1.19: In vivo subcutaneous and cardiac biocompatibility and biodegradation of PGSU films. (A) Histological 
images and anti-CD68 stained subcutaneous tissue, comparison between PGSU and PLGA. (B) characterisation of 
foreign body response during in vivo study (0 mean no infiltration and 4 severe infiltration). (C) in vivo 
biodegradation of PGSU at different reactant ratios, (D) Cross section SEM images during degradation (scale bar 
= 50 μm). (E) H&E stained sections during myocardium implantation (M = myocardium). (F) Cardiac function 
before and after PGSU implantation. Reprinted from Pereira et al. [147], with permission from John Wiley and 
Sons, copyright 2012. 
In the previous work from our group, Frydrych et al. [148], developed 3D PGSU 
scaffolds using freeze-drying, synthesised with three different hexamethylene 





crystallised (frozen) and the solvent was sublimed directly from solid phase into 
vapour phase by reducing the chamber pressure, leaving a porous PGSU prepolymer 
scaffold which was cured to obtain PGSU scaffolds [148, 149]. Frydrych et al. 
investigated the effect the crosslinker concentration had on the properties of the 
scaffolds, and a significant increase in mechanical strength (the Young’s modulus, 
UTS and elongation at break ranged between 30-40 kPa, 18-22 kPa and 49-82% 
respectively) was found. The crosslinker concentration also affected the degradation 
rate (30-62% mass loss over 112 days) and the scaffolds exhibited porosities between 
77-88% and pore sizes 55-74 μm [148]. 
1.5. Scaffold fabrication 
1.5.1. Freeze-drying 
During scaffold fabrication the porous scaffold is aimed to mimic the native structure 
of ECM. Using freeze-drying well-defined porous structures have been reported [118, 
150, 151]. 
Freeze-drying takes place in three stages, freezing, primary drying and secondary 
drying shown in Figure 1.20. For the first two stages it is extremely important to 
understand the phase that a solvent is at a certain temperature and pressure. For ease 
of understanding water will be used as an example during the description of each 
freeze drying stage, and its phase diagram is shown in Figure 1.21. The first stage is 
freezing the sample, where the sample’s temperature is reduced below its melting point 
(Tm) which is depended on the solvent. In the case of water, its Tm is 0oC at 
atmospheric pressure (101 kPa). This stage is critical for the resultant structure of the 
scaffold. The pores in the scaffold are dependent on the freezing process, as the ice 





removed they leave pores in the scaffold’s structure that reflects the ice crystal’s 
structure. With this said, the method of freezing (freezing rate) is what determines the 
crystalline structure therefore the pore structure/size. The basic principle behind the 
freezing stage is: fast freezing rate produces smaller ice crystals and slow freezing rate 
produces larger ice crystals. Additionally, the temperature gradient across the sample 
is what determines the homogeneity of the pore structure. Being able to control the 
freezing process of the sample allows a tightly controlled pore size of the scaffold 
[149]. 
During the primary drying stage, the now frozen sample is kept below its critical 
temperature allowing it to stay frozen and vacuum pressure is applied. When the 
pressure is reduced below the triple point of the solvent the process called sublimation 
occurs. Considering water, sublimation will occur when the pressure is below 0.61 
kPa and the temperature is below 0oC, when this is true the ice crystals sublime to a 
vapour skipping the liquid phase [149]. 
As a last step, secondary drying is done to remove any water which is chemically 
bound to the lattice, also called desorption process. The desorption process occurs by 
raising the temperature of the sample and reducing the pressure to the minimum [149]. 
 






Figure 1.21: Three-phase diagram of water derived from the data provided from National Institute of Standards 
and Technology (NIST, https://webbook.nist.gov/cgi/cbook.cgi?ID=C7732185&Units=SI&Mask=4#Thermo-
Phase). Ttp: Triple point temperature, Ptp: Triple point pressure. 
Faraj et al. [42], attempted to fabricate porous collagen scaffolds examining the 
freezing stage of the process. Collagen solutions frozen at -20 oC freezer resulted in 
much larger pores (top side: 100 ± 8 μm, cross-section: 89 ± 24 μm, bottom side: 123 
± 21 μm) compared to fast freezing at -80 oC (top side: 57 ± 21 μm, cross-section: 
42±6 μm, bottom side: 29 ± 3 μm) using dry ice and ethanol. Furthermore, using liquid 
nitrogen a very rapid freezing at -196 oC was established resulting in the smallest pores 
(top side: 31 ± 2 μm, cross-section: 24 ± 4 μm, bottom side: 5 ± 1 μm). Therefore, as 
mentioned previously the higher the freezing rate, the smaller the pore size. 
When freeze drying was used for fabricating PGSU scaffolds the study did not 







Airbrushing (also referred to as air jet spinning, blow spinning and solution spraying) 
is a fabrication technique that has been recently developed to fabricate nanofibers by 
spraying a polymer solution through a small nozzle (usually less than 350 μm) using 
an air pump or compressed air [152-154]. It works by ejecting air through the nozzle 
which overcomes the surface tension of the polymer solution that results into 
stretching the solution into nanoscale fibres [155]. Additionally, while the polymer 
solution is sprayed it leads into vaporising the solvent from the produced nanofibers. 
This fabrication technique has been found to be 10 folds faster and 100 fold less 
expensive to set-up compared to electrospinning (due to not needing a high potential 
voltage) [152]. 
A few materials have been fabricated using this relatively new fabrication 
technique including PCL [152], PLA [156], hydroxyapatite/PLA [153] and 
hydroxyapatite/poly(vinyl acetate [154] composites. From these fibrous scaffolds, the 
most interesting was the PCL. After air brushing PCL they used 100% ethanol to 
separate the PCL fibres and then compressed them into a 10 mm thick fibrous scaffold 
[152]. After loading these scaffolds with magnesium (Mg) particles they found that 
Mg ions were released at a controlled rate for up to 2 months, the scaffold encouraged 
human osteoblasts to attach, spread and migrate throughout the scaffold [152]. 
1.6. Summary of literature review 
Due to the limitation of donor oral tissue, treating wounds and defects caused from 
trauma, chronic infection and oral cancer in the oral cavity, remains challenging. 
OMTE is a science that has the potential to address this limitation by developing 





The most successful attempt to develop an oral mucosa equivalent was 
demonstrated using EVPOME. It was shown clinically that using Aloderm to culture 
oral keratinocytes, had superior results than using an autograft [157]. It was 
demonstrated that EVPOME was able to accelerate oral mucosa healing and matched 
the surrounding tissue properties and colour [1, 157]. The major disadvantages of 
Aloderm are batch to batch variation, limited ability to be tailored for specific 
applications and extensive processing to ensure that no disease transmission and all 
cellular components are removed. Synthetic scaffolds however do not possess any of 
the above disadvantages. Synthetic scaffolds can be synthesised with high precision 
and fabrication techniques can be optimised and established to increase the 
reproducibility of the scaffold’s physical properties. 
One important aspect of OMTE is the scaffold used and the scaffold’s properties 
must be as biomimetic as possible. Oral mucosa has multiple biomechanical 
properties, which depend on its location within the oral cavity. Therefore, the scaffold 
should have tuneable mechanical properties. Additionally, since oral mucosa is 
constantly under in vivo dynamic forces the scaffold should also be able to sustain 
those forces but at the same time it should be able to recover. With this said, PGSU is 
a promising material to investigate for OMTE, as its mechanical properties can be 
tailored, and it does not undergo plastic deformation after loading. This material has 
not been widely investigated for its TE potentials, however preliminary results from 
literature have shown that it is biocompatible, with in vivo results to be, in some 
aspects, better than existing FDA approved materials such as PLGA. 
Freeze drying is a fabrication technique that allows high control of pore size and 
pore structure and ensures high pore interconnectivity. Additionally, freeze drying can 





techniques cannot (such as electrospinning). PGSU scaffolds have been fabricated 
before using freeze drying but were never processed and optimised for its biological 
properties. For example, the pore size was never adjusted for optimum fibroblast 
growth (20-30 μm), or it was never attempted to fabricate multiple layer structures that 
could exhibit a BM-like layer to mimic oral mucosa. 
In the following thesis we fabricated porous PGSU scaffolds using freeze drying. 
The scaffolds were characterised for their microstructure, mechanical properties and 
cytocompatibility. The methods, results and discussion will be reported in the 
following chapters. 
1.7. Aims and Objectives 
The overall aim of this project is to develop a PGS based scaffold to be used in oral 
mucosa tissue engineering. The scaffold’s microstructure, mechanical properties, cell 
adherence, biocompatibility and biodegradation will be evaluated to determine the 
suitability for use in the oral cavity.  
Hypotheses 
The hypotheses of this thesis are: 
i. Pore size, mechanical properties and degradation rate can be controlled in PGSU 
scaffolds by adjusting the polymer concentration during synthesis and 
fabrication. 
ii. Differences in PGSU scaffold microstructure can affect the biological response 
of cells by influencing protein production and cell behaviour. 
iii. PGSU scaffolds can be fabricated with a BM-like layer to facilitate cell co-
culture and restrict cell infiltration. 





1. To develop PGSU scaffolds using freeze-drying and to characterise their 
physical properties and the effect that the freeze drying and sterilisation 
techniques have on mechanical properties and microstructure. 
2. To optimise the microstructure of the PGSU scaffolds and investigate how the 
mechanical properties, degradation rate, biocompatibility and collagen 
production are affected by the polymer concentration in the freeze drying 
solution. 
3. To fabricate PGSU scaffolds with multiple pore architecture (orientation, pore 
size, porosity and multi-layer) to mimic different native soft tissue structures. 
4. To develop a 2-layer scaffold resembling a basement membrane (BM) and 
lamina propria to determine the scaffold’s ability to support oral cell co-culture 
and the ability to distinguish tissue layers. 
The following thesis includes three experimental chapters that demonstrate the 
systematic approach in fabricating a PGSU scaffold for OMTE. The first experimental 
chapter (Chapter 2) shows the study of PGS and PGSU synthesis as well as PGSU 
scaffold fabrication using freeze-drying. The aim of this chapter was to understand the 
advantages and disadvantages of the scaffold and set a starting point to improve it in 
order to reach our final objective which is engineering an oral mucosa tissue. The 
scaffold was then tested for its microstructure, mechanical properties, enzymatic 
degradation, permeability as well as the sterilisation effect on its mechanical 
properties, permeability and a 9-day in vitro cell culture to demonstrate that cells can 
adhere and be metabolically active on the scaffold’s substrate. 
The second experimental chapter (Chapter 3) was built on the results from Chapter 
2 and shows that the scaffold can exhibit multiple microstructures, mechanical 





before freeze drying. The aim of this chapter was to improve the scaffold in terms of 
its physical properties and perform longer in vitro cell culture experiments before 
using human oral cells and co-cultures. 
The final experimental chapter (Chapter 4) involves fabricating complex 
microstructure scaffolds by combining mould technology, airbrushing and freeze 
drying fabrication methods. From the knowledge obtained from the previous two 
chapters we developed multi-layered scaffolds that were distinguished by their pore 
size/porosity, and mono-layer scaffolds that had unidirectional (anisotropic) pore 
structures. The aim of this chapter was to demonstrate the ability of fabricating PGSU 
scaffolds that can mimic native ECM structures. A 2-layer scaffold that exhibited a 
thin non-porous layer which acted as a BM was then used to co-culture human oral 
cells and the collagen production and epithelium development was quantified as well 
as the ability of the non-porous layer to separate the cell types during co-culture. 
The complete characterisation of the PGSU scaffolds is expected to demonstrate 





Chapter 2 Poly(glycerol sebacate urethane) synthesis, 
scaffold fabrication and effect of sterilisation method 
Aim 
To develop a fabrication technique for PGSU scaffolds with controlled properties and 
to test the biocompatibility and ability to sterilise these PGSU scaffolds. 
2.1. Introduction 
As discussed in Chapter 1, there are multiple biomaterials which have been 
successfully used in TE. PGS was shown to have the same advantages as many other 
synthetic materials, such as biocompatible, biodegradable, tailorable mechanical 
properties and degradation rate, but it also demonstrated stable mechanical properties 
prior to and post degradation. After cyclic loading PGS can recover its initial shape 
and mechanical integrity with minimal loss [122]. These properties are of great 
importance in TE as most if not all tissues are constantly under some sort of load and 
unload, therefore the scaffold should be mechanically stable during degradation and 
should recover its mechanical strength after loading. 
PGSU, developed by Pereira et al. [147] and the freeze drying fabrication technique 
utilised by Frydrych et al. [148] solve the issues of low throughput, low reproducibility 
and inability to control pore size and porosity associated with PGS 
fabrication techniques. However, PGSU as a scaffold has not been characterised for 
its in vitro biocompatibility before this thesis. 
When approaching a novel study of a newly developed scaffold that is designed to 
support cell growth in vitro, it is important to know how to sterilise it and how the 





70% ethanol, paracetic acid (PAA) and autoclaving to sterilise PGS scaffolds and films 
[126, 158]. These methods are the most common amongst most polymeric 
biomaterials in in vitro development because more clinically relevant sterilisation 
methods such as ethylene oxide and gamma irradiation are difficult to access and have 
been shown to be unsuccessful in maintaining the structural and biochemical 
properties of the scaffolds [159]. Additionally, ethanol and PAA have the advantage 
of working at low temperature, low cost and no complex equipment is needed for fast 
sterilisation [159].   
This chapter will present the study performed on PGSU scaffolds fabricated using 
freeze drying, looking at the effect that the fabrication technique and the sterilisation 
method has on the scaffold’s physical properties and biocompatibility. To assess the 
effect of pre-freezing conditions three different freezing temperatures  were used (0 
oC, -20 oC and -50 oC) and three sterilisation methods were used (paracetic acid, 
ethanol and autoclave) to sterilise PGSU samples and the scaffolds were tested for 
their chemical structure, microstructure, tensile strength, water permeability, and cell 
metabolic activity. 
2.2. Materials and Methods 
2.2.1. Materials 
Sebacic acid (99%), glycerol (>99%), 1,4-dioxane (anhydrous, 99.8%), 
hexamethylene diisocyanate (HDI, 99%), Tin(II) 2-ethylexanoate, lipase enzyme from 
porcine pancreas (54 U mg-1), Dulbecco’s modified eagle’s medium (DMEM), 
penicillin-streptomycin (P/S), L-glutamine (200 mM), fetal calf serum (FCS), MEM 





trypsin/ethylenediaminetetraacetic solution (trypsin/EDTA), thiazol blue tetrazolium 
bromide (MTT) and resazurin sodium salt were purchased from Sigma-Aldrich. 
2.2.2. Methods 
2.2.2.1. Pre-PGS synthesis 
This method was obtained from previously reported methods [160]. Pre-PGS was 
synthesised at 1:1 M ratio between sebacic acid and glycerol. The synthesis setup is 
shown in Figure 2.1. Both were mixed in a three-neck flask and attached to a 
Dean-Stark trap with a condenser and nitrogen flow. The mixture was allowed to react 
at 120 oC under stirring and low nitrogen flow for 72 hours. Highly viscous pre-PGS 
was then formed and stored in a container at room temperature. 
 
2.2.2.2. Gel permeation chromatography of pre-PGS 
Gel permeation chromatography (GPC) was used to quantify the average molecular 
weight distribution of pre-PGS, more specifically for the number average molecular 
weight, 𝑀𝑛, the weight average molecular weight, 𝑀𝑤, and the 
polydispersity index (PDI).  This works by injecting a small volume of polymer 





solution into a set of columns containing a crosslinked gel. While the solution goes 
through the gel the smaller chains are absorbed and the longer chains pass though it 
faster. The smaller chains are then released giving a distribution curve for the sample 
[161, 162]. For this experiment tetrahydrofuran (THF) was used as eluent at a flow 
rate of 1.0 ml min-1 with 1 x PLGel 10 μm Guard and 3 x PLGel 10 μm Mixed B as 
columns. A Gilson 307 pump and an Erma ERC-7512 refractive index detector were 
used for the GPC measurements, and polystyrene samples were used for calibration. 
2.2.2.3. PGSU-film and PGSU-2.5% fabrication 
For the purpose of the following experiments porous PGSU scaffolds and non-porous 
film were fabricated. Pre-PGS was firstly dissolved into 1,4-dioxane at the required 
concentrations (2.5 w/v%) and pre heated to 55 oC with 0.05% w/v of Tin(II) 2-
ethylexanoate. Once heated, HDI was added at a 0.6 molar ratio (glycerol:HDI) and 
left at 55 oC for 5 hours under constant stirring. For ease of documentation, the 
nomenclature of the samples is PGSU-X where X refers to the polymer concentration 
(w/v%), e.g. 2.5% or PGSU-film. 
 





To produce a PGSU-film the solution was cast in a PTFE tray and left in the fume 
hood to allow the 1,4-dioxane to evaporate. To produce a PGSU-2.5% scaffold the 
solution was frozen and 1,4-dioxane was removed using freeze drying (FreeZone 
Triad Freeze Dry System, Labconco Co., USA). According to the National Institute 
of Standards and Technology (NIST) the melting point of 1,4-dioxane is 11.4 oC 
(NIST, https://webbook.nist.gov/cgi/cbook.cgi?ID=C123911&Mask=4#Thermo-
Phase), therefore to freeze the solution and ensure a complete freeze it was decided to 
have 0 oC as the highest freezing temperature and the lowest freezing temperature -50 
oC (lowest temperature setting possible from the FreeZone Triad Freeze Dry System) 
as well as a temperature in between the highest and lowest to understand the effect of 
the pre-freezing temperature on the scaffold’s properties. The porous scaffold solution 
was cast into a PTFE baking tray and frozen at 0 oC, -20 oC or -50 oC overnight. On 
the next day the baking tray with the scaffold was placed in the freeze drier for 
lyophilisation. The freeze drier was set to -10 oC at 1 oC cooling or heating rate and 
left for 24 hours under vacuum pressure (0.1 mbar). Two hours before removing the 
scaffold from the freeze drier the temperature was raised to 20 oC to avoid drawing 
moisture in the scaffold upon exiting the freeze drier. The freeze drying cycle is shown 
at Figure 2.3 where during the pre-freeze stage the PGSU/1,4-dioxane solution 
temperature is reduced below its melting point to freeze and then during the primary 
drying stage the temperature and pressure is kept bellow the triple point of 1,4-dioxane 
to allow lyophilisation, shown in Figure 2.4. Finally, the scaffold and film were placed 
in the vacuum oven for 48 hours at 40 oC for further curing and drying. A schematic 






Figure 2.3: Freeze drying cycle for PGSU-2.5% scaffolds. The 1,4-dioxane/polymer solution was frozen at 3 
different temperatures, 0 oC, -20 oC or -50 oC, and lyophilised the same way. 
 
Figure 2.4: Three-phase diagram of 1,4-dioxane derived from the data provided from National Institute of 
Standards and Technology (NIST, https://webbook.nist.gov/cgi/cbook.cgi?ID=C123911&Mask=4#Thermo-
Phase). Ttp: Triple point temperature, Ptp: Triple point pressure. The purple circle shows the temperature and 






Figure 2.5: Schematic of synthesis and fabrication method for PGSU-2.5% scaffolds. 
All scaffolds were washed with ethanol to remove any unreacted substances from 
the construct. The washing was done by submerging the scaffold in 100%, 70% and 
50% Ethanol for 2 hours each, and then immersed in distilled water overnight. Shaking 
was also applied to the scaffolds during washing. 
2.2.2.4. Scaffold sterilisation 
Three different sterilisation methods were assessed. The first was submerging the 
scaffolds into 70% ethanol overnight while shaking. Then under sterile conditions the 
scaffolds were washed three times using sterile PBS and left in PBS overnight under 
shaking. The same procedure was followed for the second sterilisation method but 
instead of ethanol, 0.1 % (v/v %) paracetic acid (PAA) was used. Last sterilisation 
method was done by autoclaving at 121 oC for 15 minutes. For comparison reasons a 
PGSU film was also sterilised using the same three methods. 
2.2.2.5. Porous scaffold characterisation 
2.2.2.5.1. Fourier transform infrared spectroscopy 
Fourier transform infrared spectroscopy (FT-IR) was performed using Perkin Elmer 
Spectrum One NTS analyser. Attenuated total reflection (ATR) was used at mid-
infrared region of 4000-550 cm-1 and recording resolution of 4 cm-1 at room 
temperature. The test was repeated three times with technical triplicates using pre-





extraction. The samples were collected from the centre and sides of the fabricated 
scaffolds. A small amount of pre-PGS, cured PGS and small solid pieces of PGSU 
were placed on the test area for scan.  The number of scans was set to 20 and an average 
spectrum was plot. 
2.2.2.5.2. Scanning electron microscopy 
To examine the microstructure of the porous scaffolds scanning electron microscopy 
(SEM) was utilised using the FEI™ Inspect F50. The porous samples were attached 
on an aluminium stub and gold coated using High Resolution Polatron Spetter Coater 
at 15 kV for 1.5 minutes. To measure the average pore size ImageJ software was used. 
Firstly, the scale of the image was set into the software and then using the free hand 
selection tool, the pore’s periphery was selected and the area was measured using an 
in-built function provided by the software, as shown in Figure 2.6. The pore diameter 
was calculated using: 
𝐴 = 𝜋𝑟2      Eq. (1) 
with A = pore area and r = pore radius. Therefore, when pore size is mentioned it 
implies the pore diameter. The images were taken from the top view, cross section, 
bottom view and top to bottom of the produced scaffolds. Only fully defined pores 
were used to determine the average pore size, with 50 pores measured per image. 
 
Figure 2.6: Example of pore size measurements using ImageJ. A) Shows an example of how the scale of the SEM 





2.2.2.5.3. Porosity measurement 
The porosity of the scaffolds was measured using the gravimetric method [163]. 
Circular disks were cut with diameter 10 mm and thickness ~5 mm for the scaffold 
and ~2 mm for the film. The densities of porous scaffold (ρs) and film (ρf) were 
calculated by dividing the mass with the volume of the sample, measured using a four-
decimal point balance and a three-decimal point caliper respectively. Five specimens 
were used from each batch of scaffold. Knowing the density of the sample the equation 
below was then used to calculate the porosity Eq. (2), 
𝑃 = (1 −
𝜌𝑠
𝜌𝑓
) ×  100      Eq. (2) 
2.2.2.5.4. Mechanical testing 
PGSU porous scaffolds were tested for their tensile strength following the BS EN ISO 
1798:2008 standard using a Hounsfield H100KS testing machine (Tinius Oles, USA). 
The samples were prepared in dog-bone shape (using test sample cutter with gauge 
length = 25 mm, width = 3.25 mm) and tested at a 500 mm/min rate of travel using a 
10 N load cell until failure. Sufficient test pieces were used to provide 5 breaks within 
the gauge length. 
2.2.2.5.5. In vitro enzymatic degradation testing 
In vitro degradation was performed on the PGSU-2.5% scaffolds and films using 
lipase enzyme at an activity of 40 U/ml. Lipase can catalyse the hydrolysis of ester 
bonds in polyester materials in aqueous solutions, hence it is one of the most common 
enzymes used when examining the in vitro degradation characteristics of polyester 
materials [148, 164]. Furthermore, lipase is one of the two dominating enzymes 
(lingual lipase) found in the human saliva [165]. However, pancreatic lipase was used 





activity was chosen to mimic the in vivo lipase activity of the gastric juice (40 U/ml) 
which is attributed to the lingual lipase secreted by the Von Ebner secretory glands 
located in the back of the tongue [166]. Prior to the experiment all samples were 
sterilised with 70% ethanol overnight, and then dried in a vacuum oven overnight at 
40 oC. The samples were fully submerged in triplicates into PBS/lipase solutions for a 
total of 28 days and placed in a shaker incubator at 37 oC and 100 rpm, changing the 
enzyme solution every day because the half-life of lipase is approximately 10.2 hours 
[167]. Every 7 days the samples were washed thoroughly with distilled water to 
remove any polymer by-products and lipase that can affect the mass of the sample and 
dried in a vacuum oven at 25 oC overnight to allow the measure of the sample’s dry 
mass. The samples were then weighed, recorded, and then placed back into the enzyme 
solution. Samples were also degraded in phosphate buffered solution (PBS) without 
enzymes as a control. 
2.2.2.5.6. Water contact angle 
The water contact angle of PGS-film, PGSU-film and PGSU-2.5% scaffold was 
measured at room temperature using distilled water. The sample was placed on a 
levelled surface and a 10 μl water droplet was deposited on the top surface of the 
sample. Images were taken after 10 and 60 seconds to measure the contact angle (θ). 
ImageJ was used to measure the θ and the angle was calculated using the sphere 
approximation.  The software works by manually choosing the baseline of the droplet, 
and then another 5 points around the periphery of the droplet. It then draws a tangent 
line from the periphery of the droplet to the baseline and calculates the angle between 
them. This experiment was done at n=3 and when θ was less than 90o the surface was 






2.2.2.5.7. Permeability testing 
The term permeability is intended to show how much of fluid can permeate through 
the scaffold’s walls with respect to pressure, and this was calculated using the Darcy’s 
Law found below (Eq. 4). The setup of the experiment is called constant head method 
and it was inspired by Pennella et al [169]. As shown in Figure 2.7, the constant head 
reservoir was set to a constant height and the water was collected into a container that 
was sitting on a balance to measure the weight and use it to calculate the flow rate (Q). 
The scaffold was fixed inside a silicon sleeve (water could only go through the 
scaffold) and mounted onto tygon tubing and was hanged vertically. The fluid level of 
the constant head reservoir was kept constant using a peristaltic pump that was 
adjusted to the necessary flow rate to fulfil the fluid loss. The level of the water was 
kept constant to keep the hydrostatic pressure constant. 
Prior to the beginning of the experiment the scaffold was submerged into ethanol 
to push any air bubbles out of the scaffold construct. The whole system was filled up 
with distilled water, making sure that all air has left the system. The scaffold was then 
mounted in place and the experiment was ready to begin. Each scaffold was tested for 
10 minutes taking a recording of the flow rate every minute. Thus the volume of water 
collected divided by the time gives the Q. Knowing the constant head height, scaffold 
thickness (L), scaffold cross section area and Q the hydraulic conductivity of the 




            Eq. (3) 
And by substituting the results of Eq. (3) into Eq. (4) the permeability (k) can be 
calculated using Darcy’s law. 
𝑘 =  𝐾
𝜇
𝜌𝑔





With: k = permeability (m2), μ = dynamic viscosity (kg/ms), ρ = water density (kg/m3) 
and g = gravity (m/s2). 
 
Figure 2.7: Schematic of permeability test setup using the constant head method. dH2O is distilled water, H is 
constant head length, L is scaffold thickness and Q is flow rate. The schematic is not scaled. 
2.2.2.6. Validation of cytocompatibility and sterilisation method 
2.2.2.6.1. L929 cell culture 
L929 cells (immortalised dermal mouse fibroblast cell line) were cultured using 
DMEM 10% Serum media (10% (v/v) FCS, 2 mM L-Glutamine, 1% NEAA, 100 
IU/ml penicillin, 100 μg/ml streptomycin and 10 mM HEPES). These cells have been 
suggested by ISO 10993-5:2009 as the standard cells to use for in vitro cytotoxicity 
testing. 
Prior to the experiment two confluent T75 flasks were washed with PBS and 5mL 
of 0.1% trypsin/EDTA was added to each flask and incubated for 2-3 minutes. The 





were detached from the tissue culture plastic of the flask. Then 5 ml of warm media 
was added in each flask to neutralise trypsin and then the cell suspension was moved 
into a universal and centrifuged at 1000 rpm for 5 minutes. The supernatant was 
carefully removed, and the remaining cell pellet was resuspended in 10 ml of media. 
Using a haemocytometer, 10 μl of the cell suspension was added on each side and the 
cells were counted under a light microscope. The required cell number was then 
calculated and moved into a new universal. Media was then added to make up the 
desired volume. 
2.2.2.6.2. Sample preparation and cell seeding 
The samples were prepared by punching small 15 mm diameter circular porous 
scaffolds and films, 12 samples each. Nine of each, scaffold and film samples, were 
then sterilised using the three sterilisation methods mentioned earlier, hence three 
samples each method. The three remaining samples were autoclaved and served as the 
negative control. Afterwards, the scaffolds and films were placed into two 24 well 
plates and passively seeded, by overlaying them with 200 μl cell/media suspension 
(3.0 x 104 cells/sample). The cells were allowed to attach on the samples for 1 hour 
and then media was added to make up to 1 ml. Positive and negative controls were 
also used for comparison purposes, with positive control to be cells seeded on tissue 
culture plastic (TCP) and negative control scaffold or film with only media. Each assay 
was repeated three times (n=3) in technical triplicates. 
2.2.2.6.3. Cell metabolic activity assays 
To validate the scaffold’s cytocompatibility and how to sterilise them prior to cell 
seeding, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and 
resazurin assays were used. Both assays measure some aspect of general cell 





by converting MTT into a purple formazan product [170]. Resazurin metabolic assay 
acts the same way as AlamarBlue® [171]. The resazurin reduction test works by 
changing its original blue colour (resazurin) to a pink fluorescent dye (resorufin) in 
the medium by cell activity (likely to be by oxygen consumption through cell 
metabolism)[170, 171]. The advantage of resazurin assay over MTT assay is that it 
does not kill the cells; therefore, readings of cell metabolic activity can be taken at 
multiple time intervals. 
2.2.2.6.3.1. MTT assay 
The cell-seeded scaffolds were cultured for 48 hours in an incubator. MTT solution 
was then prepared at 0.5 mg/ml. After 48 hours, the media was removed from each 
well and washed three times with sterile PBS. Each well was then submerged into 1 ml 
of MTT solution and left for 1 hour, wrapped in aluminium foil inside the incubator. 
The MTT solution was then removed, replaced with 300 μl acidified isopropanol and 
left for 10 minutes on a shaker. Duplicates of 150 μl were then transferred to a 96 well 
plate from all the samples and the optical density (OD) was measured in an absorbance 
spectrometer reader at wavelength 570 nm. 
2.2.2.6.3.2. Resazurin reduction assay 
This experiment was run for 9 days performing a resazurin assay every 3 days. To 
prepare the resazurin stock solution at 0.25 w/v%, 0.0251g of resazurin sodium salt 
was weighed into a container. Then 100 ml of deionized water was added and the 
container was wrapped in aluminum foil to protect from light. The solution was then 
filtered using sterile syringe and sterile syringe filter (0.20 μm) inside the cell culture 






On the day of the reading, resazurin working solution was prepared by mixing 
resazurin stock solution with media at 10 v/v%. For each repeat of the experiment we 
needed 60 ml of working solution therefore 6 ml of resazurin solution plus 54 ml of 
media. The media was removed from the well and the seeded samples were washed 
with PBS. Then the samples were moved to a new well plate, to allow us to measure 
the cell activity on the samples and not on the well plate, and resazurin assay was 
performed at both well plates (well plate 1 = cells on tissue culture plastic (TCP), well 
plate 2 = cells on scaffold or film). The working solution was added at 1 ml per well. 
The well plate was then wrapped in aluminum foil and left in the incubator for 2 hours. 
Two hours later the now reduced working solution was transferred into a 96 well plate 
at 200 μl in triplicates. The plate was read using the BioTek ELx800™ absorbance 
reader at 570 nm. To prepare the samples for the next three days they were washed 5 
times with PBS ensuring that all the working solution has been washed off and then 
placed back in the original well plate with 1ml of media. The same procedure was 
repeated on Day 6 and Day 9. 
The results were normalized against the positive control (cells on TCP). To 
normalize the results, the absorbance of positive control was assumed to be 100% of 
cell activity, and the ratio of between the positive control and the absorbance obtained 
from the cells seeded on the samples was plotted. 
Additionally, the seeding efficiency was quantified during the day 3 resazurin assay 
results. The results obtained from the well plate 1 (cells on TCP) and well plate 2 (cells 
on scaffold or film) were assumed to be 100% of cells. Therefore, the seeding 
efficiency could be estimated by calculating the ratio of the metabolic activity from 





2.2.2.7. Statistical analysis 
The statistical analysis was performed using one-way and two-way ANOVA with post 
hoc Tukey with null hypothesis set that there is no interaction between sample groups, 
using Graphpad Prism 7.03. All measurements were reported as mean ± standard 
deviation (SD), and considered significant when p ≤ 0.05. 
2.3. Results 
2.3.1. Pre-PGS and PGS characterisation 
Visually pre-PGS was found to have a yellowish colour,  shown in Figure 2.8 (A); and 
when cured, the PGS film was transparent, shown in Figure 2.8 (B). 
 
Figure 2.8: Macroscopic images of (A) pre-PGS and (B) cured PGS film. 
For this project one batch of pre-PGS was synthesised, and GPC was used to 
quantify the average molecular weight distribution and the results are shown in Table 
2.1. The PDI was equal to 3.32 showing a uniform molecular weight distribution.  
Table 2.1: Gel permeation chromatography results from pre-PGS. ?̅?𝑛, ?̅?𝑤 and PDI are number average molecular 













ATR-FTIR was used to examine the chemical structure of the pre-PGS and cured 
PGS films shown in Figure 2.9. The pre-PGS spectrum presented a broad absorption 
peak at 3451 cm-1 due to hydroxyl groups as well as two sharp peaks at 2928 cm-1 and 
2852 cm-1 which belong to alkane groups stretch vibrations [172, 173]. The ester bonds 
formation is shown from the sharp peak at 1732 cm-1 and the rest of the peaks between 
1384-1049 cm-1 are due to the stretch vibration bands of carboxyl bonds. After the pre-
PGS curing process the hydroxyl group broad peak reduced and slightly shifted from 
3451 cm-1 to 3455 cm-1. A slight increase in intensity from the ester bonds at 2929 cm-
1 and 2853 cm-1 in combination with a decreased intensity from the carboxyl groups 
between 1378 cm-1 and 1047 cm-1, indicate an increase in crosslink density of PGS 
[119, 172, 173]. 
 
Figure 2.9: FTIR spectra of pre-PGS and cured PGS. (A) vertically shifted and (B) overlapped spectra. n=3 
2.3.2. PGSU-2.5% scaffold characterisation 
After characterising the PGS, HDI was mixed with pre-PGS and PGSU was 
synthesised. The PGSU-films had a transparent colour whereas the porous scaffold 
had a white colour with good mechanical properties, easy to handle, shape recovery 






Figure 2.10: Macroscopic images of PGSU-2.5% scaffolds. (A) Top, (B) cross section and (C) bottom. 
The PGSU-2.5% characterisation began with FTIR to confirm the synthesis and 
chemical structure of the scaffold. FTIR was repeated three times each repeat with a 
different PGSU-2.5% batch. The results obtained are shown below Figure 2.11. The 
ATR-FTIR spectra below are for pre-PGS, PGSU-2.5% washed with ethanol, PGSU-
2.5% not washed with ethanol, and HDI for comparison. Briefly a shift of –OH group 
from 3450 cm-1 to 3350 cm-1(-NH) is observed between pre-PGS and PGSU-2.5% 
samples indicating that the free hydroxyl groups reacted with the isocyanate groups. 
Primary and secondary amides are also found for the PGSU-2.5% samples at 1620 cm-
1 and 1578 cm-1 indicating the formation of urethane linkages. To demonstrate the 
peak of the isocyanate, pure HDI was tested using the same method applied for the 
other samples. All three spectra lack an NCO (2250 cm-1) peak implying a complete 






Figure 2.11:  ATR-FTIR spectra of pre-PGS and PGSU-2.5% scaffolds. Scaffolds were examined before prior 
ethanol extraction and post ethanol extraction and compared between them and against pre-PGS that served as a 
control. FTIR was also carried out for the HDI. n=3. 
The SEM images in Figure 2.12 represent the porous PGSU-2.5% scaffold 
fabricated using freeze-drying. The scaffolds exhibited a random structure with pores 
which are not fully defined. Additionally, the pore structure and size are different 
between sections (top, cross and bottom sections). The pore structure at the top section 
(see Figure 2.12 (A1-2)) are relatively defined and circular, whereas at the cross 
section the pore structure is not defined (Figure 2.12 (B1-2)). The pore structure at the 
bottom section is more uniform and open pore with a flake-like structure (Figure 2.12 
(C1-2)). The scaffold was also imaged from top to bottom looking into its cross 
section, Figure 2.13, and it appears that the microstructure of the scaffold is denser at 
its top and becomes less dense while moving towards the bottom section of the 
scaffold. Meaning that there is a porosity gradient moving upwards (porosity increases 






Figure 2.12: SEM images of PGSU-2.5% scaffolds taken from A1-2) top, B1-2) cross and C1-2) bottom section. 
 
Figure 2.13: PGSU-2.5% scaffold cross section from top to bottom. 
The pore size and porosity of the PGSU-2.5% scaffolds were measured and are 
summarised in Figure 2.14 and Table 2.2. The pore size changes significantly between 
sections, with the smaller pore size to be found on its top section, 12.7 ± 0.7 μm, then 
a 2-fold increase for the cross section, 24.6 ± 7.4 μm and the largest pore size was 





demonstrated, 96.9 ± 0.71 %. The higher variability of pore size in the cross section 
(± 7.4 μm) is due to the difference of the pore structure over depth, shown in Figure 
2.13. 
 
Figure 2.14: Pore size of PGSU-2.5% scaffolds. Results are shown as mean ± standard deviation. (n=50 and *** 
when p < 0.001) 
Table 2.2: Pore size and porosity of PGSU-2.5% scaffolds. Results are shown as mean ± standard deviation. (n=50 
for pore size and n=3 for porosity, *** when p < 0.001) 
PGSU-2.5% scaffold 
 Pore size (μm) ± SD Porosity (%) ± SD 
Top section 12.7 ± 0.7 *** 
96.9 ± 0.7 Cross section 24.6 ± 7.4 *** 
Bottom section 45.4 ± 2.3 *** 
 
PGSU-2.5% scaffolds were also mechanically tested for their tensile strength. 
Figure 2.15 shows the representative tensile strength – strain curve obtained from the 





and elongation at break was 61.0 ± 8.2 %. A more detailed figure is shown below at 
Figure 2.20. 
 
Figure 2.15: Representative tensile strength - strain curve of PGSU-2.5% scaffolds. 
To determine the degradation rate, PGSU-2.5% scaffolds were degraded in vitro 
using lipase and PBS, for comparison PGSU-films were also degraded, and the results 
are shown in Figure 2.16. Both the film and the scaffold samples had a very low mass 
loss in PBS, approximately ~4 % after 28 days. However, a higher mass loss was 
observed when lipase was used, and a significant difference was found between the 
PGSU-2.5% and PGSU-film. Both samples degraded linearly, reaching their highest 
mass loss at day 28, with PGSU-2.5% degraded 71.9 ± 5.4 % and the PGSU-film 






Figure 2.16: PGSU film and scaffold enzymatic degradation over 28 days period. Results are shown as mean ± 
standard deviation. (n=3, *** when p < 0.001 compared with PBS and PGSU-film) 
2.3.3. PGSU-2.5% fabrication characterisation – freezing temperature 
PGSU-2.5% scaffolds were fabricated at different freezing conditions to determine the 
effect on the microstructure.  SEM was used to image the microstructure of the 
scaffolds freeze dried at 0 oC and -50 oC shown in Figure 2.17 and Figure 2.18 
respectively. 
Similar to previous results, there is a gradient in pore size (increasing from top to 
bottom) and shape, however the scaffolds fabricated at 0 oC have a fairly uniform and 
circular pore structure. The SEM images from the PGSU scaffolds frozen at -50 oC 
have a completely different pore structure compared to the 0 oC and large voids were 


















 When the pore size was calculated, Figure 2.19, there was a significant difference 
found when changing the freezing temperature during the first stage of freeze drying. 
However, when comparing the pore sizes from -20 oC and -50 oC there was no 
significant difference observed. Additionally, within each freezing condition group the 
pore size changes significantly between scaffold sections. 
 
Figure 2.19: Pore sizes of PGSU-2.5% scaffolds frozen at different temperature, 0 oC, -20 oC and -50 oC. Results 
are shown as mean ± standard deviation. n=50, *** when p < 0.001 between groups and ### when p < 0.001 within 
groups (colours are used for # to distinguish the groups). 
The calculated porosity of the scaffolds is not affected by the freezing condition, as 
there was no significant difference between them, see Table 2.3. 
Table 2.3: Porosity of PGSU-2.5% scaffolds frozen at different temperatures. Results are shown as mean ± standard 
deviation. n=3. 
Freezing condition Porosity (%) ± SD 
0 oC 96.61 ± 0.29 
-20 oC 96.89 ± 0.71 





The mechanical properties of the scaffolds are shown in Figure 2.20. The Young’s 
modulus, Figure 2.20 (B), ranges between 0.029 ± 0.009 to 0.319 ± 0.297 MPa, but 
no significant difference was found. Similarly, the elongation at break, Figure 2.20 
(D), did not change significantly. However, it was found that the UTS from the 
scaffolds frozen at -20 oC is significantly lower than the scaffolds frozen at higher and 
lower temperatures, ranging between 0.02 ± 0.01 to 0.93 ± 0.02 MPa, shown at Figure 
2.20 (C). 
 
Figure 2.20: Mechanical properties of PGSU-2.5% scaffolds frozen at different temperatures, 0 oC, -20 oC and -50 
oC. Results are shown as mean ± standard deviation. (n=5, ** when p < 0.01, *** when p < 0.001) 
Figure 2.21 shows the results of the water contact angle measurements from the PGS-
film, PGSU-film and PGSU-2.5% scaffolds. A significant increase in the water contact 
angle was found between PGS and PGSU (both film and scaffold) probably due to the 
urethane linkages formed during crosslinking. The PGSU-film and PGSU-2.5% 





at 10 seconds but at 60 seconds the water contact angle reduced significantly (θ = 59.1 
± 2.9ο and θ = could not be measured; respectively), while cured PGS-film had a 
hydrophilic surface (θ = 46.5 ± 3.3o) for both time points. The droplet was fully 
absorbed from the PGSU-2.5% scaffolds (Figure 2.21 (C2)) and it could not be 
measured. 
 
Figure 2.21: Water contact angle of cured PGS film, PGSU-film and PGSU-2.5% scaffold over a period of 60 





angle. The water contact angle of PGSU-2/5% scaffold was 0o at 60 seconds. Results are shown as mean ± 
standard deviation. (n=3, *** when p < 0.001) 
Figure 2.22 shows the permeability results from PGSU-2.5% scaffolds fabricated 
at different freezing temperatures. Despite the significant difference in pore size and 
pore structure the permeability of the scaffold was not affected, and it ranged between 
2.7 x 10-3 – 2.8 x 10-3 m2. 
 
Figure 2.22: Permeability results measured from PGSU-2.5% scaffolds frozen at different temperature, 0 oC, -20 
oC and -50 oC. Results are shown as mean ± standard deviation. n=3. 
2.3.4. PGSU scaffold - sterilisation effect 
2.3.4.1. Physical properties 
FTIR was used to determine if the sterilisation method affected the chemical structure 
of the PGSU scaffolds, shown in Figure 2.23. It was found that the sterilisation method 
did not have a significant effect on the chemical structure, despite the fact that in the 







Figure 2.23: FTIR spectra of PGSU-2.5% compared against their sterilisation method. 
To assess the effect of the sterilisation on the scaffold’s mechanical properties they 
were tested for their UTS, Young’s modulus and elongation at break, shown in  Figure 
2.24. The highest Young’s modulus was acquired by the samples sterilised with 0.1 % 
PAA (0.042 ± 0.014 MPa), whereas the samples sterilised with 70% ethanol had 
higher UTS and elongation at break (0.506 ± 0.127 MPa and 1.373 ± 0.546 %, 






Figure 2.24: Mechanical properties obtained from the porous PGSU-2.5% scaffolds compared against their 
sterilisation method. A) Representative tensile strength - strain curves, B) Young's modulus, C) ultimate tensile 
strength and D) elongation at break. NS = non sterilised, EtOH = 70% ethanol, PAA = 0.1% paracetic acid. Results 
are shown as mean ± standard deviation. n=5. 
The permeability of the scaffolds was also characterised and the results are shown 
in Figure 2.25. Similar to before no significant difference was observed between 







Figure 2.25: Permeability of PGSU-2.5% compared against their sterilisation method. Results are shown as mean 
± standard deviation. n=3. 
2.3.4.2. Cell metabolic activity 
To examine the effects of the scaffold and its sterilisation on cellular activity, MTT 
and resazurin reduction assays were used. 
2.3.4.2.1. MTT assay 
Results obtained from MTT assay of the scaffolds and films are shown below in Figure 
2.26. The results are normalised against the TCP, presented as a percentage 
considering the TCP as 100%. The MTT assay performed on the scaffold samples 
sterilised with all three methods showed a statistically significant low optical density 
compared to the positive control, ranging between 10-20% (p<0.001). Additionally, 
the cell activity measured from the PGSU-2.5% sterilised with 70% ethanol is 
significantly higher than the 0.1% PAA. The results obtained from the film have higher 
optical density than the scaffold with no significant difference between the TCP and 






Figure 2.26: MTT assay of (A) PGSU-2.5% scaffolds (B) and films normalised against the TCP. Results are shown 
as mean ± standard deviation. n=3, * when p < 0.05. 
2.3.4.2.2. Resazurin reduction assay 
This experiment was done in such a way so that cell activity would be detected on the 
porous scaffold and film over time. For comparison reasons the reduction of the 
resazurin from the cells found on the well plate was also recorded and considered as 
the positive control. The seeding efficiency was also calculated using the day 3 results 
by normalising the absorbance of scaffold/film against the absorbance found on the 
well plates. 
Starting with the results obtained from the cell-seeded PGSU-film (Figure 2.27 (A)) 
no significant difference was observed between sterilisation methods during all time 
intervals, but the samples sterilised with 70% ethanol had the highest cell activity. 
However, the cell activity measured from the cells on the films was significantly lower 
than the TCP at all three time points. In the case of cell activity from cells cultured on 
the PGSU-2.5% scaffolds (Figure 2.27 (B)) a positive trend was recorded throughout 
the experiment with the 0.1% PAA having higher values in most cases compared to 
the other two sterilisation groups. However, no significant difference was found 





the results of PGSU-2.5% on day 3 with the TCP control, and on day 6 only the cell 
activity from the autoclaved samples were significantly different than the TCP. 
 
Figure 2.27: Normalised absorbance from the resazurin assays of PGSU-film and PGSU-2.5%. A) Metabolic 
activity of cells seeded on the PGSU-film. B) Metabolic activity from cells seeded on the PGSU-scaffold. Results 
are shown as mean ± standard deviation. n=3, ** when p < 0.01, *** when p < 0.001. 
Finally, Figure 2.28, shows the seeding efficiency calculated on day 3 by 
normalising the cell activity of the scaffold or film against their corresponding the cell 
activity measured from cells that left on the seeding well plate. In all cases the seeding 
efficiency on the scaffolds was significantly higher than the films. But no significant 
difference was found between sterilisation methods. 
 
Figure 2.28: Seeding efficiency achieved from seeding PGSU-2.5% scaffold and films. The asterisks signify the 
significant difference between PGSU-2.5% scaffold and film. Results are shown as mean ± standard deviation, 






The study presented in this chapter began with synthesising PGS. To assess the 
synthesis procedure, that was according to studies published by [118, 146, 148], ATR-
FTIR was used. The sharp peak at 1732 cm-1 confirms the formation of ester bonds. 
Additionally, the absorption peak at 3451 cm-1 indicates the presence of hydroxyl 
groups which were then used for PGSU synthesis. 
The PGSU was synthesised successfully and the porous structure formed using 
freeze-drying resulted in a large (50 mm diameter x 15 mm thickness), easy to handle 
soft PGSU porous scaffold. The scaffold could be removed from the baking tray 
effectively without damaging its structure, Figure 2.10. The size of the scaffold 
fabricated is considerably thicker than other PGS scaffolds described in Chapter 1, 
which depending on the fabrication method ranged between 1.50 – 5 mm thick. This 
is a great advantage over other PGS fabrication techniques, as being able to have a 
high throughput immediately reduces the cost of the fabrication and allows the 
scaffold to be examined and developed for larger tissue grafts. Additionally, using 
freeze drying allows the thickness of the scaffold to be adjusted by altering the volume 
of the polymer solution, therefore even larger scaffolds could be fabricated using this 
technique if required. 
The synthesis procedure of PGSU was reported previously by [118, 147, 148, 160] 
and accordingly this study followed similar procedures. To determine the reaction 
efficiency and chemical structure of the material synthesised we used ATR-FTIR, 
Figure 2.11. As expected, the free hydroxyl groups from pre-PGS reacted with the 
isocyanate group to form a urethane group. Primary and secondary amides are also 
found from the PGSU spectra signifying the formation of urethane linkages. 





been shown that HDI is highly toxic when inhaled (acute toxicity: category 1) as well 
as it can cause skin corrosion when in contact with skin (skin corrosion/sensitisation: 
category 1C). However, when used to synthesise a polymer such as PU, or crosslink 
collagen, no significant adverse effect in terms of cytotoxicity was found [174, 175]. 
Due to HDI’s hazardous properties the PGSU scaffolds that were not washed with 
ethanol were characterised to investigate if any HDI has been left unreacted and 
remained in the structure (Figure 2.11). A peak between 2270-2250 cm-1 would be 
indicative of an isocyanate group if it was present, however this peak was not present 
in any of the samples. In all repeats similar spectra were obtained confirming the 
successful synthesis of PGSU using the synthesis method established by Pereira et al. 
and replicated in this work [147]. 
To observe the scaffold’s microstructure SEM imaging was used (Figure 2.12). An 
open-pore interconnected porous structure was shown during all repeats. 
Microstructure like this is commonly found when freeze-drying is used with 1,4-
dioxane as the solvent [160, 164]. From these results the scaffold’s pore size increases 
while moving from the top to the bottom. The reason for this association between pore 
size and scaffold depth is related to the pre-freezing stage of the freeze-drying cycle, 
more specifically the freezing rate within the polymer solution. To explain this in a 
simple way, having the top surface of the polymer solution directly exposed to cold 
air coming from the freezer (-20 oC) the freezing rate is higher than the polymer 
solution that is in contact with the Teflon baking tray. Additionally, due to the low 
thermal conductivity of Teflon (0.25 W/m K) the freezing rate is reduced even more.  
Since the ice crystal size is affected by the freezing rate the pore size gradient is 
formed. Nevertheless, the pore size gradient could be advantageous in cases where the 





behaviour, pore size and structure are required for optimum results in terms of cell 
growth and neovascularisation [71, 72]. The disadvantage of pore size gradient could 
be when the scaffold is used for homogeneous tissues where a uniform pore size 
scaffold is necessary these scaffolds may not encourage uniform tissue regeneration.  
According to literature the optimum pore size for fibroblast growth varies 
significantly. One study has found that 5-15μm pore size is optimum for fibroblast 
growth [72], while another study has found that scaffolds made from poly(lactic-co-
glycolic acid)/polybutylene terephthalate copolymer has the highest fibroblast growth 
when pore sizes were 160 ± 56 μm [176]. Additionally, a more recent study, found 
that poly(2-hydroxyethelmethacrylate) scaffolds with 40 μm pore size were able to 
form dermal and epidermal layers of skin [177]. Combining the knowledge from the 
above three studies concludes to that the cell growth is not only depended on the pore 
size, but also from the biomaterial and pore structure. The pore sizes of the PGSU-
2.5% scaffolds fabricated in this study varied between 24.6 ± 7.4 – 96.2 ± 19.8 μm 
(cross section pore size) depending on the freezing temperature during the fabrication 
process. This means that the PGSU scaffolds used in this study fall within the range 
of the optimum pore sizes reported in literature for fibroblast growth, however PGSU 
scaffolds using freeze drying were never examined for their cytocompatibility, and 
this was one of the objectives of the next chapter. 
The aim of this thesis was to develop a PGSU scaffold for OMTE, which the 
scaffold structure should exhibit a uniform pore size distribution layer with a thin 
surface layer that acts as a basement membrane to separate the cell types, fibroblasts 
and epithelial cells. However, we found that pore size distribution was not uniform for 
the PGSU-2.5% scaffolds and the freezing temperature did not improve the 





will be characterized in the following chapters. The first is change the polymer 
concentration, and the second is change the mould material to a high thermal 
conductive material, for example stainless steel. The thermal conductivity of the 
mould used in this chapter, Teflon, is 0.25 W/m K which is very small compared to 
stainless steel (16 W/m K). A study done by Davidenko et al. [178] produced 5 
different moulds made from different materials aiming to fabricate  anisotropic pore 
architecture. Of interest from this work is that the mould they made by a high thermal 
conductive 316L stainless steel (diameter 45 mm and height 13 mm) was able to 
successfully produce a collagen porous scaffold, fabricated using freeze-drying, with 
a consistent pore size throughout its depth. 
The porosity of the scaffolds in this study was very high, average porosity 96.89 ± 
0.71 % (Table 2.2) and due to the high porosity, the water permeability was also very 
high (Figure 2.25). The combination of these two characteristics of the PGSU-2.5% 
scaffold aid in pore interconnectivity and subsequently in seeding efficiency, cell 
distribution and adequate nutrient and gas exchange between cells. As with pore size, 
the optimum porosity for tissue engineering is again debated in the literature and it is 
heavily depended on application, cell type and biomaterial. For example, for 
chondrogenesis a PCL scaffold should have 95% porosity [179] while a chitosan 
scaffold should have 80% porosity [180]. Regarding fibroblast proliferation, a silk 
fibroin scaffold with 86% porosity had lower cell proliferation than the same scaffold 
with 91% porosity [181]. 
The permeability of the scaffold is also important (Figure 2.22). This property is 
rapidly gaining interest in the literature because a direct link was found between 
permeability and nutrient diffusion and it also serves as a measure of interconnectivity 





but the permeability did not change between samples, even though the pore size and 
structure was different. Therefore, since the permeability was not affected by pore size 
and pore structure, it can be concluded that the porosity plays a more important role 
on the permeability of the scaffold. Comparing the permeability results from the 
PGSU-2.5% scaffold with the literature is difficult because there is no standard method 
for measuring permeability [169]. In this study we used the constant head method and 
calculated the permeability using Darcy’s law. One study fabricated 
collagen/hydroxyapatite scaffolds using freeze drying with the highest porosity equal 
to ~87.5% and measured the permeability of their scaffolds with the same method as 
in this study. The permeability reported from their scaffolds was between 0.17 x 10-8 
- 7.0 x 10-8 m2, and compared to the scaffolds from this study (~2.8 x 10-3 m2) they are 
five orders of magnitude less permeable, probably because of the ~10% higher 
porosity found from the PGSU-2.5% scaffolds, as well as the hydrophobic property of 
the scaffold (2.68 ± 0.93 % swelling ratio in PBS solution after 24h [148]) compared 
to a high hydrophilic collagen scaffold (>200 % swelling ratio in PBS solution at 5 
min) [182, 183]. The results presented in this chapter demonstrate we have developed 
a scaffold with high pore interconnectivity that will allow nutrient diffusion, which is 
necessary for cell and tissue viability before a sufficient blood supply is established. 
The PGSU-2.5% scaffolds were also characterized for their mechanical strength 
using tensile testing, Figure 2.15. The purpose of this was to understand the 
mechanical behavior of the scaffold and determine the maximum load it can withstand 
as well as how much it can be stretched before breaking. The scaffold appears to have 
weak UTS (0.013 ± 0.005 MPa) compared to the oral mucosa (1.29 ± 0.19 MPa), 
which could be a problem as high forces will be applied to it once implanted and the 





properties is its high porosity and non-uniform pore structure. The material itself when 
it was characterised by Pereira et al. [147] as a 2D film had mechanical properties 
higher than oral mucosa (1.35 ± 0.76 – 12.1 ± 1.9 MPa), however in their case they 
were using PGSU-film. When the PGSU was fabricated into a highly porous structure 
it immediately lost its mechanical strength. This could be solved by three ways; the 
first one is by altering the molar ratio of the reactants; the second is to change the 
microstructure of the scaffold; and third is change the polymer concentration. The 
latter two will be investigated in this thesis (Chapter 3). 
In vitro enzymatic degradation was also examined for PGSU-2.5% and PGSU-
films to determine the degradation kinetics. The enzyme used, lipase, is known to play 
an important role in degrading polyesters when in vivo acting as a catalyst for 
hydrolysis.  It was found that the PGSU-2.5% degraded (71.85 ± 5.4 %) significantly 
faster than the PGSU-film (24.5 ± 1.9 %). From previous work on PGSU it was shown 
that this polymer degrades through hydrolysis by surface erosion [147]. Knowing this 
we can justify that the faster degradation rate of the scaffold was because it is a 
scaffold, it has a higher surface area compared to the film, meaning higher exposure 
to lipase and hydrolysis. Pereira et al., characterised the in vivo degradation rate of 
PGSU films, lower and higher reactant ratio than this study (Figure 1.19 (C)), and 
found that the PGSU films degraded slower than in vitro (Figure 1.15) [147]. This 
does not agree with PGS. PGS was found to completely degrade in 60 days when in 
vivo whereas it degraded 18% in vitro [126]. This contradiction is probably because 
of the urethane linkages found within PGSU, that protect the ester bonds from 
degrading as fast as PGS does. Therefore, from Pereira et al., work we can assume that 
PGSU-2.5% and PGSU-film will degrade slower in vivo, however this should be 





We attempted to investigate the freezing temperature effect on the scaffold’s 
microstructure. The aim of this was to understand how the scaffold’s microstructure 
relates to its mechanical properties and permeability. Knowing that the melting point 
of 1,4-dioxane is 11.4 oC we chose three temperatures that were below the melting 
point, 0 oC, -20 oC and -50 oC. The scaffolds fabricated at -20 oC are the ones that were 
discussed above. When the polymer solution was frozen at higher temperature, 0 oC, 
in other words lower freezing rate, we found that the pore structure had a more defined 
circular structure and was more uniformly distributed (Figure 2.17). But in the case of 
lower temperature, -50 oC, or higher freezing rate, a less defined structure was 
observed with large voids and thin walls separating each pore (Figure 2.18). The size 
of the pores also significantly decreases as freezing rate increase, which was expected. 
Therefore, we determined that the slower the polymer solution is frozen a more 
defined and uniform pore structure is achieved, and significantly higher pore size. 
However, the pore size gradient is evident from these scaffolds as well, meaning that 
altering the freezing rate cannot eliminate the gradient in pore size but only change its 
size and make it more defined when it is frozen at a slower rate. 
The mechanical properties increased significantly when the freezing rate was both 
higher and lower, Figure 2.20. This is probably due to the microstructure of the 
scaffolds, and since the porosity remained the same it is most likely due to differences 
in the pore size and structure. Beginning with the lower freezing rate, or highest 
temperature, 0 oC, the scaffold had the highest pore size and circular uniform pore 
structure which most probably helped in increasing the UTS by distributing the 
mechanical load evenly throughout its structure. For the highest freezing rate, or 
lowest temperature, -50 oC, the scaffold did not show any significant difference in pore 





to a higher UTS. Therefore, the pore structure has a significant effect on how the 
scaffold behaves under mechanical load by increasing its UTS but keeping its 
resistance to deformation (Young’s modulus) and elongation at break similar. 
The next step of this chapter was to determine the best and easiest method to 
sterilise the scaffold for laboratory cell culture use. We chose the three most used 
sterilisation methods for preliminary laboratory use, 70% ethanol, 0.1% PAA and 
autoclave, and a preliminary study was performed to understand the effect that each 
sterilisation method had on the scaffold’s chemical structure, mechanical properties, 
permeability, cell metabolic activity and cell seeding. FTIR was used to characterise 
the chemical structure of the scaffolds after sterilizing (Figure 2.23) and no difference 
was found between the spectra, meaning that the chemical structure remained the same 
after sterilisation. 
The effect the sterilisation method had on the scaffold’s mechanical properties was 
also investigated. It was found that the sterilisation method did not significantly affect 
the tensile strength of the scaffolds. The only consistency found was that the 
autoclaved samples had the lowest UTS, Young’s modulus and elongation at break 
which indicated that the high temperature during autoclaving (120oC) might have a 
negative effect on the mechanical properties. However, no significant difference was 
found. These results are advantageous, as the scaffold should not have its mechanical 
properties changed when sterilized if it is going to be used commercially. With this 
said we have not tested any other clinically acceptable sterilisation methods (ethylene 
oxide, gamma irradiation) as we did not have access to these, but it is planned for 
future work. There are a few studies that looked into how their scaffolds change when 
sterilised and most of them looked into the mechanical properties. For example when 





when ethanol was used, believed to be due to scaffold structural change [184]. 
Additionally, when PLA scaffold was autoclaved its mechanical strength increased 
due to recrystallisation of the polymer [185]. 
When comparing the permeability of the scaffolds sterilised with different methods 
there was not significant difference found, meaning that after sterilizing the scaffold 
it will still be highly permeable and allow good nutrient diffusion essential for the cell 
survivability.  
To examine the cytocompatibility of PGSU-2.5% scaffolds and PGSU-films we 
used MTT and resazurin assays. MTT assay was the first assay used performed 48 
hours post seeding the samples. It was noticed that the optical density from PGSU-
2.5% scaffolds was very low compared to the PGSU-film and TCP. Examining 
visually the scaffolds after the MTT assay it was realised that the scaffolds converted 
the MTT into dark purple formazan, expected from MTT assay, however the stain 
could not be eluted from the scaffold and read, hence a low optical density was 
measured. This issue was not present for the PGSU-film and TCP resulting in a non-
accurate comparison for cell activity assay. 
We then moved into using resazurin assay that eliminated the procedure of eluting 
off the substance produced by the assay to measure its optical density. It also had the 
advantage of not killing the cells after the assay, therefore we were able to measure 
the cell activity through nine days culture at multiple time points. When examining 
PGSU-2.5% scaffold for their cell activity a positive trend was formed during the nine 
days of culture. This indicated that cells adhered and were metabolically active on the 
samples as the amount of cell metabolism increased over time, most likely as a result 





found that only the scaffolds sterilised with 70% ethanol and 0.1% PAA had a 
significantly higher metabolic activity between days 3 and 9 compared to autoclaved 
samples. This means that sterilising PGSU scaffolds with autoclave has a small 
negative effect on both mechanical properties and cytocompatibility. To allow us to 
further establish which sterilisation method we should use for the rest of the project, 
we examined the seeding efficiency. As shown in Figure 2.28 the seeding efficiency 
was significantly higher for the PGSU-2.5% scaffolds compared to the PGSU-film, 
and this is because the scaffold has higher surface area and pores which allows the 
cells to penetrate its structure. When looking at the effect of the sterilisation method, 
the PGSU-2.5% scaffolds showed no significant difference between sterilisation 
methods, but it was found that the standard deviation was higher for 0.1% PAA and 
autoclaved samples compared to those sterilised in 70% ethanol. For this reason, 70% 
ethanol was used for subsequent experiments. The non-reproducible seeding 
efficiency was directly reflected to the cell activity assays, both MTT and resazurin, 
thus the high error bars found in those assays. With this said, the seeding method must 
be modified, and a robust, repeatable protocol should be established. The resazurin 
assay demonstrated an advantage over the MTT assay allowing us to examine the cell 
metabolism over time, overcoming the issues occurred while using MTT assay. 
2.5. Conclusion 
This experimental chapter focused on understanding the synthesis and fabrication of 
the PGSU scaffold as well as to determine how the scaffold should be treated and 
prepared for cell culture. The results from this study demonstrate that: 





2. PGSU-2.5% scaffolds were successfully fabricated with high porosity and 
water permeability 
3. The pore size, pore structure and mechanical properties of the scaffolds was 
significantly different when the pre-freeze temperature was changed 
4. Pore size gradient was evident for all the PGSU scaffolds that were fabricated 
5. The permeability of the scaffolds was not affected by pore size/structure but 
was determined solely by the porosity of the scaffolds 
6. The mechanical properties of the scaffolds were significantly lower than oral 
mucosa’s biomechanical properties 
7. The sterilisation method did not affect the chemical structure and mechanical 
properties of the scaffold, and no contamination was observed during the 9 
days in vitro cell culture 
8. The seeding efficiency was more consistent when the scaffolds were sterilised 
with 70% ethanol 
The findings of this chapter demonstrate that the PGSU scaffold should be 
improved in terms of its mechanical properties to be able to mimic at least the buccal 
mucosa in order to ensure that it can withstand in vivo mechanical forces. Furthermore, 
the pore size gradient should be reduced which can help in improving mechanical 
properties (by distributing the mechanical load homogeneously), but also to mimic the 
lamina propria of the oral mucosa. Regarding the in vitro cell culture aspect of this 
chapter, it was determined that the seeding technique requires significant optimisation 
to increase the seeding efficiency. From the three sterilisation methods used, it was 
decided to proceed with using 70% ethanol because it did not affect the physical 











Chapter 3 Biocompatible poly(glycerol sebacate urethane) 
scaffolds with controllable porous structures and mechanical 
properties 
Aim 
To fabricate PGSU scaffolds with controlled microstructure, mechanical properties 
and degradation rate and to investigate their effect in tissue development. 
3.1. Introduction 
The successful synthesis and scaffold fabrication of PGSU described in Chapter 2 
allowed us to characterise its physical and biological properties and helped us to 
understand what needs to be optimised and how to further examine these scaffolds. 
Following the results of Chapter 2 we wanted to improve the microstructure of the 
scaffold and mechanical properties as well as the cell seeding technique. The aims of 
this chapter were to achieve a homogeneous architecture with good reproducibility, 
and to significantly increase the mechanical properties, to make them closer to native 
oral mucosa, compared to those reported in the previous chapter. 
One method to vary a scaffold’s properties is to alter porosity without changing the 
chemical structure of the polymer. Porosity is essential to a scaffold, as it is necessary 
for cell seeding and vascular/cell ingrowth [186]. For example, PU scaffolds were 
fabricated with two different porosities, 73% and 86%, and were subcutaneously 
implanted on the back of 24 Winstar albino rats and examined for tissue ingrowth after 
24 weeks. Significantly higher tissue ingrowth was found for the 86% porosity 





allows for bodily fluids to perfuse the structure more easily, and may allow for more 
rapid ingrowth of host tissue [188].  
The freeze-drying scaffold fabrication technique enables control of pore size and 
porosity based on freezing procedure and polymer concentration [149]. In this study 
freeze-drying was used to fabricate PGSU scaffolds with different pore sizes and 
porosities by changing the polymer concentration. We aimed to determine the effect 
of polymer concentration on the mechanical properties and degradation of the scaffold 
as well as the biological response to the scaffolds in vitro (measuring cell viability and 
matrix production). SEM was used to determine the scaffold’s microstructure, the 
mechanical properties were investigated in a range of mechanical tests (tensile testing, 
cyclic loading etc) and the degradation rate was measured in vitro using enzymes. The 
in vitro cell activity was studied using resazurin assay over 15 days of culture. The 
new knowledge gained from this study will inform the development of PGSU 
scaffolds for a range of TE applications. 
3.2. Materials and Methods 
3.2.1. Materials 
The materials for this chapter are the same as in Chapter 2 with the addition of: 
Direct red 80 was purchased from Sigma-Aldrich and Rat tail high concentration 
collagen type I was purchased from Corning®. The aluminium plate 6082 T651 was 
purchased from Aluminium Warehouse. 
3.2.2. Methods 
3.2.2.1. Pre-PGS synthesis 





3.2.2.2. PGSU-5, 10, 15% scaffolds 
3.2.2.2.1. Aluminium tray mould 
An inhouse aluminium grade 6082T6 tray was manufactured to feature 6 symmetrical 
wells as shown in Figure 3.1. This mould will be referred as “Mould-random” in the 
following sections. 
 
Figure 3.1. Aluminium tray mould with 6 wells for random orientation (mould-random) scaffold fabrication. Scale 
bar is 5 cm. 
3.2.2.2.2. Random orientation PGSU scaffolds 
Porous PGSU scaffolds were synthesised by dissolving pre-PGS into 1,4-dioxane at 
the required concentrations (5, 10 and 15 w/v%) and pre heated to 55 oC with 0.05% 
w/v of Tin(II) 2-ethylexanoate. Once heated, HDI was added at a 0.6 molar ratio 
(glycerol:HDI) and left at 55 oC for 5 hours under constant stirring. For ease of 
documentation, the nomenclature of the samples is PGSU-X where X refers to the 





The PGSU solution was cast into mould-random and placed into a freeze dryer 
(FreeZone Triad Dry System, Labconco Co., USA) set at -50 oC and left for 3 h for 
the solution to completely freeze. The lyophilisation process then started with the shelf 
temperature heated at a rate of 1 oC/min to 0 oC and left for 16 h under vacuum pressure 
(0.1 mbar). For the secondary drying stage, the temperature was increased at a rate of 
1 oC/min to 40 oC for another 24 h. The reason the freeze-drying cycle changed was 
to increase the freezing rate which was hypothesised that it will increase the uniformity 
of the scaffold microstructure, and the lyophilisation (primary drying) temperature 
was increased to 0 oC from -10 oC because the 1,4 dioxane could still be below its 
triple point (shown in Figure 3.3) but the sublimation rate could be increased. The 
freeze drying cycle is shown in Figure 3.4. 
 
Figure 3.2. Synthesis and fabrication method schematic for PGSU scaffolds. 
 
Figure 3.3: Three-phase diagram of 1,4-dioxane derived from the data provided from National Institute of 





Phase). Ttp: Triple point temperature, Ptp: Triple point pressure. The purple circle shows the temperature and 
pressure of the 1,4-dioxane during primary drying in the freeze drier. 
 
Figure 3.4. Freeze drying cycle during the PGSU porous scaffolds fabrication procedure. 
All scaffolds were washed with ethanol to remove any unreacted substances from 
its construct. The washing was done by submerging the scaffold in 100%, 70% and 
50% Ethanol for 2 hours each, and then immersed in distilled water overnight. Shaking 
was also applied to the scaffolds during washing. 
3.2.2.3. Porous scaffold characterisation 
The scaffold was characterised as in Chapter 2: Section 2.2.2.5 with the addition of 
cyclic loading and suture retention strength described below. 
The cyclic loading was performed using the same sample dimensions as in Section 
2.2.2.5.4 (n = 3) in which the samples were tensile loaded to 30% strain for 100 cycles 
at 100 mm/min rate of travel using a 10 N load cell. The first and last cycle were 





The suture retention strength was done according to BS EN ISO 7198:2017 
standard. The sample was cut normal to the long axis and a suture was inserted 2 mm 
from the end of the sample and a half loop was formed. The suture was then pulled, 
using a 10 N load cell, at 200 mm/min and the force required to pull the suture through 
was recorded and plotted in grams. Five specimens were tested for each condition. 
3.2.2.4. Microstructure effect on cell viability 
L929 mouse fibroblasts cells were cultured as in Chapter 2: Section 2.2.2.6.1. 
3.2.2.4.1. Sample preparation and cell seeding 
All the cell experiments were repeated three times in triplicates. PGSU scaffolds were 
prepared with diameter = 10 mm, thickness = 2 mm in triplicates for each 
concentration. The samples were sterilised overnight with 70% ethanol and then under 
sterile environment washed thoroughly with PBS. To optimise the seeding efficiency 
from the previous chapter, the samples were placed in a 12 well-plate and fixed within 
a 10 mm inner diameter surgical stainless steel ring. The samples were passively 
seeded, by overlaying them with 200 μl of cell/media suspension (0.5, 1.0, 2.0 x 106 
cells/sample which amounts to ~3000, 6000, 12000 cells/mm3) and topped up to 2 ml 
after 2 h incubation. The next day the seeded scaffolds were moved to a fresh well-
plate to ensure that any cell activity measured during the experiments was due to the 
cells on the scaffold. All the cell cultures were carried out for 15 days. Cells seeded 
on TCP acted as positive control, and acellular scaffolds as negative control. 
3.2.2.4.2. Resazurin reduction assay 
The cell metabolic activity was measured every 3 days using resazurin metabolic 
activity assay. The resazurin stock and working solutions were prepared as mentioned 





ml of working solution was added to each sample and left in the incubator for 3 h, 
wrapped in aluminium foil. Then, 200 μl of reacted resazurin working solution were 
transferred into a 96 well-plate in sextuplicate, and the plate was read using the BioTek 
ELx800™ absorbance reader at 570 nm. The samples were then washed three times 
and fresh media was added. 
3.2.2.5. Histology 
After 15 days culture the samples were fixed in 3.7% formaldehyde. The samples were 
paraffin-embedded and sectioned (6 μm). The sections were dewaxed, rehydrated and 
stained with haematoxylin and eosin (H&E). 
3.2.2.6. Sirius red staining 
Sirius red is used to stain collagen for histochemistry and to assess the amount of 
collagen found in the samples. Sirius red is an anionic dye, which can bind on the 
positively charged guanidine group of arginine found on the collagen molecule, more 
specifically collagen types I and III [189]. 
The collagen production was quantified using Sirius red stain (0.1% (w/v) Direct 
Red 80 in saturated picric acid). The stain was added (2 ml per sample) and left for 16 
h to bind on the collagen. The excess stain was then removed by washing the samples 
distilled water for 15 times. The samples were then dried in a vacuum oven at 25 oC, 
weighed and the stain was eluted using 2 ml of 0.2 M NaOH:methanol 1:1 for 15 min 
on a rocking shaker. The absorbance was then measured at 490 nm in an absorbance 
plate reader (Bio-Tek ELx800). 
 To create a Sirius red standard curve the same procedure above was done on 
known amounts of rat tail collagen type I. Briefly, the collagen, which was dissolved 





mg/ml in cold distilled water. The solutions were then frozen and freeze dried to 
remove all the solvents (acetic acid and water). Sirius red was then carried out as above 
and the results were plotted as absorbance against collagen mass. 
3.2.2.7. Statistical analysis 
The statistical analysis was performed as in Chapter 2: Section 2.2.2.7. 
3.3. Results 
3.3.1. Characterisation of PGSU scaffold 
3.3.1.1. ATR-FTIR of PGSU scaffolds 
ATR-FTIR was carried out to confirm the synthesis and chemical structure of PGSU, 
with the spectra shown in Figure 3.5. The pre-PGS is characterised by the -OH stretch 
at 3450 cm-1, sharp peaks at 2929 cm-1 and 2856 cm-1 which belong to the stretch 
vibration of C-H, finally carbonyl (C=O) and ether (C-O) stretching vibrations are 
observed at 1732 cm-1 and 1160 cm-1, respectively [172]. The PGSU samples exhibit 
amine (-NH) stretch vibration at 3350 cm-1 and bending vibration of amide I, II and 
III bands at 1620 cm-1, 1578 cm-1 and 1238 cm-1, respectively, which are all absent in 
pre-PGS proving the formation of urethane linkage [147, 148]. Additionally, HDI was 
examined using FTIR and compared with the spectra obtained from the PGSU 
scaffolds and it was found that the scaffolds were lacking from an NCO peak at the 






Figure 3.5: ATR-FTIR spectra of pre-PGS and the PGSU scaffolds. All three polymer concentrations were 
examined and compared against pre-PGS that served as a control. FTIR was also carried out for the HDI. n=3. 
3.3.1.2. Microstructure of the PGSU scaffolds 
Unlike the previous chapter a different mould was used, referred to as mould-random, 
and the -50 oC freeze drying cycle was used to fabricate PGSU porous scaffolds. The 
scaffolds were imaged using SEM and they presented a more uniform open pore 
interconnected structure. Figure 3.6 shows the measured pore size and porosity from 
each scaffold respectively. The top section of PGSU-5% and PGSU-10% (Figure 3.7 
(A1-2), (B1-2) respectively) presented a circular pore structure and there was no 
significant difference in pore size. However, the pore structure and pore size were 
significantly different for the PGSU-15% (Figure 3.7 (C1-2)), where the pore size 
decreased by almost half (from 12.3 ± 1.9 μm to 6.4 ± 1.6 μm). The cross sectional 
area of all scaffolds had the same uniform pore structure, with elongated pores stacked 
on each other, but the pore size significantly decreased from 28.2 ± 5.3 μm to 16.1 ± 
2.6 μm, as polymer concentration increased. The bottom section of the scaffolds had 
less pores when the polymer concentration was increased to the higher concentration, 





when there were pores they were larger than in the PGSU-10%. Pore size gradient was 
found for all three scaffolds. The less gradient was observed from PGSU-10% as there 
was no significant difference when comparing its top with bottom sections. 
Additionally, it was observed that for PGSU-5% and PGSU-10% scaffolds their cross-
section had the largest pores compared to their top and bottom sections. The porosity 
was also affected by the polymer concentration. It was found that PGSU-5% (lowest 
polymer concentration) was the most porous (96.4 ± 0.3%), PGSU-15% the least 
porous (88.9 ± 0.4%), and PGSU-10% was in between (92.3 ± 0.7%). 
 
Figure 3.6: Measured (A) pore size (n=50) and (B) porosity (n=5) of the PGSU scaffolds from three different 
sections. Results are shown as mean ± standard deviation, (A) n=5, *** when p < 0.001 between groups and ### 











3.3.1.3. Mechanical Properties 
The scaffolds were subjected to tensile testing to examine their mechanical behaviour. 
Figure 3.8 (A) shows the stress-strain curves of PGSU scaffolds fabricated with 
different polymer concentrations, and Figure 3.8 (B-D) show a summary of the results. 
When the polymer concentration increased, so did the Young’s modulus, UTS and 
elongation at break with the highest values obtained from PGSU-15% equal to 0.65 ± 
0.18 MPa, 0.86 ± 0.21 MPa and 122 ± 19 %, respectively. The polymer concentration 
significantly affected UTS, when comparing PGSU-5% to PGSU-10% the UTS 
increased by ~9-fold and comparing PGSU-10% to PGSU-15% UTS increased ~2-
fold. Similar increases were found for the Young’s modulus as well, which increased 
~9-fold between PGSU-5% and PGSU-10%, ~12-fold for PGSU-5% against PGSU-
15% and ~1.5-fold when comparing PGSU-10% with PGSU-15% (Figure 3.8 (B)). 
The elongation at break was only statistically higher when comparing the values of 
PGSU-5% and PGSU-15% (~1.3-fold higher) (Figure 3.8 (D)). A negligible loss of 
tensile strength was observed for all three scaffolds after 100 tensile cycles, signifying 
the ability of the scaffold to recover its strength and shape after deformation. The last 
mechanical property that was examined was the suture retention strength of the 
scaffolds, shown in Figure 3.8 (F). As expected the suture retention was significantly 
increased while the polymer concentration increased, with the highest force of 247.5 
± 37.5 g obtained from the PGSU-15%, which is well above the surgical requirement 






Figure 3.8: (A) Representative stress-strain curve, (B) Young’s modulus, (C) ultimate tensile strength, (D) 
elongation at break, (E) cyclic loading, and (F) suture retention strength of the PGSU scaffolds. Results are shown 
as mean ± standard deviation, n=5, * when p < 0.05. 
3.3.1.4. In vitro enzymatic degradation 
Figure 3.9 shows the mass loss of scaffolds over time degraded in lipase solution, with 
enzyme-free PBS as a control. When the concentration of polymer was increased, the 
degradation rate decreased. In lipase, PGSU-5% degraded 52.3 ± 3.8%, a slightly 
slower degradation rate was observed for PGSU-10% with mass loss equal to 39.3 ± 
3.9% and consequently, the highest concentration, PGSU-15%, exhibited an even 
smaller mass loss of 19.1 ± 1.0%. For the scaffolds degrading in the PBS without the 
enzyme there was only minimal losses observed (PGSU-5% = 1.99 ± 0.55%, PGSU-
10% = 0.47 ± 0.23%, PGSU-15% = 0.22 ± 0.19%) from all three scaffolds with no 






Figure 3.9: In-vitro enzymatic degradation of PGSU5%, 10% and 15% scaffolds. Samples were degraded in PBS 
as a control. Results are shown as mean ± standard deviation, n=3, *** when p < 0.001. 
3.3.1.5. Scaffold permeability 
The permeability of the scaffolds (Figure 3.10) was also significantly affected by the 
polymer concentration. The PGSU-5% scaffolds had the highest water permeability 
(3.8 x 10-3 m2), in PGSU-10% scaffolds the permeability reduced by almost half (1.9 
x 10-3 m2), while for PGSU-15% scaffolds the permeability was reduced by an order 






Figure 3.10: Scaffold water permeability using the constant head method and Darcy's law. Results are shown as 
mean ± standard deviation, n=3, *** when p < 0.001. 
3.3.2. Long term cell culture 
The cell culture study began with an investigation into a suitable cell seeding density 
(L929 mouse fibroblasts) using resazurin assay at day 1 (Figure 3.11). It was found 
that seeding the scaffolds (10 mm diameter, 2 mm thickness) with 0.5 x 106 cells had 
a significant variation between cell activity on the PGSU scaffolds, with PGSU-10% 
having the lowest cell metabolic activity. However, the other two seeding densities, 
1.0 and 2.0 x 106 cells, did not show any significant difference between them, leading 
to the assumption that the scaffolds had the same number of cells attached. 
The seeding efficiency was also examined by normalising the day 3 resazurin assay 
results (seeded with 1.0 x 106 cells) with the TCP (positive control) (Figure 3.12). 
There was significant difference found between the cell metabolic activity on the 
scaffolds compared to the TCP, but no significant difference was found between 







Figure 3.11: Resazurin assay of multiple cell seeding densities at day 1. Results are shown as mean ± standard 
deviation, n=3, * when p < 0.001. 
 
Figure 3.12: Seeding efficiency experiment calculated by the cell metabolic activity found on the scaffolds 
normalised against the TCP (positive control) on day 3 using resazurin assay. The statistical significance is 
shown against the TCP. Results are shown as mean ± standard deviation, n=3, *** when p < 0.001. 
3.3.2.1. Cell activity 
Scaffolds in TE must provide the cells with a viable environment to let them adhere 





fibroblast cells (1.0 x 106 cells), which are the cells suggested by BS EN ISO 10993-
5:2009 for biological evaluation of medical devices and the results are shown in Figure 
3.13. In the range of 15 days culture the cell activity significantly increased every 3 
days reaching ~4-fold increase in cell activity, but no significant difference was found 
between polymer concentration groups. Between days 12 and 15 there was no 
significant increase in cell metabolic activity which suggests that high cell confluency 
was reached around day 12. 
 
Figure 3.13: Cell activity of L929 cells seeded on PGSU-5%, 10% and 15% scaffolds measured by resazurin assay. 
(n=3, *** when p < 0.001) 
The samples were fixed and sectioned at the end of the 15 days culture and 
histological analysis was performed, their cross section is shown in Figure 3.14. Cells 
were attached onto all three types of scaffold, with a dense cell layer on the seeding 
surface. When comparing the cell penetration inside the scaffolds, the cells penetrated 
deeper into the PGSU-5%, and less penetration was found in the scaffold with the 






Figure 3.14: Histological analysis (H&E staining) of the cell seeded PGSU scaffolds for all three concentrations 
(A) PGSU-5%, (B) PGSU-10% and (C) PGSU-15% after 15 days L929 culture. 
3.3.2.2. Collagen content 
To produce a Sirius red standard curve an assay was run on known amounts of collagen 
type I isolated from rat tail. The results are shown below in Figure 3.15. The gradient 
of the curve was almost equal to 1 which shows that the equation produced will give 
accurate results when converting absorbance into collagen mass, with limit of 
detection (LOD) = 0.000413 mg and limit of quantitation (LOQ) = 0.001251, shown 
in Figure 3.15 insert (bottom right corner). 
 
Figure 3.15: Standard curve of Sirius red on known amounts of collagen type I isolated from rat tail. A 
magnification of the standard curve is also shown to indicate with a vertical dotted line where the limit of detection 





Figure 3.16 shows the results of the collagen content measured by Sirius red on cell 
seeded scaffolds cultured for 15 days. The results are presented as collagen / dry 
sample (w/w%), and their summary is shown in Table 3.1. The PGSU-5% showed a 
significantly higher collagen content, 7.5 ± 2.6%, compared to the PGSU-10%, 1.7 ± 
0.6%, and PGSU-15%, 0.4 ± 0.3%. Macroscopic images of the stained PGSU samples 
were also taken and are shown in Figure 3.17, which demonstrated the difference in 
colour intensity prior to eluting the stain. Additionally, there was contraction observed 
for the PGSU-5%, assumed to be cell driven, due to the higher collagen content and 
weaker mechanical properties. SEM images were also taken looking at the cross 
sectional area of the samples after the 15 days cell culture (Figure 3.16 (B-D)). The 
SEM images demonstrated that a previously highly porous PGSU-5% scaffold had an 
enclosed pore structure due to the collagen deposition, and the amount of collagen 






Figure 3.16: (A) Collagen content as a percentage of the dry sample’s mass deposited by L929 cells after 15 days 
of culture. SEM images of (B) PGSU-5%, (C) PGSU-10% and (D) PGSU-15% from the cross section area of the 
scaffolds after culture. Results are shown as mean ± standard deviation, n=3, ** when p < 0.01. 
 
Table 3.1: Collagen content and dry sample mass measured on each sample group. The ratio was then calculated 
and demonstrated as collagen concentration per dry sample mass. Results are shown as mean ± standard deviation, 






(% of dry sample weight) 
PGSU-5% 0.16 ± 0.08 1.81 ± 0.13 7.48 ± 2.13** 
PGSU-10% 0.10 ± 0.08 3.42 ± 0.18 1.72 ± 0.48 
PGSU-15% 0.03 ± 0.02 4.56 ± 0.73 0.44 ± 0.26 
 
PGSU-5% PGSU-10% PGSU-15% Negative control 
    
Figure 3.17: Representative images showing the scaffolds after picrosirius red staining, which stains collagen with 
red dye A shrinkage is observed for the PGSU-5%, due to its weaker mechanical properties and higher collagen 
content. Negative control were acellular scaffolds. Scale bar is 10 mm. 
3.4. Discussion 
Following the results from Chapter 2 the objective of this chapter was to optimise the 
microstructure and enhance the mechanical properties of the scaffolds. The 
microstructure of the scaffold had to be uniform with defined pore structure, while 





UTS and Young’s modulus, needed to be enhanced since they were considerably 
weaker than the biomechanical properties of oral mucosa. Since the fabrication 
technique was freeze drying, we determined a simple method to alter both 
simultaneously and we performed a thorough characterisation of these scaffolds in this 
chapter. Therefore, to perform this study, we synthesised and fabricated porous PGSU 
scaffolds with various  uniform microstructures and enhanced physical properties as 
both have been shown to affect the cell biocompatibility and tissue regeneration [187, 
191]. 
When changing the PGSU synthesis procedure, by either changing the reactant ratio 
or the polymer concentration, the chemical structure of the material might change as 
well. This was well demonstrated by [147] and [118, 148], which found that by 
changing (increasing) the reactants ratio there were more urethane groups present. In 
this study we did not change the reactant ratio (1:0.6) but we increased the 
concentration of pre-PGS during polymer synthesis. Using ATR FT-IR (Figure 3.5) 
we found that the results closely resembled the results of Chapter 2, Pereira et al. [147] 
and Frydrych et al. [148]. Additionally, the absence of the characteristic HDI peak 
(2250 cm-1) from the PGSU spectrum, demonstrates a complete reaction of the 
isocyanate groups with the hydroxyl groups. As mentioned in the previous chapter it 
is essential to completely remove the HDI from the scaffold construct because of its 
highly toxic properties. Hence the reason for the thorough ethanol washing that was 
done to all PGSU scaffolds in this study. In an encyclopaedia of industrial chemistry 
it was reported that one of the best ways to purify from HDI is using 50% ethanol due 
to its solubility in this solvent [192]. 
During freeze drying the pores in the scaffold are dependent on the freezing 





has dried. Therefore, controlling the way of freezing leads to controlling the crystalline 
structure and subsequently the pore size and structure [149]. In this chapter, unlike the 
scaffolds fabricated in Chapter 2 we designed a new mould made from aluminium and 
from the results of Chapter 2 we used an optimised freeze drying cycle. The 
modification in the scaffold fabrication was to increase the freezing rate. The control 
of freezing rate and thermal gradient is also called ice templating. During the freezing 
stage, the nucleation is considered as the moment that defines the ice structure 
formation, which renders it important in scaffold fabrication using freeze drying [193]. 
However, the final pore structure is also affected by the ice crystal growth, which is 
influenced by the freezing system. A major contribution in the freezing system was 
found to be the mould (its design and material) [194]. The role of the mould during 
ice templating is to control the heat flow. It was shown before that having a 
symmetrical mould in terms of geometry and thermal conductivity, less gradient in 
heat flow is formed therefore more uniform pore structures can be obtained [194]. In 
this chapter we improved both freezing system and freeze drying cycle. Using 
aluminium over Teflon the thermal conductivity of the mould was ~820 times higher 
and the pre-freeze stage happened in the freeze drier at -50 oC compared to freezer at 
-20 oC.  This fast freezing allowed a more uniform microstructure to be formed.  
By keeping the fabrication technique the same but altering the polymer 
concentration allowed us to develop scaffolds with different pore size and porosity. 
We found that the freeze dried scaffolds using the same freeze drying cycle but 
different polymer concentrations, exhibited different pore sizes ranging between 16.1 
± 2.6 μm to 28.2 ± 5.3 μm. These results demonstrate that altering the polymer 
concentration is an alternative way to control pore size as well as the porosity of the 





The porosity decreased significantly when polymer concentration increased, which 
is higher than previously reported PGSU scaffolds (87.9 ± 1.3%) that used polymer 
concentration of 2.6% (less polymer concentration than the PGSU-5%) [148]. This 
could be due to two reasons. First, in Frydrych et al. different methods were used to 
measure the densities of the scaffold and film (combination of helium pycnometer and 
gravimetric method). Second reason is, because of the difference in freeze drying cycle 
as well as mould. It is known from previous studies that the mould can affect the final 
porous structure [193, 195]. Our findings are that in all cases the scaffolds 
demonstrated a highly porous structure with evenly distributed pores. A highly porous 
scaffold with interconnected pores, will allow uniform cell distribution after seeding, 
cell ingrowth and enable neovascularisation [69]. The high porosity is also 
advantageous as it is required to allow adequate gas and nutrient exchange. This was 
tested by measuring water permeability through the scaffold. We found that all 
scaffolds exhibited high permeability and that permeability was significantly affected 
by the polymer concentration. Comparing the permeability of this study’s PGSU 
scaffolds with other freeze dried scaffolds made from collagen/hydroxyapatite hybrid 
the PGSU scaffolds had at least 4 orders of magnitude higher permeability (PGSU 
scaffolds permeability: 3.8 x 10-3 – 2.2 x 10-4 m2 compared to 7.0 x 10-8 m2) [182]. 
The next objective was to enhance the mechanical properties of the scaffolds 
without sacrificing its microstructure and porosity. It is well known that tissue 
engineering scaffold needs to have mechanical strength sufficient to withstand 
physiological in vivo forces and maintain its integrity until it is replaced by the newly 
formed tissue. The material itself plays an important role on the mechanical properties 
of the scaffold but the microstructure does as well. With this in mind there should be 





infiltration, angiogenesis and mechanical stability [163].  Native soft tissues exhibit 
elastic behaviour strongly influenced by their ECM structural arrangement. For 
example soft tissues such as skin and aorta have UTS between 1-20 MPa and 0.3-0.8 
MPa respectively, and their elongation at break is 30-70% and 50-100%, while tendon 
and ligaments exhibit UTS ranging 50-100 MPa and elongation at break 10-15% [196, 
197]. The PGSU scaffolds fabricated for this work were highly flexible and there was 
no yielding found before failure despite the high porosity, their UTS ranged between 
0.05 – 0.86 MPa, Young’s modulus ranged between 0.05 – 0.65 MPa and elongation 
at break ranged between 91.42 – 122.60 %. Therefore, the UTS is close to skin and 
within the range of aorta, while the elongation at break is within the range of all above 
mentioned tissues. Regardless of the changes made to scaffold preparation the 
mechanical properties of the oral mucosa (UTS: 1.06 – 2.83 MPa, Young’s modulus: 
2.48 – 19.75 MPa [16]) are still above the range of mechanical strengths obtained from 
this chapter’s scaffolds. Despite this, it has previously been shown that softer and less 
strong materials have been used successfully in OMTE which indicates that the PGSU 
scaffolds still have the potential to be used successfully for this application [15].  
Mimicking the target tissue’s mechanical properties has been proven to be 
beneficial in studies where the response of individual cell types was examined on 
substrates with different mechanical properties. As discussed in Section 1.3.3, it was 
found that epidermal keratinocytes proliferated better on stiffer surfaces (2.0 MPa) 
compared to softer surfaces (0.18 MPa) [100]. Similarly, human dermal fibroblasts 
cell number doubled in 2 days on stiffer collagen gels (1.81 MPa) as opposed to soft 
collagen gels (0.42 MPa) [101]. On the PGSU scaffolds in this study, the L929 mouse 
fibroblast cells demonstrated a ~4.5 folds higher metabolic activity over 15 days 





supported the deposition of collagen but in this case the PGSU-5% had ~4 folds higher 
collagen compared to PGSU-10% which indicates the scaffold’s properties are able to 
support the desired cell behaviour in vitro despite the low mechanical properties of the 
scaffolds compared to oral mucosa. While not tested here it may be that the deposited 
collagen is able to increase the scaffold’s mechanical strength prior to implantation, 
bringing it closer to native tissue. 
In terms of mechanical properties, an advantage of PGSU over most other synthetic 
and natural biomaterials is its ability to recover its initial structure and strength after 
loading is applied. This was confirmed from the cyclic loading experiment, where all 
scaffolds showed a negligible loss of mechanical strength after 100 cycles at 30% 
strain, indicating that these scaffolds can maintain their mechanical strength after 
deformation making them suitable for load-bearing applications, where both strength 
and elasticity is required. Other polymeric materials, such as, PLGA, PCL and PEG, 
lack this property which and have been reported to undergo plastic deformation after 
tensile testing, making them incompatible for use in soft TE [198]. Additionally, 
biomaterials are usually manipulated before transplantation during which they should 
maintain their structure and mechanical integrity [147].   
When a scaffold is implanted, in most cases it is sutured at the implantation site, 
thus the suture retention strength of the scaffold needs to be characterised. It was 
reported that the suture retention surgical requirement is 1.8 N (or 183 g, shown with 
dotted line Figure 3.8 (F)) [190]. The PGSU-15% scaffold had a higher suture 
retention strength than the surgical requirement meaning that it can be securely sutured 
at the implantation site without structure failure. While sutures are the most commonly 
used method to secure biomaterials in place, other methods are available which may 





The degradation mechanism of PGSU is based on surface erosion [147, 148]. 
Lipase can catalyse the hydrolysis of ester bonds in polyester materials, hence it is one 
of the most common enzymes used when examining the in vitro degradation 
characteristics of polyester materials [118, 146, 199]. Degrading the PGSU samples 
in vitro with lipase shows a linear degradation rate which is dependent on the polymer 
concentration. The polymer concentration affects the degradation kinetics by reducing 
the surface area exposed to the enzyme, and since PGSU degrades by surface erosion, 
the degradation rate is decreased. Previous work has shown that the surface to volume 
ratio has a significant effect on the degradation rate of the scaffold, which is in 
agreement with the results of this study [200]. Additionally, the permeability of the 
scaffolds was significantly lower when the polymer concentration was higher, which 
means that it was more difficult for the lipase solution to penetrate the inner part of 
the scaffold to cleave the ester bonds, therefore reducing its efficiency. The linear 
degradation observed from these scaffolds is also found from PGS scaffolds, which 
have previously been shown to retain their mechanical properties during degradation, 
losing mechanical strength at a lower rate than mass loss [120, 126]. As PGSU is based 
on PGS and they both exhibit linear degradation, it can be assumed that the PGSU 
scaffolds could also retain their mechanical strength in a similar manner. In order to 
estimate the in vivo degradation rate of the PGSU scaffolds we can use and combine 
the in vitro and in vivo degradation results from the original PGSU study [147]. It was 
reported that the PGSU film (1:0.5 crosslinker ratio) degraded ~10% in 5 days in vitro 
(Figure 1.15) while it degraded ~34% in 20 weeks in vivo (Figure 1.19 (C)). In the 
present study, PGSU-film (1:0.6 reactant ratio) degraded ~10% in 5 days in vitro, 
which is similar to the results from Pereira [147]. Comparing the PGSU-film (Figure 





(~15% mass loss). Therefore, if we assume that the degradation rate is linear and the 
ratio between PGSU-film and PGSU-5% remains true over time, it is expected that the 
PGSU-5% scaffold should degrade approximately ~51% in 20 weeks in vivo.  
Pereira et al. examined PGSU films in vitro for their cell biocompatibility using 
MTT assay concluding to no adverse effect on cell activity [147], however they did 
not examine the biocompatibility of 3D PGSU scaffolds. PGSU porous scaffolds could 
affect the cell biocompatibility differently, since the scaffold has significantly higher 
surface area allowing cells to infiltrate its structure which may lead to isolating the 
cells from cell culture media which may lead to cell death.  The in vitro cell 
biocompatibility results from this study showed an increase in cell activity over time 
and did not indicate any adverse effect on cell metabolic activity. These results show 
that the scaffolds provided a surface for the cells to adhere and proliferate despite the 
hydrophobic nature of PGSU (2.68 ± 0.93 % swelling ratio in PBS solution after 24h 
[148]). This is maybe due to the carboxyl group found in PGSU, shown in the FTIR 
results Figure 3.5. Multiple studies have examined how and why cells adhere on 
surfaces and they found that surface with carboxylic acid (COOH) has superior cell 
adherence and spreading compared to other more hydrophilic surfaces that exhibit 
functional groups such as hydroxyl groups (OH) [58, 60]. This occurs because of 
protein adsorption on the materials surface prior to cell adhesion. However, strong 
adsorption of some proteins might be disadvantageous when the surface is meant for 
cell attachment and growth [58]. For example, albumin (major component of serum) 
adsorbs strongly on hydrophobic surfaces, and larger proteins, such as fibronectin, 
cannot displace it to facilitate cell attachment [58]. Faucheux et al., characterised the 
ability of fibroblast cells to attach and spread on COOH and they concluded that more 





surfaces with OH groups [60]. In terms of spreading the cells were fully spread within 
2 h on COOH, and the fibroblasts were also producing fibronectin which is known to 
help in regulating cell attachment, growth and function [60, 201]. 
Plenty of studies have shown that the cell metabolic activity is influenced 
significantly by pore size and porosity [163]. In the case of this study, there was no 
effect found on cell metabolic activity when pore size and porosity were different. 
However, the cell penetration and cell distribution were affected. When the scaffolds 
were histologically analysed it was observed that the cells could penetrate less when 
the pore size was decreased. These finding are thought to be due to the hydrophobic 
nature of PGSU and small pore size of the scaffold meaning seeding cells into these 
scaffolds passively is extremely inefficient. The average size of human fibroblasts is 
10-15 μm [202]. The PGSU-15% had a significantly smaller pore size (6.4 μm) on the 
top surface which would not allow the cells to penetrate, rather providing a surface for 
them to attach, adhere and proliferate through the mechanism mentioned above. The 
PGSU-15% scaffold also had a significantly lower permeability (2.2 x 10-4 m2) which 
could also be responsible for the lower cell penetration. It is believed that the reason 
this smaller pore size surface is formed is because during the pre-freezing stage the 
1,4-dioxane freezes first at the bottom and then the top surface at a high freezing rate 
resulting in small pores. This theory will be examined further in the next chapter. The 
top surface of the scaffold could be removed in future studies to enhance the cell 
penetration and distribution by slicing it off. 
Natural ECM is largely composed of collagen, therefore it is important to examine 
if the cells produced new collagen. The tissues we aim to replace are predominantly 
collagen therefore as scaffold degrades new collagen should be produced to replace 





research studies have shown that cell produced collagen, aids to retain or even increase 
the mechanical properties of the scaffold, thus the scaffold maintains its structure 
integrity allowing enough time for the ECM to completely replace it as it degrades 
[203, 204]. The PGSU-5% supported the deposition of a significantly higher collagen 
amount (7.5 ± 2.6% of dry sample weight) compared to the other two scaffolds, which 
can be explained by better cell penetration, distribution and a higher surface area [205]. 
For comparison reasons, the collagen in bone tissue accounts for 25-30% of the dry 
weight of bone, in cartilage 10-20% and in ligaments 70-80%, aorta 25-35% and skin 
60-80% [197, 206]. In this study we demonstrated that PGSU-5% encouraged collagen 
production reaching collagen amount close to cartilage tissue in 15 days static cell 
culture. This occurred because of the combination of chemical structure, pore size, 
porosity and permeability of the PGSU-5% scaffold. PGSU-5% degraded 
approximately 23% on day 14 which is faster degradation compared to collagen 
production (7.5 ± 2.6%). This might be beneficial in terms of accelerating the collagen 
production because the surface area increases while the scaffold degrades which might 
lead to higher collagen production rate. Wang et al. demonstrated that cell orientation 
determines the alignment of cell produced collagen matrix [207]. With this said, the 
PGSU-5% microstructure had a random orientation meaning the subsequent collagen 
produced by the cells also had random orientation. Longer cell culture should be 
examined to determine if the collagen amount further increases over time. Despite the 
potential increase in mechanical strength due to collagen production, another 
advantage of having collagen presence is that the scaffold becomes more 






The aim of this chapter was to improve the uniformity of the PGSU microstructure 
and to enhance the mechanical properties of the scaffold to make them closer to oral 
mucosa. In conclusion in this chapter we: 
1. Improved the freeze drying protocol by changing the freeze drying cycle and 
freeze drying system to fabricate uniform scaffold microstructures. 
2. Controlled the pore size, structure and porosity of the scaffold by changing the 
polymer concentration. Scaffolds made with higher polymer concentrations 
had smaller pore sizes and lower porosity. 
3. Enhanced the mechanical properties of the scaffolds to make them closer to 
the oral mucosa’s biomechanical properties and demonstrated the shape and 
strength recovery of the scaffolds using cyclic loading. 
4. Found that the permeability of the scaffolds was dependent on the porosity of 
the scaffolds. 
5. Demonstrated that the cell metabolic activity was not different between 
scaffold microstructures but significantly increased over time. 
6. Used histology to examine the cell distribution and found that the cells could 
not penetrate the surface of the scaffolds with smaller pore sizes (PGSU-15%). 
7. Examined the cell collagen production of the scaffolds and found that the 
scaffold with the highest porosity had a significantly higher collagen 
production. 
The results of this chapter have shown that the PGSU scaffold physical properties 
have significant effect on the biological properties of the scaffold. It was realised that 
PGSU-5% had the best microstructure to allow adequate cell metabolic activity and 





PGSU-5% had lower mechanical properties compared to oral mucosa and the cells 
were minimally infiltrating within the scaffold’s structure probably because of the cell 
seeding technique. Therefore, for the next chapter it was decided to proceed with using 
PGSU-5% for oral mucosa tissue engineering, but to attempt to improve the cell 
seeding technique and imitate the 2-layer structure of the native oral mucosa (lamina 
propria + basement membrane). Furthermore, some initial, proof-of-concept results 
will be included in the next chapter to demonstrate the ability of freeze-drying to 





Chapter 4 Hierarchical multilayer poly(glycerol sebacate 
urethane) scaffolds to replicate native tissues 
Aim 
To develop novel methods to fabricate isotropic, anisotropic and multilayer scaffolds 
with hierarchical microstructure to be used in oral mucosa and soft tissue engineering. 
4.1. Introduction 
In the last two chapters we demonstrated that PGSU scaffolds can be fabricated with 
multiple pore sizes and porosities as well as sterilised with conventional laboratory 
methods without a major effect on its properties. It exhibits chemical structure that is 
advantageous for cell attachment and spreading and provides a biocompatible 
environment for the cells to be metabolically active and the PGSU-5% produced 
significant amounts of collagen while it degraded linearly in lipase. The scaffolds 
fabricated in Chapter 3 display good mechanical properties with almost full and fast 
recovery of its tensile strength. From these results we can therefore complicate the 
scaffold porous structure to mimic the native ECM of oral mucosa and other soft 
tissues. 
As mentioned in Chapter 1, oral mucosa consists of an epithelium that overlies the 
lamina propria, which are attached at the basement membrane [8]. On the one hand, 
to grow an epithelium in 3D it requires a surface for the epithelial cells to attach and 
go through various degrees of differentiation to build a stratified squamous epithelium. 
On the other hand, the fibroblast cells require a scaffold to be seeded in and then 
develop the lamina propria [30]. Meanwhile, a BM is found between them to keep the 





communication and gas/nutrient exchange. Therefore, a scaffold should be designed 
to provide a surface for epithelial cells, a scaffold for fibroblasts and a thin BM-like 
layer to separate them until fibroblasts generate the natural ECM and BM. 
A major part in the field of TE is the scaffold which temporarily provides the cells 
with a 3D structure until they produce their own ECM and replace it. Until then this 
scaffold should be able to sustain cell growth and collagen production as well as 
provide guidance to the newly developed tissue. A logical way to provide guidance is 
to produce a scaffold that mimics the native ECM which allows the cells to grow in a 
specific direction. Knowing that every tissue has its own specific 3D ECM structure it 
is important to be able to produce scaffolds that follow that structure in a reproducible 
and inexpensive manner. According to the literature controlling the freezing of the 
polymer solution during freeze drying can control the architecture of a scaffold’s 
microstructure and pore direction [178, 191, 193]. The advantage of having oriented 
pore architecture is that it can mimic natural in vivo ECM of tissues which require 
alignment, for example tendons and nerves. Several research groups approached this 
topic by fabricating scaffolds with anisotropic pore architecture by combining freeze 
drying technique and moulding technology [178, 193]. Successful attempts to 
fabricate unidirectional scaffolds using freeze drying were reported in [178, 193, 208-
211] using various biomaterials, such as collagen, gelatin, poly(vinyl alcohol) and 
PLGA. A general conclusion from most of these studies was that the scaffolds 
fabricated were unidirectional (anisotropic), had optimised mechanical properties in 
the direction of the pores and ECM production from the cells was aligned with the 
pores.  
Multilayer scaffolds were also fabricated to further mimic the native tissue 





were used to fabricate 2-layer PGS porous scaffold with 100 – 150 μm pore size for 
the purpose of cardiac tissue engineering. Neal et al. seeded these scaffolds with rat 
heart cells and cultured them in vitro for a week and they found that the multilayer 
structure promoted the cell growth and enhanced the mechanical properties by 
allowing contraction [212]. However, as mentioned in the literature review (Chapter 
1) the micromoulding fabrication technique can only produce thin scaffolds, 
approximately 150 μm, which limits their application. Another group used freeze 
drying to develop a natural triple layered vascular graft made out of collagen type I, 
fibrils and elastin fibres for vascular tissue engineering. Three tubular moulds that had 
different sizes were used to build the scaffold layer by layer. The scaffolds were tested 
for their mechanical properties and exhibited suitable properties for vascular tissue 
engineering [213]. 
Until now we demonstrated the fabrication techniques to develop one-layer 
scaffolds with uniform pore structures that were depended on the polymer 
concentration. However, there is a gap in our knowledge and techniques to fabricate 
more complex, hierarchical multilayer scaffolds to mimic multilayer ECM native 
structures. To address this, we will utilise freeze drying, moulding and airbrushing 
techniques and their combinations to develop one-, two- and three-layer scaffolds that 
exhibit different porosities and pore sizes as well as one-layer scaffolds that have 
unidirectional pore structure. 
  
In this chapter we will fabricate PGSU scaffolds that mimic the 3-D architecture of 
the native ECM of oral mucosa. For these scaffolds a combination of two fabrication 





found in tissues such as skin and oral mucosa. A step-by-step process will be used to 
examine firstly the ability of oral keratinocytes to adhere and survive on the PGSU-
film, then solve the seeding issue we had during chapters 2 and 3, and last apply cell 
co-culture on the scaffolds and examine them using histology and 
immunohistochemistry. Additionally, a proof-of-concept study was done to fabricate 
unidirectional, and multilayer PGSU scaffolds using freeze-drying that could 
potentially be used in soft TE. 
4.2. Materials and Methods 
4.2.1. Materials 
The materials for this chapter are the same as in Chapters 2 and 3 with the addition of: 
Nutrient mixture F12 (Ham’s F12) was purchased from Biosera. Adenine, Inslin, 
hydrocortisone, epidermal growth factor, cholera toxin, 3,3,5-Tri-iodothyronine/Apo-
Transferrin, amphotericin B and collagenase A (extracted from Chlostridium 
histolyticum) were purchased from Sigma Aldrich. Vectastain Elite ABC kit and 3’-
diaminobenzidine tetrahydrochloride (DAB) were purchased from Vector Labs. 
AE1/AE3 primary antibodies were purchased from Dako. Polytetrafluoroethylene 
(PTFE) virgin rod was purchased from Plastock. 
4.2.2. Methods 
4.2.2.1. Pre-PGS synthesis 
Pre-PGS was synthesised as in Chapter 2: Section 2.2.2.1. 
4.2.2.2. PGSU-5, 10, 15% scaffolds 
PGSU was synthesised as in Chapter 3: Section 3.2.2.2 and the scaffold fabrication 





4.2.2.2.1. Aluminium tray with PTFE mould 
To control the orientation of the porous microstructure of the scaffolds two inhouse 
moulds were designed that allowed scaffolds to be produced with vertical and 
horizontal direction pores. The moulds were comprised of aluminium grade 6082T6 
base and PTFE moulds as shown in Figure 4.1. The mould designed to produce vertical 
orientation scaffolds will be mentioned in the thesis as “Mould-vertical” and the mould 
for horizontal orientation scaffolds will be mentioned as “Mould-horizontal”. For both 
moulds the PTFE walls were detachable to allow the easy removal of the scaffolds. 
 
Figure 4.1. Inhouse designed moulds with aluminium base and PTFE walls for multiple orientation scaffold 
fabrication. (A) Top view of the mould-vertical, (B) side view of mould-vertical, (C) top view of mould-horizontal 
and (D) side view of mould-horizontal. Scale bar is 5 cm. 
4.2.2.2.2. Controlled orientation PGSU scaffolds 
The fabrication method is similar to the method described in Chapter 3: Section 
3.2.2.2.2 except the mould that the PGSU solution was cast in was either mould-
vertical or mould-horizontal dependent on the desired porous architecture, and the 
polymer concentration was kept at 10% (w/v) only. This polymer concentration was 





will be between 5% and 15% (w/v) polymer concentrations which may indicate the 
range of microfeatures that can be achieved; and second was due to the potential 
application of these scaffolds it may require stiffer mechanical properties than the 
PGSU-5% scaffolds had in Chapter 3. Therefore, the scaffolds with vertical pore 
orientation will be mentioned as “PGSU-vertical” and the scaffolds with horizontal 
orientation as “PGSU-horizontal”. 
4.2.2.2.3. Multilayer PGSU scaffolds 
The multilayer scaffolds are composed from layers that have different pore sizes and 
porosities. The PGSU synthesis was performed as previously described in Chapter 3: 
Section 3.2.2.2.2 using the three different polymer concentrations (5%, 10% and 
15%). The fabrication was done by building the scaffold layer by layer.  
Two double-layer scaffolds were produced, the first one was composed from two 
layers PGSU-10% and PGSU-15% (will be referred as PGSU-bilayer); and the second 
scaffold was composed from PGSU-5% and a thin film (that resembles a basement 
membrane), will be referred as PGSU-BM.  
To fabricate the PGSU-bilayer, both PGSU-10% and PGSU-15% were synthesised 
with 2 hours delay between them. Firstly, PGSU-10% was cast into mould-random 
and left to freeze at -50 oC for 2 hours inside the freeze drier. After 2 hours, the solution 
was completely frozen and PGSU-15% was ready to be casted on top of the frozen 
PGSU-10%, however before casting, the temperature of the solution was reduced from 
55 oC to 15 oC (just before 1,4-dioxane melting point: 11.7 oC) and then it was cast on 
top of the already frozen base layer (PGSU-10%) allowing the surface of it to defrost 
and immediately freeze back. The mould was then placed back into the freeze drier 





To fabricate PGSU-BM, PGSU-5% scaffold was synthesised and freeze dried as in 
Chapter 3: Section 3.2.2.2.2. To add the second layer, PGSU-5% was synthesised and 
instead of casting it on top of the base layer, a fabrication technique called airbrushing 
was utilised. For this technique an air spray gun was used to spray 1 or 2 ml of PGSU 
solution on top of the PGSU-5% scaffold to produce a second thin layer. Using 
published methods [152] with slight modifications to produce a film instead of fibres, 
the PGSU-5% solution was fed into a gravity fed cup of a double action/internal 
mixing spray gun with a nozzle size of 600 μm and the polymer solution was ejected 
from a 15 cm distance at a steady air pressure using an air compressor (lowest setting 
used; unknown air pressure). To determine how the second layer should be fabricated 
(Table 4.1) three methods were investigated: 
i) the scaffold was frozen at -20 oC and then freeze dried 
ii) the scaffold was frozen in liquid nitrogen and then freeze dried 
iii) or the scaffold was left inside the fume cabinet for 48 hours to air dry, and then 
placed in the vacuum oven for another 24 hours at 40oC. 
Table 4.1: PGSU-BM airbrushing conditions. 
Condition Polymer solution volume Scaffold name 
-20 oC 1 ml PGSU-BM(1) 
Liquid nitrogen 
1 ml PGSU-BM(2) 
2 ml PGSU-BM(3) 
Air dried 
1 ml PGSU-BM(4) 






One three-layer scaffold was also fabricated with different pore size, porosity and 
a thin film on top (to resemble a basement membrane). This trilayer scaffold was built 
from base to top, composed from PGSU-5%, PGSU-10% and thin film respectively, 
and it will be referred to as PGSU-trilayer. To fabricate this scaffold PGSU-5% was 
synthesised, cast into mould-random and frozen at -50oC for 2 hours. PGSU-10% was 
then synthesised and the solution’s temperature was reduced to 15 oC and immediately 
cast on top of the frozen PGSU-5% solution. The now 2-layer scaffold was freeze 
dried following the freeze drying cycle shown at Figure 3.4. The top thin film was 
fabricated using the airbrushing technique mentioned above (PGSU solution volume 
= 1 ml). The PGSU-trilayer scaffold was then left to dry for 48 hours and then placed 
in the vacuum oven for another 24 hours at 40oC.  
All scaffolds were washed with ethanol to remove any unreacted substances from 
its construct. The washing was done by submerging the scaffold in 100%, 70% and 
50% Ethanol for 2 hours each, and then immersed in distilled water overnight. Shaking 
was also applied on the scaffolds while washing. 
4.2.2.2.4. Mould characterisation – polymer solution freezing rate 
The temperature gradient of the PGSU solution (10 % w/v) during the pre-freeze stage 
was recorded using a temperature probe at three different locations for all three 
moulds. For the mould-random and mould-vertical, a temperature probe was placed 
inside the PGSU solution at positions 0 mm (top), 5 mm (middle) and 10 mm (bottom) 
as soon as the pre-freeze stage began, and the temperature was recorded every minute 
for a total of 3 h. For the mould-horizontal a temperature probe was placed at 0 mm 
(bottom), 20 mm (middle) and 40 mm (top). The nucleation event was defined as the 
temperature point where the solution reached before latent heat was released and the 





defined as the two points that the temperature remained almost constant after the 
nucleation event and before dropping again. 
 
Figure 4.2: Schematic showing the moulds and the locations that the temperature probes were placed to quantify 
the freezing rate of the polymer solution. A) is the mould-random (asterisk: red = 0 mm, green = 5 mm, blue = 10 
mm), B) is the mould-vertical (asterisk: red = 0 mm, green = 5 mm, blue = 10 mm) and C) is the mould-horizontal 
(asterisk: red = 0 mm, green = 20 mm, blue = 40 mm). The schematic is not scaled. 
4.2.2.2.5. Multilayer scaffold characterisation 
The scaffolds were characterised for their microstructure and pore size using SEM; 
and their permeability following the methods described in Chapter 2: Sections 
2.2.2.5.2 and 2.2.2.5.7 respectively. 
4.2.2.3. Oral mucosa in vitro cell culture experiments 
4.2.2.3.1. OKF6 cell culture 
Immortalised human oral keratinocytes were grown using Keratinocyte – SFM 
(KSFM) media and cultured the same way as L929 cells described in Chapter 2: 
Section 2.2.2.6.1 above. OKF6/TERT2 cells were originally produced in Dickson et 
at. [214] and were obtained from Professor Martin Thornhill (School of Clinical 





4.2.2.3.2. Normal oral keratinocytes cell culture 
Normal oral keratinocytes (NOK) were isolated from oral mucosa biopsies from 
consenting human volunteers (according to our protocol approved by the University 
of Sheffield Research Ethics Committee, ethical approval number: 09/H1308/66). The 
biopsies were incubated overnight in 0.1% (w/v) Difco trypsin solution at -4 oC. Using 
sterile scalpel and forceps the epithelium was peeled off the connective tissue layer 
and then the keratinocytes were scraped from the epithelium and the top side of the 
connective tissue. The Difco trypsin and epithelium were then transferred into a 
universal and centrifuged for 5 min at 1000 rpm. The supernatant was then removed 
and the pellet was resuspended in Green’s media, consisting of DMEM and Ham’s 
F12 medium in a 3:1 (v/v) ratio supplemented with 10% (v/v) FCS, 0.1 μM cholera 
toxin, 10 ng/ml epidermal growth factor, 0.4 μg/ml hydrocortisone, 0.18 mM adenine, 
5 μg/ml insulin, 5 μg/ml transferrin, 2 mM glutamine, 0.2 μM triiodothyronine, 0.625 
μg/ml amphotericin B, 100 IU/ml penicillin and 100 μg/ml streptomycin. To culture 
the NOK, flasks previously seeded with irradiated mouse fibroblasts (i3T3) were used 
to seed on top. These cells act as a feeder cell layer by secreting growth factors 
important to allow good proliferation of keratinocytes and delaying their terminal 
differentiation [215]  The media was changed as necessary, usually within 3 days, and 
not passaged before 80% confluency. To passage, the media was removed, and the 
flask was washed with PBS, then 5 ml of 0.02% EDTA solution was added for 5 min 
to detach i3T3 cells, washed with PBS, and then using trypsin for approximately 5 min 
the NOK were detached, collected, centrifuged and passaged into more flasks again 
on top of fresh i3T3. Prior to seeding the methods described for cell counting in 






4.2.2.3.3. Normal tonsil fibroblasts cell culture 
Normal oral fibroblasts isolation was attempted from the biopsies used in Section 
4.2.2.3.2, however due to low number of cells isolated they could not grow into an 
adequate cell number to use for this chapter. Therefore, normal tonsil fibroblasts 
(NTF) were isolated from waste tissue from surgery (according to our protocol 
approved by the NHS Research Ethics Committee 09/H1308/66) and cultured in 
Green’s media as for NOK and were cultured the same way as L929 cells in Chapter 
2: Section 2.2.2.6.1 above. Prior to seeding the methods described for cell counting in 
Chapter 2: Section 2.2.2.6.1 were used here as well. NTF cells were used between 
passages 3-8. 
4.2.2.3.4. Oral cells co-culture 
4.2.2.3.4.1. OKF6 attachment on PGSU-film 
PGSU-films were punched (10 mm diameter) and sterilised using 70% ethanol 
overnight and then washed in sterile PBS. The films were then placed in a 12 well 
plate and fixed with a surgical stainless-steel ring (10 mm inner diameter) to facilitate 
with cell seeding. OKF6 cells were then seeded at a 1.0 x 106 cells/scaffold and left to 
attach for 24 hours. The next day the surgical stainless-steel rings were removed and 
the samples were transferred to a fresh well plate, and cultured for 9 days, performing 
resazurin assay every 3 days following the methods described in Chapter 2: Section 
2.2.2.6.3.2. Cells seeded on TCP and acellular PGSU-film served as positive and 
negative controls respectively. The experiment was repeated 3 times and each repeat 
was in triplicates. 
4.2.2.3.4.1.1. Live/Dead staining 
Live/dead assay consists of SYTO©9, which has green fluorescence and propidium 





is an intercalating membrane permeant stain that stains both live and dead cells, 
whereas the PI can only bind to dead cells, and it because it has stronger affinity for 
nucleic acid it displaces the SYTO©9 and the cell will fluorescence in red [216]. 
Therefore, live cells are stained green and dead cells are stained red. 
The samples were washed with PBS and live/dead working solution was added to 
the samples, covered with aluminium foil and left at room temperature for 30 min 
while shaking. The working solution used was commercially available and consisted 
of 1:1000 dilution of SYTO©9 (0.001% (v/v)) and a 1:100 dilution of PI (0.0015% 
(v/v)). After 30 min the samples were washed with PBS and submerged again in PBS 
and visualised using fluorescence microscopy. 
4.2.2.3.4.2. NOK attachment on PGSU-film 
The same methods as Section 4.2.2.3.4.1 were used to examine the NOK attachment 
on PGSU-films, with the addition of i3T3 cells were seeded the day before the 
experiment. Prior to resazurin assay, the samples were moved to a fresh well plate for 
the assay and then back to their original plate (with i3T3). 
4.2.2.3.4.3. PGSU-BM sample preparation 
All samples were prepared as in Chapter 3: Section 3.2.2.4.1, with inner diameter 10 
mm and 3 mm thickness. The samples were placed in a 12 well-plate inside a surgical 
stainless-steel ring with the sprayed BM mimic on the bottom of the well and the 
porous PGSU scaffold exposed. A 200 μl cell suspension containing 5.0 x 105 of NTF 
was seeded using a dynamic seeding technique, following the methods established by 
[217] with some modifications. Briefly, after overlaying the samples with the cell 
suspension, the well-plate was placed in sterile plastic bag with syringe and syringe 





pressure up to 0.1 bar followed by a rapid ventilation to atmospheric pressure, the 
cycle was repeated 6 times, shown in Figure 4.3. The samples with NTF were then 
incubated and cultured overnight. On the next day, the samples were turned 180o so 
the BM mimic was now on top while keeping them inside the ring. NOK were then 
passively seeded in a 200 μl cell suspension containing 5.0 x 105 cells. The media was 
then topped up to 2 ml and incubated for 2 more days. On day 3, the PGSU-BM 
samples were placed on a stainless-steel grid and lifted to an air-liquid interface (ALI), 
ensuring that the bottom layer of the scaffold was covered with media and the top 
exposed to air to promote the epithelial stratification. The samples were cultured for 
another 12 days at the ALI. The experiment was repeated three times in triplicates. 
 
Figure 4.3: Image showing the PGSU-BM ready for dynamic seeding. The scaffolds are fixed in a surgical 
stainless-steel ring and overlaid with cell/media suspension. The well-plate was then placed in a sterile plastic 
bag with a syringe and a syringe filter to sterilise the returning air while ventilating. 
4.2.2.3.4.4. Preparation of de-epithelialised dermis 
De-epithelialised dermis was pre-prepared as described in Colley et al. [2], from 





(according to our protocol approved by the NHS Research Ethics Committee 
15/YH/0177). On the day of seeding, sterile DED was cut into squares (~12 x 12 mm) 
and placed in a 6 well-plate submerged in Green’s media. Surgical stainless-steel rings 
were pushed onto the DED to provide a tight seal with inner diameter of 10 mm. The 
samples were seeded with 1 ml cell suspension containing 5.0 x 105 NTF and 5.0 x 
105 NOK, at this point Green’s media was added outside the ring to stop cells leaking 
out of the ring. After 2 days half the media inside the ring was replaced with fresh 
Green’s media. On day 3, the DED was placed onto a stainless-steel grid and raised to 
ALI, making sure that the bottom of the DED was in contact with the media and the 
top exposed to air to enhance the epithelial stratification and cultured for another 12 
days. The experiment was repeated three times in triplicates. 
4.2.2.3.5. Histology 
Histology was performed as mentioned in Chapter 3: Section 3.2.2.5. 
4.2.2.3.6. Immunohistochemistry 
Cytokeratin AE1/AE3 antibodies were used to characterise the epithelium of the tissue 
engineered oral mucosa cultured on PGSU-BM and DED. Paraffin embedded (5 μm) 
sections were dewaxed with xylene and rehydrated through a series of ethanol 
dilutions. The endogenous peroxidase was neutralised with 0.3% hydrogen peroxide 
for 30 min. The sections were then washed in PBS for 5 min. For antigen retrieval the 
sections were submerged in pre-warmed 0.01M tri-dofium citrate buffer (pH 6) and 
placed in a microwave at medium heat for 8 min. The samples were then washed again 
in stirring tap water for 5 min. The sections were then blocked with blocking serum 
mixture from Vectastain elite ABC kit for 20 min at room temperature. The 
cytokeratin AE1/AE3 antibodies were prepared as shown in the table below. A drop 





left for 1 h at room temperature. The slides were washed for 5 min in PBS. Then 
biotinulated secondary antibody solution was added for 30 min and incubated at 37oC 
and 5% CO2 and washed again for 5 min in PBS. The slides were then again incubated 
with Vectastain Elite ABC reagent mixture for 30 min. The samples were again 
washed for 5 min in PBS. Finally, DAB solution was prepared and mixed well, and 
then added on the slides for 2-10 min, depending on the staining intensity required, 
therefore the samples were monitored under the microscope until the desire staining 
was obtained. The samples were then washed and counter-stained with haematoxylin 
following the methods described in Chapter 3: Section 3.2.2.5. 






(in PBS) Antigen retrieval Source 
AE1/AE3 AE1/AE3 1 : 100 0.01 M sodium citrate buffer Dako 
 
4.2.2.4. Statistical analysis 
The statistical analysis was performed as in Chapter 2: Section 2.2.2.7. 
4.3. Results 
4.3.1. Mould characterisation – polymer solution freezing rate 
The thermal profile of the in-house build moulds was characterised to understand how 
each mould and its design can affect the freezing behaviour of the PGSU solution 
(10% (w/v)) therefore the pore architecture of the PGSU scaffolds.  
In view of mould-random, the nucleation event of the PGSU solution happened first 
at the 0 mm then 10 mm and last at 5 mm (see Figure 4.4), indicating that the solution 





the highest nucleation temperature, 14oC at 10 min, demonstrating that the solution 
froze within the first 10 min. This temperature is also above the melting point of 1,4-
dioxane (Tm). The other two nucleation events occurred at the same temperature, 11oC, 
but different time points, 3 min for the 0 mm and 5 min for the 10 mm. The time at 
equilibrium, at the 0 mm position was less than 1 min and it could not be measured 
precisely using the methods of this thesis, but 5 mm and 10 mm were at equilibrium 
for 5 min and 6 min respectively. 
 
Figure 4.4: Thermal profile of the PGSU/1,4-dioxane solution during freezing using the mould-random. Tm = 
melting point of 1,4-dioxane. The schematic represents the mould and the freezing direction of the polymer solution 
(schematic is not scaled). 
Regarding the mould-vertical, the nucleation event happened first at the 0 mm 
point, 12oC at 6 min, and then second was the 5 mm position, 12oC at 10 min, and last 
the 10 mm, 17oC at 12 min (see Figure 4.5). This means that the PGSU solution froze 
from the bottom to the top, as expected. Additionally, the whole solution froze within 
the first 12 min, with only 6 min separating the first nucleation event to the last. The 





measured, but the 5 mm was at equilibrium for 11 min and the 0 mm was at equilibrium 
for 13 min. 
 
Figure 4.5: Thermal profile of the PGSU/1,4-dioxane solution during freezing using the mould-vertical. Tm = 
melting point of 1,4-dioxane. The schematic represents the mould and the freezing direction of the polymer solution 
(schematic is not scaled). 
The thermal profile was recorded from the mould-horizontal and is shown in Figure 
4.6. The bottom of the solution, at 0 mm, had its nucleation point 8 minutes after the 
start of the experiment, at 3oC, followed by the top part of the solution at 40 mm after 
62 minutes, at 12oC. However, the nucleation point could not be identified for the 
midpoint, at 20 mm, but a linear negative gradient was observed until it reached its 
lowest temperature. Therefore, the solution froze first from the bottom and slowly 
moved upwards and, the nucleation events had 54 min difference between them. The 






Figure 4.6: Thermal profile of the PGSU/1,4-dioxane solution during freezing using the mould-horizontal. Tm = 
melting point of 1,4-dioxane. The schematic represents the mould and the freezing direction of the polymer 
solution (schematic is not scaled). 
4.3.2. Microstructure of PGSU scaffolds 
SEM was used to visualise the microstructure of the PGSU scaffolds. Figure 4.7 show 
the images from the PGSU-random scaffold fabricated using mould-random. This 
scaffold was fabricated the same way as the scaffolds in Chapter 3. There was a 
difference in pore structure found between the top and bottom sections. The top section 
had a random pore structure, some pores are circular, and others are ovoid. Regarding 
the bottom section, circular pores were found but at a lower density compared to the 
rest of the scaffold. The cross section shows an ovoid shaped pore structure. 
The pore size and permeability of this scaffold was calculated in Chapter 3 and is 
shown in Figure 3.6 and Figure 3.10 respectively.  Briefly, the pore size of the scaffold 
ranged from 12 μm to 28 μm dependent on the depth of the scaffold. The water 











Figure 4.8 shows the SEM images from the PGSU-vertical scaffolds fabricated 
using mould-vertical. As expected this scaffold had a unidirectional pore structure 
moving from the bottom to top (vertical) forming porous channels that interconnect to 
the top part of the scaffold. 
 
Figure 4.8: SEM images of PGSU-vertical. A1-2) Top section and B1-2) cross section. The schematic 
demonstrates the plywood structure of the scaffold. 
The pore size of the PGSU-vertical, Figure 4.9, is significantly different between 
its cross section and top section with pore sizes of 34.1 ± 2.1 and 40.3 ± 1.0 μm 
respectively. The water permeability of the PGSU-vertical was measured parallel and 
perpendicular to the pore direction, as shown in Figure 4.10. High permeability was 
observed from both directions (4.2 x 10-3 and 3.7 x 10-3 m2) and no significant 






Figure 4.9: PGSU-vertical pore size measured from the top and cross section. Results are shown as mean ± standard 
deviation, n=50, * when p < 0.05.  
 
Figure 4.10: Water permeability of the PGSU-vertical. The anisotropic structure of the scaffold was examined by 
measuring the permeability parallel (longitudinal) and perpendicular to the pore direction. Results are shown as 
mean ± standard deviation, n=3. 
The SEM images of the PGSU-horizontal scaffold are shown in Figure 4.11. In this 
case the resulting scaffold had a rectangular parallelepiped shape and the pore 





with porous channels formed along the horizontal axis. When it was examined for its 
cross section, open pores are found throughout the scaffold. 
The uniformity of the pore structure is also demonstrated from the pore size 
measurements shown in Figure 4.12. The PGSU-horizontal scaffold had no significant 
difference in pore size between the top, cross and bottom sections and its pore sizes 
ranged from 67.8 ± 20.0 to 78.8 ± 24.2 μm. Figure 4.13 shows the permeability of the 
PGSU-horizontal. It was found to have the highest water permeability from all 
scaffolds fabricated in this study ranging between 8.7 x 10-3 m2 to 1.1 x 10-2 m2. 
Furthermore, there was significant difference (p < 0.001) found when the permeability 
was measured parallel to the pore direction compared to perpendicular demonstrating 













Figure 4.12: PGSU-horizontal pore size measured from the top, cross section and bottom of the scaffold. Results 
are shown as mean ± standard deviation, n=50. 
 
Figure 4.13: Water permeability of PGSU-horizontal. The anisotropic structure was examined by measuring the 
permeability parallel (longitudinal) and perpendicular to the pore direction. Results are shown as mean ± standard 





Below, Figure 4.14 the PGSU-bilayer is illustrated. In this case top layer was made 
from PGSU-15% and bottom layer from PGSU-10%, thus there is a difference in pore 
structure when looking from the cross section. It is clear where the layers meet and a 
good attachment between them is also evident. However, the pore structure was 
similar when imaging the scaffold from its top and bottom section. 
Following the results from Chapter 3 it was expected the pore size to vary between 
sections and layers of the PGSU-bilayer. To examine this the pore sizes of the PGSU-
bilayer were measured and plotted in Figure 4.15. Multiple pore sizes were found 
depending on the layer and the section. Considering each layer individually, there was 
significant difference found between the pore size of the top layer (PGSU-15%) when 
comparing its top and cross section. Similar observation was found from the bottom 
layer (PGSU-10%). Most importantly there was a significant difference found when 
comparing the pore size between the layers, especially in cross section. The pore size 
for the PGSU-15% layer was 26.2 ± 9.7 μm and the pore size for the PGSU-10% layer 
was 74.0 ± 4.9 μm, which is approximately a 3-fold difference. The water permeability 
was measured in the longitudinal direction and high permeability was found (1.1 x 10-






Figure 4.14: SEM images of PGSU-bilayer. A1-2) Top section, B1-2) bottom section and C1-3) cross section (C2 = PGSU-15% and C3 = PGSU-10%). The schematic demonstrates the 







Figure 4.15: PGSU-bilayer pore size measured from the top, cross section (CS) and bottom. Since it is consisted 
of two layers the top and bottom layers of the scaffold were measured separately. Results are shown as mean ± 
standard deviation, n=50, *** when p < 0.001. 
 
Figure 4.16: Water permeability of PGSU-bilayer measured longitudinal to the scaffold. Results are shown as mean 





To fabricate PGSU-BM the freeze drying technique was combined with 
airbrushing. To characterise the methods for airbrushing we used 2 different polymer 
solution volumes (1 and 2 ml) and either frozen the sample at -20 oC, in liquid nitrogen 
or left it to air dry in room temperature. The results from these scaffolds are shown in 
Figure 4.17. The PGSU-BM that had 1 ml of polymer solution sprayed on it and then 
frozen at -20 oC (Figure 4.17 (A1-2)) had a porous top layer, and the polymer solution 
was absorbed inside the scaffold filling some of the pre-existing pores making them 
less porous. For the same polymer solution but frozen in liquid nitrogen the polymer 
solution was not absorbed within the scaffold and a non-porous layer (61.2 ± 19.0 μm 
thick) was formed (Figure 4.17 (B1-2)). Similar observations were seen for the PGSU-
BM that had 1 ml of polymer solution sprayed on it and then left in room temperature 
to dry the solvent (Figure 4.17 (C1-2)), but it had a significantly lower thickness (36.0 
± 14.7 μm, p < 0.001). When the polymer solution volume increased from 1 ml to 2 
ml it was found that the polymer solution was absorbed deeper into the scaffold for 
the sample that was frozen in liquid nitrogen (Figure 4.17 (D1-2)) and in the case of 
air drying at room temperature a significantly thicker layer (202.2 ± 103.7 μm, p < 
0.001) was formed on top of the scaffold (Figure 4.17 (E1-2)). It was therefore decided 
to proceed with the PGSU-BM fabricated using 1 ml polymer solution and letting it 
air dry in room temperature because the thinnest BM was achieved compared to the 
other methods and simpler steps were involved in the fabrication procedure (no 
additional freezing and freeze drying), shown in Figure 4.17 (C1-2). 
The selected PGSU-BM scaffold is shown in Figure 4.18, where a thin layer of low 
porosity was formed on the top section of a PGSU-5% scaffold to replicate a BM. The 





from the bottom section. Additionally, it was important to ensure that the two layers 






Figure 4.17: PGSU-BM fabricated with different airbrushing techniques. (A1-2) 1 ml of polymer solution was sprayed and frozen at -20 oC before freeze drying (PGSU-BM(1)), (B1-2) 1 ml 
polymer solution was sprayed and frozen in liquid nitrogen before freeze drying (PGSU-BM(2)), (C1-2) 1 ml of polymer solution was sprayed and left in room temperature to dry (PGSU-BM(4)), 
(D1-2) 2 ml of polymer solution was sprayed and frozen in liquid nitrogen before freeze drying (PGSU-BM(3)) and (E1-2) 2 ml of polymer solution was sprayed and left in room temperature to 











The pore size of the PGSU-BM scaffold (Figure 4.19) is 20.2 ± 1.9 μm at its cross 
section and 20.4 ± 0.7 μm at its bottom section and there was no significant difference 
between them. Even though a low porosity film was fabricated on top of the scaffold 
the permeability of the scaffold (Figure 4.20) was still very high (5.6 x 10-3 m2) 
showing that water can still pass through the dense layer which is extremely important 
in tissue development because it allows for gas and nutrient exchange. 
 
Figure 4.19: PGSU-BM pore size was measured from the cross section and bottom of the scaffold. Results are 
shown as mean ± standard deviation, n=50. 
 
Figure 4.20: Water permeability of the PGSU-BM measured longitudinal to the scaffold. Results are shown as 





The last scaffold that was fabricated was PGSU-trilayer and the results are shown 
in Figure 4.21. In this case the top layer acts as a BM with low porosity, and at the 
same time the bottom section has an open pore structure. The connection of all three 
layers is also shown, which confirms that one solid scaffold can be fabricated from 
three different layers that can be distinguished by their difference in pore structure and 
porosities. 
As expected the pore size was significantly different between the layers of the 
scaffold (Figure 4.22), with the top layer demonstrating a pore size of 20.3 ± 5.0 μm 
and the bottom layer demonstrating a pore size of 49.2 ± 10.8 μm. This demonstrates 
that by changing the polymer concentration different pore sizes can be achieved, as in 
Chapter 3, and that by stacking these scaffolds on top of each other, the same scaffold 
can exhibit multiple pore sizes. The water permeability of the PGSU-trilayer (Figure 
4.23) was the lowest from all the scaffolds of this study, 7.3 x 10-4 m2, which can be 
explained by the dense PGSU-15% layer of the scaffold in addition with the BM (99.2 
± 34.2 μm thickness) on top of the scaffold, which is significantly thicker (p < 0.001) 
than the BM (36.0 ± 14.7 μm thickness) for the PGSU-BM scaffold. 
Finally, in Table 4.3, a summary of the scaffolds fabricated in this chapter are 
shown. Multiple pore structures, pore orientations, pore sizes and permeabilities were 






Figure 4.21: SEM images of PGSU-trilayer. A1-2) Top section, B1-2) Bottom section and C1-4) cross section. (C3 = PGSU-15% and C4 = PGSU-10%). The schematic demonstrates the 







Figure 4.22: PGSU-trilayer pore size was measured from the cross section (CS) and bottom. Since the scaffold is 
consisted of three layers and the first layer is low porosity, the other two layers were measured and plotted 
separately. CS = cross section. Results are shown as mean ± standard deviation, n=50, *** when p < 0.001. 
 
Figure 4.23: Water permeability of the PGSU-trilayer measured longitudinal to the scaffold. Results are shown as 
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Figure 4.24: Water permeability of all PGSU scaffolds fabricated for this chapter. 
Statistical significance was found in all multiple comparison cases, except PGSU-
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4.3.3. Oral mucosa in vitro cell culture 
For OMTE, the PGSU-BM scaffold was chosen, shown in Figure 4.18, as it had the 
thinnest low porosity layer that was expected to act as basement membrane to keep 
the keratinocytes from penetrating the inner porous structure of the scaffold (the area 
where fibroblasts are expected to reside). The aim of this part of the work was to 
demonstrate our ability to produce a scaffold with biomimetic microstructure that had 
a second layer which functions as a cell barrier but allows cell communication and 
gas/nutrient exchange. We approached this study systematically and it began with 
studying the ability of oral keratinocytes to adhere on the scaffold and to be 
metabolically active. 
4.3.3.1. OKF6 cell attachment on PGSU-film 
PGSU-films were seeded with OKF6 cells (1.0 x 106 cells) to characterise the ability 
of the cells to adhere on the surface of the film. Cells cultured on TCP were considered 
as the positive control. Resazurin assay over 9 days showed a significant increase in 
metabolic activity between days 3 – 9 and days 6 – 9 indicating that the OKF6 cells 
adhered on the PGSU films and were metabolically active (Figure 4.25 (A)). When 
normalised against the positive control a significant decrease in metabolic activity was 
found between days 3 and 6, which then a significant increase was observed reaching 
approximately ~20% of the TCP, Figure 4.25 (B). The samples were also imaged after 
every resazurin assay, shown in Figure 4.26, to quantify the staining progression on 
the PGSU-films. It was observed that the staining intensity increased between days 





Figure 4.25: PGSU films seeded with OKF6. (A) The absorbance obtained from OKF6 cultured on PGSU films 
and TCP which served as the positive control; (B) Normalised absorbance against the positive control (TCP) of the 
resazurin assay for all 9 days, Results are shown as mean ± standard deviation, n=3 in triplicates, *** when 
p < 0.001. 
 
Figure 4.26: Images taken from the samples after resazurin assay at each time point. A) day 3, B) day 6 and C) day 
9. PC = positive control, cells cultured on TCP; NC = negative control, acellular films. 
The samples were also stained with live/dead to determine the ratio between live 
and dead cells. The samples were visualised using a brightfield microscope and a 
fluorescence microscope. Looking at the positive control (cells cultured on TCP), 
Figure 4.27 (A1-2), most of the cells were alive at a high confluency with a very small 
number of dead cells. In the case of PGSU-film, the cells were visible when brightfield 




on the PGSU material and it was not possible to visualise the cells under the 
fluorescence microscope. To confirm that this was an issue from the PGSU-film 
material and cells were not dead, we performed the same assay on acellular PGSU-
films in which case it should not have any dye attached to it, but it can be seen in (C2) 
that the sample is again completely covered with the red dye. Furthermore, the 
autofluorescence of the PGSU-film was examined and compared with the 
autofluorescence of TCP, shown in Figure 4.27 (D1-2 and E1-2). A slight 
autofluorescence is observed from the PGSU-film, however not as evident as the 





Figure 4.27: OKF6 cells cultured on PGSU-film for 9 days and stained with live/dead assay. A1-2) TCP, B1-2) 
PGSU-film, C1-2) NC, D1-2) autofluorescence of TCP and E1-2) autofluorescence of PGSU with the 




4.3.3.2. NOK attachment on PGSU-films 
Similar behaviour to the OKF6 was noticed for the NOK cell attachment study. It was 
found that the NOKs were metabolically active on the PGSU-films and a significant 
increase was found between days 3 – 9 and days 6 – 9, Figure 4.28 (A). When the 
results were normalised against the positive control, again a significant increase was 
found between day 3 – 9 and days 6 - 9 however the activity was not as high as the 
TCP control, reaching slightly over ~22% at day 9 (Figure 4.28 (B)). 
 
Figure 4.28: PGSU films seeded with NOK cells. (A) The absorbance obtained from NOK cultured on PGSU films 
and TCP which served as the positive control; (B) Normalised absorbance against the positive control (TCP) of the 
resazurin assay for all 9 days, Results are shown as mean ± standard deviation, n=3 in triplicates, *** when 
p < 0.001. 
4.3.3.3. Dynamic seeding 
An issue we had when passively seeding the PGSU-scaffolds was that the cells were 
not penetrating the internal area of the sample, see Figure 3.14. This is thought to be 
due to the hydrophobicity (water contact angle = 106.7 ± 4.5o for the PGSU-2.5% 
scaffold, shown in Figure 2.21) of the PGSU and the lack of stimuli encouraging cell 
penetration. Therefore, dynamic seeding was used which was a method though which 
cells could be pushed inside the scaffold. Comparing the histological images from 




scaffolds that were passively seeded (Figure 4.29 (A1, 2)) compared to the 
dynamically seeded (Figure 4.29 (B1, 2)). Additionally, a better cell distribution was 
observed with cells distributed all over the internal structure of the PGSU-5% scaffold. 
 
Figure 4.29: Histology (H&E) of PGSU-10% scaffolds seeded with L929 fibroblasts using (A1 and A2) Static (B1 
and B2) Vacuum seeding. Scale bar is 50 μm. n=3. 
Sirius red was also used to investigate the effect that the cell seeding method had 
on the collagen production, Figure 4.30. No significant difference was found between 






Figure 4.30: Collagen produced on the scaffolds measured using Sirius red and standardised using the standard 
curve in chapter 3. The results are demonstrated as a percentage of collagen mass per dry sample's mass. Results 
are shown as mean ± standard deviation, n=3. 
4.3.3.4. Human oral cells co-culture  
With the results described above, it was confirmed that oral keratinocytes can adhere 
on the PGSU-film and dynamic seeding leads to better cell seeding efficiency and 
distribution. Therefore, the final experiment performed for this study was to seed 
human oral cells in co-culture on PGSU-BM scaffolds for 15 days. Sirius red was used 
to quantify collagen production and immunohistochemistry was used to stain the 
cytokeratin which are keratin proteins found inside the intracytoplasmic cytoskeleton 
of epithelial cells.  
Figure 4.31, shows the collagen produced within the scaffolds during the 15 days 
culture compared to PGSU-5% (from Chapter 3) and DED (which is predominantly 
made from collagen). As expected the DED (54.4 ± 6.5 %) resulted to a significantly 




5% (7.5 ± 2.6 %), however no significant difference was found between the PGSU-
BM and PGSU-5% scaffolds. 
 
Figure 4.31: Collagen produced on the scaffolds measured using Sirius red and standardised using the standard 
curve in Chapter 3. The results are demonstrated as percentage of collagen mass against the scaffolds dry mass. 
PGSU-5% is from Chapter 3 and is there for comparison reasons. Results are shown as mean ± standard deviation, 
n=3, *** when p < 0.001. 
Figure 4.32 (A1-2), show the H&E stained samples with multiple layers of cells 
found on the BM of the scaffold and a good distribution of cells dispersed in the porous 
part of scaffold. When the cytokeratin antibody was used (AE1/3) it showed that the 
NOK cells migrated and proliferated laterally over the BM surface with limited 







Figure 4.32: Representative sections from PGSU-BM samples after cell co-culture with NTF and NOK. A1-2) 
are PGSU-BM stained with H&E, B1-2) immunohistochemically stained PGSU-BM with AE1/AE3. n=3. Scale 
bar is 100 μm. 
4.4. Discussion 
The aim of this chapter was to identify tissues with different microstructures and to 
fabricate PGSU scaffolds using ice templating, airbrushing and mould technology 




special ECM microstructures (isotropic, anisotropic and multilayer) and we utilised 
the techniques mentioned above to mimic their native architecture. Since the main 
objective of this thesis was to fabricate PGSU scaffolds for OMTE, we concluded this 
chapter with results demonstrating the development of PGSU scaffolds for OMTE 
with a structured scaffold which could support cell co-culture while providing an 
environment that promotes tissue generation. 
The objective of ice templating (also known as modified thermal induced phase 
separation (mTIPS)) is to control the microstructure of the scaffold by controlling the 
ice crystal formation. Ice templating is not a new technology, and there are numerous 
studies that used it to fabricate anisotropic scaffolds for a range of applications, 
including cartilage, skeletal muscle, tendons and neurons [211, 218, 219]. To 
characterise the ice templating and mould technology we investigated the thermal 
profiles of the in-house moulds. These moulds were carefully designed to allow heat 
to enter the polymer solution in an isotropic or anisotropic manner dependent on the 
end product. These different moulds enabled (i) the polymer solution to freeze 
uniformly, with heat distributed evenly from multiple directions within the polymer 
solution to create a uniform isotropic (random) structure; and (ii) the polymer solution 
to freeze from only one direction, with heat distributed evenly but from one direction 
to create a uniform anisotropic (oriented) structure. Most of the ice templating methods 
used in previous studies involved a glass tube where it is lowered into liquid nitrogen 
at a control rate which results in unidirectional freezing [211, 218]. This methodology 
results in good anisotropic structures however it requires more steps and more 
equipment, such as a moving platform for lowering the glass tube inside the liquid 
nitrogen bath. Additionally, the temperature of the bath cannot be controlled unless a 




the temperature; and in combination with the mould we directed the heat transfer in a 
uniform anisotropic or isotropic direction. For example, the polymer solution in 
mould-random froze at its bottom and top with only 2 min difference meaning that ice 
crystals were growing upwards and downwards almost simultaneously and within 5 
minutes the middle area of the solution was completely frozen. This isotropic heat 
transfer then converts to a uniform isotropic scaffold (Figure 4.7). However, when the 
walls of the mould were isolated using PTFE (low thermal conductivity) the polymer 
solution froze from the bottom to top, resulting in an anisotropic heat transfer therefore 
anisotropic scaffold microstructure (Figure 4.9 and Figure 4.12). The terms isotropic 
and anisotropic do not only refer to structural properties. The isotropic structure means 
that the scaffold exhibits the same properties (structural, mechanical, permeability 
properties etc.) when viewed from any direction, while anisotropic distributes the 
structural, mechanical and permeability properties to a specific direction (longitudinal 
to the pore alignment). In this study the mechanical properties of the anisotropic 
scaffolds were not characterised due to time limit, however we visualised their 
anisotropic structure using SEM and demonstrated their anisotropic behaviour by 
characterising their water permeability. Visually, the scaffolds exhibited the structure 
we expected, and reflected the results from the heat transfer results. 
Regarding the water permeability, we found significant difference when the 
scaffold was tested longitudinal to the pore alignment as opposed to transversely. This 
means that the permeability properties are anisotropic and that the gas/nutrient 
exchange is enhanced in the more permeable direction, which could direct the tissue 
development in the more permeable direction. We observed very high permeability 
for all the scaffolds. We found that all the scaffolds that were fabricated in this study 




in tissue engineering [183]. We believe this is due to the highly porous structure, with 
pores interconnected through mesopores forming a complex microstructure. These 
results demonstrate PGSU scaffolds are able to ensure an adequate transport of 
nutrients and waste during in vitro and in vivo cell culture. The isotropic and 
anisotropic PGSU scaffolds (PGSU-random, PGSU-vertical and PGSU-horizontal) 
are structured and could be used for one layer tissues such as adipose, tendon and 
nerve tissues, and they can also display anisotropic mechanical properties to promote 
guided tissue generation. These scaffolds should be further characterised specifically 
for each tissue. The mechanical properties found in previous chapters suggests PGSU 
is likely to be more suitable for tissues which have lower mechanical requirements 
such as adipose tissue compared to tissues such as tendon. 
Multilayer ECM structures are found when a tissue is composed from multiple cell 
types and functionalities. Such tissues could be skin and oral mucosa. These tissues 
have different tissue layers and are separated with a BM, which as mentioned earlier, 
functions by separating the tissue layers while allowing gas/nutrient exchange and cell 
communication. Research in fabricating multilayer scaffolds has been successful in 
the past, using multiple materials (collagen, PCL, PLGA) and fabrication techniques 
(porogen leaching, electrospinning, freeze drying, 3D printing) [220-222]. The aim of 
all these studies including this thesis is to mimic the complex hierarchical multilayer 
characteristics of native ECM which has been shown to guide tissue development and 
stem cell differentiation. Tissue development was enhanced mainly due to difference 
in pore size, porosity and mechanical properties. For example, in cartilage tissue 
engineering a bilayer scaffold was fabricated with PLGA and collagen [223]. These 
scaffolds were then seeded with mesenchymal stem cells (MSCs) and 4 months after 




cartilage and bone like tissues in each respective layer [223]. Here we propose a 
similar approach, but to fabricate the hierarchical multilayer scaffolds we combined 
two fabrication techniques, freeze drying and airbrushing, using the same polymer. 
The combination of these techniques allowed to design novel PGSU scaffolds that 
either exhibited a thin low porosity layer (BM like structure) or multiple porous layers 
with different pore structure, size and porosities. As the previous study the difference 
in pore structure, size and porosities is there to provide the appropriate structure for 
either MSCs to differentiate to localised specific cells or for those specific cells to be 
seeded individually and reside within a biomimetic environment. The BM like 
structure, as second or third layer of the scaffold is there to restrict the epithelial cells 
from penetrating to the porous section of the scaffold were fibroblasts are supposed to 
reside. It was found that any loss of full thickness skin that is more than 4 cm in 
diameter will not regenerate well without a graft, and when substantial amount of skin 
is needed autologous skin cannot be used to reconstruct the defect [116]. Probably, 
PGSU-trilayer could be used to co-culture cells to develop a hypodermis (bottom 
layer), dermis (middle layer, and epidermis (on top of BM-layer). It was important 
though to make sure that the transportation for gas and nutrients was sufficient to allow 
cell survival and cell communication since epithelial cells require signals, in the form 
of growth factors, to attach and be metabolically active. For this reason, we 
characterised the permeability of the scaffolds with BM (PGSU-BM and PGSU-
trilayer) to determine if the non-porous film would allow sufficient water transport. 
We found that the PGSU-BM had high water permeability and it was significantly 
higher than all the other scaffolds in this chapter except the PGSU-horizontal, even 
higher than the PGSU-vertical which was not expected since it is a one layer porous 




10% but the PGSU-BM was made using PGSU-5% despite the fact that it had a low 
porosity film as a second layer. However, the PGSU-trilayer had the lowest water 
permeability than all other scaffolds but had the same BM layer with the PGSU-BM 
which indicates that as long as the BM is thin, the porous structure afterwards is what 
determines the permeability of the scaffold. 
Unfortunately, oral mucosa was never characterised for its BM thickness but as 
mentioned earlier, oral mucosa and skin have many similarities. Natively, human skin 
BM has a thickness of 0.5 – 1.0 μm [224], which is significantly thinner than the BM-
like layer of the PGSU-BM (36.0 ± 14.7 μm). Hence, to fabricate a biomimetic BM 
like structure is extremely difficult. 
With the SEM images and permeability results we were able to proceed with co-
culturing oral mucosa cells on the PGSU-BM scaffolds and investigate its structural 
ability to separate the cell layers and assess the collagen production. A step by step 
approach was used to examine this. The oral mucosa is comprised from two cell types, 
keratinocytes and fibroblasts, and because of seeding issues found in the previous 
chapters we decided to assess first the keratinocyte adherence and then the fibroblast 
seeding efficiency individually prior to the co-culture.   Ralston et al. studied the 
epidermal keratinocytes cell attachment with and without fibroblasts and found that 
fibroblasts are essential for keratinocytes attachment and proliferation [225]. They 
also showed that both cell types are required to maintain a BM [225]. Furthermore, a 
study by Vintermyr et al. has showed that fibroblasts are necessary for oral epithelial 
development and thickening in oral models [226]. Therefore, we began to assess the 
keratinocyte viability on PGSU-films using OKF6. The reason for using OKF6 was 
the fact that these cells do not require fibroblasts to be able to adhere and proliferate 




their metabolic activity over the 9 days culture, but not as metabolically active as the 
positive control. This is because of the seeding technique. It is extremely difficult to 
seed cells on a hydrophobic non-porous film without losing a large portion of cells to 
the TCP. Nevertheless, when the samples were imaged, cells were attached in a 
confluent layer on the PGSU-film which allowed us to move to the next step of this 
chapter. Another observation was that the live/dead stain was unsuitable for use with 
the PGSU-film. This is believed to be because of the propidium iodide was absorbed 
by the material itself, therefore masking the green dye, which was confirmed by the 
negative control without cells. We also assessed the metabolic activity of NOKs on 
PGSU-films and similar results as OKF6 were observed. These positive results 
allowed us to then move to optimising the fibroblast seeding technique. 
In the previous chapters we showed that cell distribution was poor when cells were 
seeded passively, since passive seeding relies on the hydrophilicity of the material 
(which is low for PGSU) and gravity only to encourage cell infiltration. Previous work 
by Solchaga et al. [217] showed that dynamic seeding was able to improve cell 
distribution for 3D scaffolds and we modified their protocol to suit our scaffolds. 
Dynamic cell seeding works by placing the scaffold under vacuum to remove the air 
from the chamber and from the pores of the scaffold. The result is, when the air 
pressure returns to atmospheric pressure the returning air passes through the 
media/cell suspension that is overlaying the scaffold pushing it inside the pores of the 
scaffold. Repeating this vacuum/ventilation cycle resulted into a uniform cell 
distribution. As a results fibroblast cells were well distributed within the porous 
structure of the scaffold, which should result in better cell growth as cells have higher 
surface area to grow in. The success of the dynamic seeding technique used in this 




This in-house, easy to make, sterile chamber functioned by sterilising the returning air 
entering the scaffold. During the first attempt of the dynamic seeding a sterile chamber 
was not used and caused a rapid contamination which killed all the cells. 
During cell co-culture, using NOK and NTF, we managed to combine static seeding 
and dynamic seeding for each cell type respectively. We methodically seeded the 
scaffolds with NTF and NOK following published co-culture methods in engineering 
oral mucosa tissue equivalents using DED [2, 228, 229]. We quantified the collagen 
produced during co-culture and compared it against the DED and PGSU-5% (results 
from Chapter 3, Figure 3.16). As expected DED had significantly higher collagen 
concentration in comparison to the other two, because it is predominantly made out of 
collagen (skin collagen content is 60-80 % [197]). What was interesting from this 
experiment was the higher collagen produced from the PGSU-BM during co-culture 
(NOKs and NTFs) compared to PGSU-5% during monoculture (L929 cells). We 
believe this is because of different fibroblast cells used, but most importantly we 
believe the NOKs promoted NTF proliferation and production of ECM because of 
growth factors that keratinocytes secrete (platelet-derived growth factors) [230].  The 
PGSU-BM scaffolds facilitated a structural support for cell co-culture, by separating 
the cell layers restricting cell penetration while providing a surface for the NOK to 
develop an epithelium. The cytokeratin staining was observed throughout the 
epithelial layer demonstrating these cells maintained their phenotype however the 
intensity of staining observed did not increase in intensity in the lower third of the 
epithelium as in the work of Colley et al. [2]. This is possibly because cells were not 
cultured long enough at ALI or that the epithelium was not as mature cells grown on 
the dermal scaffold. The NOKs within the epithelial layer of the PGSU-BM had 




work of Colley et al. [2], but lower cell confluency and tissue development was also 
evident. This could be due to NOK variation between patients but we believe longer 
culture period is necessary to characterise the tissue development. 
Further examination is required, however we managed to demonstrate our ability 
to fabricate synthetic scaffolds for, but not limited to, oral mucosa tissue engineering. 
With some improvements on fabrication and cell co-culture methods such scaffolds 
have the potential to be used as an oral mucosa tissue equivalent to measure toxicity, 
drug delivery and to model oral diseases (similar to [2, 228, 231]) but also for the 
purpose of regenerating oral mucosa tissue defects. DED has multiple advantages such 
as good durability, can retain its structural ability and lwo antigenicity, but lacks in 
fibroblast infiltration and there is limited availability [15]. Natural scaffolds used in 
OMTE such as gelatin-base scaffolds which promote epitheliasation; and collagen-
based scaffolds which support excellent fibroblast growth; have the disadvantages of 
not being available in large quantities (limits their scalability), batch-to-batch variation 
(limits their reproducibility) and low range of physical properties (mechanical 
properties, degradation rate) [15]. The advantages of the above mentioned scaffolds 
could be achieved from the PGSU-BM scaffolds which allowed keratinocyte 
attachment, limited cell infiltration, an early development of epithelium and collagen 
production. Additionally, synthetic PGSU solves their disadvantages as well. In terms 
of: scalability, large quantities of PGSU can be synthesised and fabricated at a low 
cost; the scaffold is reproducible, with controlled chemical synthesis and freeze drying 
the reproducibility could be high; and physical properties, there are multiple ways to 
alter both the mechanical properties and degradation rates (change the reactant ratio, 
change polymer concentration). Furthermore, as demonstrated in this chapter, multiple 




influence the differentiation of MSCs into specific localised cells [232], making the 
scaffold a potential candidate for stem cell delivery, acting as not just a cell carier but 
also as a guide to stem cell differentiation. As mentioned in the litarature review, the 
native basement membrane functions by orchistrating growth factor-mediated 
extracellular communication, cellular adhesion, migration and differentiation [10]. 
Despite the fact that this was not tested in this thesis, it is extremely difficult to 
fabricate a synthetic BM with the native functionality. However, it is possible to mimic 
the structure functionality of BM, which is to keep the two tissue layers seperated 
while allowing cell communication. With this in mind, the PGSU-BM had some 
success in seperating the cell layers by restricting cell infiltration, however more 
studies are necessary to fully characterise its ability to mimic the structure 
functionality of native BM. 
4.5. Conclusion 
In this chapter we demonstrate that: 
1. Combining freeze drying with mould technology produced uniform isotropic 
and anisotropic scaffolds. 
2. Combining freeze drying with mould technology and airbrushing produced 
scaffolds with complex, hierarchical, multilayer scaffolds with different pore 
structure, pore sizes and porosities. 
3. PGSU scaffolds can be fabricated with a second layer that resembles the cell 
separation functionality of BM (PGSU-BM). 
4. The BM of PGSU-BM successfully acted as a cell barrier with limited cell 




5. PGSU scaffolds seeded with oral cells produced collagen indicating tissue 
generation and ECM production over 15 days. 
In conclusion it was found that the in-house designed moulds could direct the heat 
transfer during pre-freeze stage concluding to anisotropic PGSU scaffolds. Potential 
applications of these scaffolds are tissues that exhibit anisotropic structure however 
these scaffolds were not characterised for their physical and biological properties and 
these scaffolds can be examined in future work. Furthermore, multilayer scaffolds 
were also fabricated, and PGSU-BM was used to co-culture oral cells focusing on 
assessing their ability to sustain cell growth and restrict cell infiltration. It was found 
that normal oral keratinocytes could grow on the surface of the PGSU and low cell 
infiltration was evident during immunohistochemistry. Additionally, the scaffold 
provided an environment for the fibroblast cells to start producing ECM. Nevertheless, 
more research is required into PGSU scaffolds to understand their potential in oral 




Chapter 5 Conclusions and suggestions for future work 
5.1. Conclusions 
The overall aim of this thesis was to develop PGSU scaffolds with a focus on specific 
microstructures and mechanical properties that are similar to the native oral mucosa 
tissue. In each individual chapter the key findings were identified and discussed. The 
major conclusions from each chapter are underlined below. 
Before testing our first hypothesis, PGSU scaffolds were fabricated using different 
freeze drying cycles to try and achieve a uniform microstructure. For PGSU-2.5% this 
was not possible at any of the three freezing temperatures used, most probably due to 
the mould. However, we used these scaffolds to characterise the effect that the 
sterilisation method has on them. It was found that the scaffolds could be sterilised 
with all three methods used in Chapter 2 (70% Ethanol, 0.1% PAA and autoclave) 
without any significant difference between their chemical structure, mechanical 
properties and cell metabolic activity. This part of the thesis did not have a significant 
contribution into the science of TE, but since it was the first time that PGSU scaffolds 
were fabricated it was important to set a starting point in order to understand what had 
to be improved before testing the scaffold for OMTE. From Chapter 2 we concluded 
to that the scaffolds required an improvement on their microstructure (more uniform), 
mechanical properties (try to achieve biomimetic to oral mucosa’s mechanical 
properties) and improve the cell culture techniques (seeding and culture). 
To test our first hypothesis, we focused on improving the freeze drying protocol, 
improve the microstructure and mechanical properties of the scaffolds, and perform a 
longer more reproducible cell culture. The freeze drying protocol was improved by 




the mould) and changing the polymer concentration during synthesis. The polymer 
concentration also caused an increase on the mechanical properties of the scaffolds 
due to more material present within the scaffold and less void space. By reducing the 
void space (porosity), the pore size was also reduced which resulted into low cell 
infiltration, however it did not affect the cell metabolic activity. It did however affect 
the tissue generation by reducing the amount of collagen produced by the fibroblast 
cells. We also showed that the PGSU scaffolds (all three polymer concentrations) 
exhibited elastomeric properties with almost no loss in shape and mechanical strength 
during cyclic tensile loading. This property is an advantage over all the other synthetic 
materials used in OMTE, and it is needed if biomimicry is wished to be achieved. 
Therefore, considering our first hypothesis it can be concluded that it was found to be 
true, as adjusting the polymer concentration allowed us to adjust the microstructure, 
mechanical properties and degradation rate of the PGSU scaffolds. Our second 
hypothesis was also found to be partially true, as the scaffold microstructure affected 
protein production but did not affect cell metabolic activity. By the end of this chapter 
it was realised that PGSU-5% is a scaffold that might be a good candidate to be used 
in OMTE. The only limitation that was evident at this point was the mechanical 
properties of the PGSU-5% were significantly lower than oral mucosa. According to 
the definition of biocompatibility this might be an issue, however, collagen was found 
to be successful in OMTE and skin TE and in both cases collagen has significantly 
lower mechanical properties than both tissues. Having lower mechanical properties 
when the scaffold is implanted might be a disadvantage because it makes it susceptible 
to breaking and failing, but if the material can facilitate co-culture, degrades linearly 




may end up matching the ones of the native tissue that they are replacing, as in the 
case of collagen scaffolds. 
We believed that the reason that lower collagen production was found from the 
higher polymer concentration scaffolds was mainly because of the lack of cell 
infiltration within the scaffold, which reduced the surface area that cells could work 
with and produce their ECM. Therefore, we used a vacuum seeding technique that 
significantly improved the seeding efficiency. However, after cell culture and Sirius 
red, the collagen produced was not significantly different between seeding techniques 
(static and vacuum seeding). Therefore, most probably the porosity of the scaffold that 
influences the protein production but does not affect the cell metabolic activity. 
Nevertheless, the vacuum seeding technique demonstrated in this thesis could be used 
with other scaffolds and cells as well. By adjusting the speed and number of the 
vacuum/ventilation cycles most scaffolds can be dynamically seeded with no need of 
advanced equipment. 
Since freeze drying was used extensively in this thesis it was of interest to attempt 
in complicating the microstructure of the scaffolds aiming to fabricate PGSU scaffolds 
with a BM-like layer. Having a second layer which provides the structural 
functionality of the native BM was hypothesised to be beneficial by allowing cell co-
culture without epithelial cells infiltrating the lamina propria area of the scaffold, or 
fibroblasts infiltrating into the epithelium. This infiltration issue was seen from 
collagen scaffolds, where epithelial islands were formed inside the porous area of the 
collagen scaffolds. During the exploitation of freeze drying it was realised that 
interesting scaffold microstructures could be achieved by using the knowledge gained 
from Chapter 3 (polymer concentration affects porosity and pore size) and directing 




were fabricated with layers distinguished by their pore alignment or porosity/pore size. 
These scaffolds were not characterised fully, but they demonstrated a proof of concept 
and supported the second hypothesis of this thesis that stated that using freeze drying, 
multiple layer scaffolds can be fabricated to mimic the native tissue aiming to replace. 
These native tissues could be skin (PGSU-trilayer) and tendon (PGSU-horizontal), 
however these scaffolds should be characterised fully for their specific application 
before concluding to their TE impact. Furthermore, the fabrication techniques 
demonstrated in this thesis can be used with other materials, that have been shown to 
be optimum for their target tissue but are lacking the complex, hierarchical multilayer 
ECM structure that the native tissue exhibits. 
Nevertheless, the aims and objectives of this work was about fabricating scaffolds 
for OMTE. Since epithelial cells do not require a porous structure, but a surface to 
adhere and proliferate, while fibroblasts require a porous structure to develop into a 
connective tissue, it was logical to fabricate a scaffold that exhibited a porous layer 
and a thin film on top. The porous layer was decided to be the one achieved from the 
PGSU-5% scaffold since the best biological results were achieved by it making it the 
best candidate for lamina propria development. However, a reproducible second thin 
layer was difficult to achieve using freeze drying alone, hence the use of airbrushing. 
Airbrushing was recently developed, and it was used to fabricate nanosized fibres. 
Since the native BM of oral mucosa is ~1 μm thick, airbrushing was assumed to be a 
good technique to achieve this. The 1 μm thickness was not achieved in this thesis, but 
an approximately ~36 μm which is significantly thicker than the native BM of oral 
mucosa. This occurred because of the methods used during airbrushing and it can be 
improved and optimised in future works. When these scaffolds were used for oral cell 




cell infiltration while early stages of epithelium development was evident. From these 
findings we can conclude that the third and final hypothesis of this thesis is true, but 
improvements are necessary to optimise the PGSU-BM scaffold. The results 
histological/immunohistochemical results were not completely resembling the native 
oral mucosa nor oral mucosa equivalents developed using EVPOME or DED, but with 
improvements into the fabrication, seeding and culture methods these results could 
improve and add to the development of synthetic scaffolds for OMTE. 
The PGSU scaffold in general was found to be an interesting material for TE. It 
allowed to be fabricated with multiple microstructures, mechanical properties and 
degradation rates, and certainly the range can be expanded by changing freeze drying 
protocols and reactants molar ratio. This material also demonstrated that it can 
facilitate cell attachment and activity as well as collagen production, which are very 
important in the field of TE. While not being an advantage over other materials, these 
scaffolds have not been significantly investigated by the scientific community 
surrounding biomaterials and TE but results from this thesis support that it can be 
potentially used in soft tissue engineering. Furthermore, the freeze drying techniques 
developed and used in this thesis has shown the flexibility of freeze drying as a 
fabrication technique. All the freeze drying techniques as well as the mould technology 
used can be used with other materials too, for example collagen. Since collagen has 
attracted lots of attention for its use in TE trying to mimic the microstructure of the 
target tissue may be beneficial. Finally, this thesis has shown that airbrushing can be 
used to fabricate BM-like layer with PGSU, but generally speaking it can be used to 
fabricate any soluble biomaterial into a thin BM-like layer. While not a true 
biomimetic BM because of the biological complexity involved in the native BM, 




can be used to overlay a collagen scaffold which has shown to form epithelial islands 
within its connective tissue area to restrict the cell infiltration. 
In conclusion, by identifying some specific limitations in OMTE and PGSU 
scaffolds we developed methods to address them in a methodical manner. The field of 
OMTE lacks from synthetic scaffolds that exhibit elastomeric properties with the 
ability to recover their shape and strength after loading. Therefore, we developed 
PGSU scaffolds that are elastomeric with recoverable shape and strength, degrade 
linearly, and exhibit specific physical features to allow cell culture and tissue 
development. These physical properties were the pore size, pore structure, 
permeability and oral mucosa biomimetic structure. It was demonstrated that the BM-
like scaffold functioned by restricting the oral keratinocytes from infiltrating to the 
lamina propria. These scaffolds could have a great impact in OMTE because it solves 
multiple disadvantages that scaffolds exhibit in this field. 
5.2. Future Work 
We believe PGSU scaffolds have a great potential in TE. Through this study we 
demonstrated that scaffolds can be fabricated with multiple pore size/porosities and 
different microstructure architectures that exhibit similar structure properties with oral 
mucosa, skin and other soft tissues. However, more characterisation and 
improvements are necessary to demonstrate PGSU’s full potential in TE and this can 
be done in future work. Future research work should firstly address in improving the 
PGSU scaffold for OMTE, use sterilisation methods that are applied clinically and 
investigate the potential of PGSU in other soft TE applications. 
Regarding PGSU in OMTE, the scaffold mechanical properties should be improved 




reactants molar ratio which according to literature the mechanical properties of PGSU 
increase approximately by 2-folds when the reactants molar ratio is altered from 1:0.6 
(used in this thesis) to 1:1. Furthermore, a complete assessment should be done on the 
fabrication technique used to introduce a BM-like layer by assessing its microstructure 
using transmission electron microscopy (TEM) to visualise the BM-like layer at the 
nanoscale and characterise its nanostructure. The airbrushing technique should also be 
improved by changing the nozzle size, distance of spraying, volume and polymer 
concentration of the polymer solution in order to achieve a thinner more biomimetic 
2nd layer. The optimised PGSU-BM scaffold should then be characterised for its 
tensile and compression properties as well as its suitability to culture oral keratinocytes 
and fibroblast cells. The oral mucosa tissue development should also be assessed using 
cell proliferation assays (DNA assay) and histology/immunohistochemistry. The 
sterilisation method may have tremendous effects on the scaffold’s chemical structure, 
microstructure, mechanical properties and sometimes biological properties. For the 
purpose of using the optimised PGSU scaffolds clinically, conventional and approved 
clinical sterilisation methods should be examined, such as sterilisation by ethylene 
oxide and gamma irradiation. Establishing a solid clinically approved sterilisation 
method that has minimal or no effect on the scaffold’s tissue engineering abilities will 
improve its potential for clinical use. Finally, these scaffolds should be examined in 
pre-clinical animal models to assess their in vivo biocompatibility, tissue development 
and angiogenesis. 
Future research work may also involve developing PGSU scaffolds using the 
fabrication techniques of this thesis for other tissue applications. For example, the field 
of tendon tissue engineering is growing because of tendon’s low regenerative capacity. 




and/or mesenchymal stem cells to engineer a tendon tissue for tendon therapy. 
Literature suggests that the anisotropic nature of the PGSU scaffolds will guide the 
tissue development to mimic the tendon tissue. For this specific application the PGSU-
horizontal scaffolds can be fabricated and the mechanical properties of the scaffold 
will probably need to be enhanced by increasing the reactant ratio, and we believe the 
anisotropic structure of the scaffold will direct the mechanical properties along the 
mechanical loading axis. Furthermore, if mesenchymal stem cells are to be used, 
literature has shown that proteins such as bone-morphogenic protein-12 (BMP-12) can 
guide stem cell differentiation into tenocytes. Therefore, loading PGSU-horizontal 
with BMP-12 can be beneficial. For drug loading it is hypothesised that BMP-12 can 
be loaded into collagen nanoparticles to protect the protein during PGSU synthesis. 
Since drug release properties will be exhibited form the PGSU scaffolds, a complete 
characterisation into drug release kinetics should be performed. 
Furthermore, cartilage is a more complex tissue with low regenerative capacity. 
The need for cartilage tissue engineering is increasing due to the increase in physical 
activities and longer life span, which renders it impossible for the cartilage to 
synchronise its regeneration with its degeneration. Trilayer PGSU scaffolds with 
different pore orientations can be used to mimic the native ECM of cartilage. 
Compression properties of these scaffolds should be characterised and optimised to 
function similar to cartilage tissue. The biomimetic microstructure and mechanical 
properties could provide guided stem cell differentiation into localised cells and tissue 
generation. Growth factors could also be loaded in the scaffolds with similar methods 
as suggested above to promote stem cell differentiation. 
Finally, regenerating skin tissue can also be a future application of PGSU-BM. 




epidermis and dermis.  Reconstruction of full thickness burn injuries (more than 4 cm 
in diameter) is necessary as it will not heal well without surgical intervention. In this 
case PGSU-BM should be approached as suggested for OMTE but its mechanical 
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